id	sid	tid	token	lemma	pos
cord-011302-pfepyvaw	1	1	key	key	JJ
cord-011302-pfepyvaw	1	2	:	:	:
cord-011302-pfepyvaw	1	3	cord-011302-pfepyvaw	cord-011302-pfepyvaw	JJ
cord-011302-pfepyvaw	1	4	authors	author	NNS
cord-011302-pfepyvaw	1	5	:	:	:
cord-011302-pfepyvaw	1	6	Edlmann	Edlmann	NNP
cord-011302-pfepyvaw	1	7	,	,	,
cord-011302-pfepyvaw	1	8	Ellie	Ellie	NNP
cord-011302-pfepyvaw	1	9	;	;	:
cord-011302-pfepyvaw	1	10	Whitfield	Whitfield	NNP
cord-011302-pfepyvaw	1	11	,	,	,
cord-011302-pfepyvaw	1	12	Peter	Peter	NNP
cord-011302-pfepyvaw	1	13	C.	C.	NNP
cord-011302-pfepyvaw	1	14	title	title	NN
cord-011302-pfepyvaw	1	15	:	:	:
cord-011302-pfepyvaw	1	16	The	the	DT
cord-011302-pfepyvaw	1	17	changing	change	VBG
cord-011302-pfepyvaw	1	18	face	face	NN
cord-011302-pfepyvaw	1	19	of	of	IN
cord-011302-pfepyvaw	1	20	neurosurgery	neurosurgery	NN
cord-011302-pfepyvaw	1	21	for	for	IN
cord-011302-pfepyvaw	1	22	the	the	DT
cord-011302-pfepyvaw	1	23	older	old	JJR
cord-011302-pfepyvaw	1	24	person	person	NN
cord-011302-pfepyvaw	1	25	date	date	NN
cord-011302-pfepyvaw	1	26	:	:	:
cord-011302-pfepyvaw	1	27	2020	2020	CD
cord-011302-pfepyvaw	1	28	-	-	HYPH
cord-011302-pfepyvaw	1	29	04	04	CD
cord-011302-pfepyvaw	1	30	-	-	SYM
cord-011302-pfepyvaw	1	31	25	25	CD
cord-011302-pfepyvaw	1	32	journal	journal	NN
cord-011302-pfepyvaw	1	33	:	:	:
cord-011302-pfepyvaw	2	1	J	J	NNP
cord-011302-pfepyvaw	2	2	Neurol	Neurol	NNP
cord-011302-pfepyvaw	2	3	DOI	DOI	NNP
cord-011302-pfepyvaw	2	4	:	:	:
cord-011302-pfepyvaw	3	1	10.1007	10.1007	CD
cord-011302-pfepyvaw	3	2	/	/	SYM
cord-011302-pfepyvaw	3	3	s00415	s00415	NN
cord-011302-pfepyvaw	3	4	-	-	HYPH
cord-011302-pfepyvaw	3	5	020	020	CD
cord-011302-pfepyvaw	3	6	-	-	HYPH
cord-011302-pfepyvaw	3	7	09854	09854	CD
cord-011302-pfepyvaw	3	8	-	-	SYM
cord-011302-pfepyvaw	3	9	9	9	CD
cord-011302-pfepyvaw	3	10	sha	sha	NNP
cord-011302-pfepyvaw	3	11	:	:	:
cord-011302-pfepyvaw	3	12	717b69885ef54ac00216d998646fb04936ab51a9	717b69885ef54ac00216d998646fb04936ab51a9	NNP
cord-011302-pfepyvaw	3	13	doc_id	doc_id	NNP
cord-011302-pfepyvaw	3	14	:	:	:
cord-011302-pfepyvaw	3	15	11302	11302	CD
cord-011302-pfepyvaw	3	16	cord_uid	cord_uid	NNS
cord-011302-pfepyvaw	3	17	:	:	:
cord-011302-pfepyvaw	3	18	pfepyvaw	pfepyvaw	JJ
cord-011302-pfepyvaw	3	19	Increased	increased	JJ
cord-011302-pfepyvaw	3	20	life	life	NN
cord-011302-pfepyvaw	3	21	expectancy	expectancy	NN
cord-011302-pfepyvaw	3	22	and	and	CC
cord-011302-pfepyvaw	3	23	illness	illness	NN
cord-011302-pfepyvaw	3	24	prevention	prevention	NN
cord-011302-pfepyvaw	3	25	and	and	CC
cord-011302-pfepyvaw	3	26	treatment	treatment	NN
cord-011302-pfepyvaw	3	27	have	have	VBP
cord-011302-pfepyvaw	3	28	led	lead	VBN
cord-011302-pfepyvaw	3	29	to	to	IN
cord-011302-pfepyvaw	3	30	a	a	DT
cord-011302-pfepyvaw	3	31	growing	grow	VBG
cord-011302-pfepyvaw	3	32	population	population	NN
cord-011302-pfepyvaw	3	33	of	of	IN
cord-011302-pfepyvaw	3	34	older	old	JJR
cord-011302-pfepyvaw	3	35	patients	patient	NNS
cord-011302-pfepyvaw	3	36	.	.	.
cord-011302-pfepyvaw	4	1	These	these	DT
cord-011302-pfepyvaw	4	2	changes	change	NNS
cord-011302-pfepyvaw	4	3	in	in	IN
cord-011302-pfepyvaw	4	4	patient	patient	JJ
cord-011302-pfepyvaw	4	5	population	population	NN
cord-011302-pfepyvaw	4	6	are	be	VBP
cord-011302-pfepyvaw	4	7	apparent	apparent	JJ
cord-011302-pfepyvaw	4	8	in	in	IN
cord-011302-pfepyvaw	4	9	neurosurgery	neurosurgery	NNP
cord-011302-pfepyvaw	4	10	;	;	:
cord-011302-pfepyvaw	4	11	however	however	RB
cord-011302-pfepyvaw	4	12	,	,	,
cord-011302-pfepyvaw	4	13	relatively	relatively	RB
cord-011302-pfepyvaw	4	14	little	little	JJ
cord-011302-pfepyvaw	4	15	is	be	VBZ
cord-011302-pfepyvaw	4	16	reported	report	VBN
cord-011302-pfepyvaw	4	17	about	about	IN
cord-011302-pfepyvaw	4	18	specific	specific	JJ
cord-011302-pfepyvaw	4	19	outcomes	outcome	NNS
cord-011302-pfepyvaw	4	20	and	and	CC
cord-011302-pfepyvaw	4	21	prognostication	prognostication	NN
cord-011302-pfepyvaw	4	22	in	in	IN
cord-011302-pfepyvaw	4	23	this	this	DT
cord-011302-pfepyvaw	4	24	group	group	NN
cord-011302-pfepyvaw	4	25	.	.	.
cord-011302-pfepyvaw	5	1	This	this	DT
cord-011302-pfepyvaw	5	2	review	review	NN
cord-011302-pfepyvaw	5	3	summarises	summarise	VBZ
cord-011302-pfepyvaw	5	4	the	the	DT
cord-011302-pfepyvaw	5	5	challenges	challenge	NNS
cord-011302-pfepyvaw	5	6	and	and	CC
cord-011302-pfepyvaw	5	7	management	management	NN
cord-011302-pfepyvaw	5	8	changes	change	NNS
cord-011302-pfepyvaw	5	9	occurring	occur	VBG
cord-011302-pfepyvaw	5	10	in	in	IN
cord-011302-pfepyvaw	5	11	the	the	DT
cord-011302-pfepyvaw	5	12	treatment	treatment	NN
cord-011302-pfepyvaw	5	13	of	of	IN
cord-011302-pfepyvaw	5	14	three	three	CD
cord-011302-pfepyvaw	5	15	common	common	JJ
cord-011302-pfepyvaw	5	16	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	5	17	pathologies	pathology	NNS
cord-011302-pfepyvaw	5	18	;	;	,
cord-011302-pfepyvaw	5	19	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	5	20	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	5	21	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	5	22	,	,	,
cord-011302-pfepyvaw	5	23	head	head	NN
cord-011302-pfepyvaw	5	24	injury	injury	NN
cord-011302-pfepyvaw	5	25	,	,	,
cord-011302-pfepyvaw	5	26	and	and	CC
cord-011302-pfepyvaw	5	27	haemorrhagic	haemorrhagic	JJ
cord-011302-pfepyvaw	5	28	stroke	stroke	NN
cord-011302-pfepyvaw	5	29	.	.	.
cord-011302-pfepyvaw	6	1	A	a	DT
cord-011302-pfepyvaw	6	2	move	move	NN
cord-011302-pfepyvaw	6	3	towards	towards	IN
cord-011302-pfepyvaw	6	4	less	less	RBR
cord-011302-pfepyvaw	6	5	invasive	invasive	JJ
cord-011302-pfepyvaw	6	6	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	6	7	techniques	technique	NNS
cord-011302-pfepyvaw	6	8	has	have	VBZ
cord-011302-pfepyvaw	6	9	implications	implication	NNS
cord-011302-pfepyvaw	6	10	on	on	IN
cord-011302-pfepyvaw	6	11	the	the	DT
cord-011302-pfepyvaw	6	12	risk	risk	NN
cord-011302-pfepyvaw	6	13	–	–	:
cord-011302-pfepyvaw	6	14	benefit	benefit	NN
cord-011302-pfepyvaw	6	15	profile	profile	NN
cord-011302-pfepyvaw	6	16	of	of	IN
cord-011302-pfepyvaw	6	17	interventions	intervention	NNS
cord-011302-pfepyvaw	6	18	.	.	.
cord-011302-pfepyvaw	7	1	This	this	DT
cord-011302-pfepyvaw	7	2	creates	create	VBZ
cord-011302-pfepyvaw	7	3	the	the	DT
cord-011302-pfepyvaw	7	4	opportunity	opportunity	NN
cord-011302-pfepyvaw	7	5	to	to	TO
cord-011302-pfepyvaw	7	6	intervene	intervene	VB
cord-011302-pfepyvaw	7	7	in	in	IN
cord-011302-pfepyvaw	7	8	older	old	JJR
cord-011302-pfepyvaw	7	9	patients	patient	NNS
cord-011302-pfepyvaw	7	10	with	with	IN
cord-011302-pfepyvaw	7	11	greater	great	JJR
cord-011302-pfepyvaw	7	12	co	co	NN
cord-011302-pfepyvaw	7	13	-	-	NN
cord-011302-pfepyvaw	7	14	morbidity	morbidity	JJ
cord-011302-pfepyvaw	7	15	,	,	,
cord-011302-pfepyvaw	7	16	as	as	RB
cord-011302-pfepyvaw	7	17	long	long	RB
cord-011302-pfepyvaw	7	18	as	as	IN
cord-011302-pfepyvaw	7	19	improved	improve	VBN
cord-011302-pfepyvaw	7	20	outcomes	outcome	NNS
cord-011302-pfepyvaw	7	21	can	can	MD
cord-011302-pfepyvaw	7	22	be	be	VB
cord-011302-pfepyvaw	7	23	evidenced	evidence	VBN
cord-011302-pfepyvaw	7	24	.	.	.
cord-011302-pfepyvaw	8	1	A	a	DT
cord-011302-pfepyvaw	8	2	critical	critical	JJ
cord-011302-pfepyvaw	8	3	part	part	NN
cord-011302-pfepyvaw	8	4	of	of	IN
cord-011302-pfepyvaw	8	5	assessing	assess	VBG
cord-011302-pfepyvaw	8	6	appropriateness	appropriateness	NN
cord-011302-pfepyvaw	8	7	for	for	IN
cord-011302-pfepyvaw	8	8	surgical	surgical	JJ
cord-011302-pfepyvaw	8	9	intervention	intervention	NN
cord-011302-pfepyvaw	8	10	in	in	IN
cord-011302-pfepyvaw	8	11	older	old	JJR
cord-011302-pfepyvaw	8	12	patients	patient	NNS
cord-011302-pfepyvaw	8	13	may	may	MD
cord-011302-pfepyvaw	8	14	be	be	VB
cord-011302-pfepyvaw	8	15	to	to	TO
cord-011302-pfepyvaw	8	16	change	change	VB
cord-011302-pfepyvaw	8	17	from	from	IN
cord-011302-pfepyvaw	8	18	a	a	DT
cord-011302-pfepyvaw	8	19	mindset	mindset	NN
cord-011302-pfepyvaw	8	20	of	of	IN
cord-011302-pfepyvaw	8	21	age	age	NN
cord-011302-pfepyvaw	8	22	to	to	IN
cord-011302-pfepyvaw	8	23	one	one	CD
cord-011302-pfepyvaw	8	24	of	of	IN
cord-011302-pfepyvaw	8	25	frailty	frailty	NN
cord-011302-pfepyvaw	8	26	and	and	CC
cord-011302-pfepyvaw	8	27	growing	grow	VBG
cord-011302-pfepyvaw	8	28	interest	interest	NN
cord-011302-pfepyvaw	8	29	in	in	IN
cord-011302-pfepyvaw	8	30	scales	scale	NNS
cord-011302-pfepyvaw	8	31	assessing	assess	VBG
cord-011302-pfepyvaw	8	32	this	this	DT
cord-011302-pfepyvaw	8	33	may	may	MD
cord-011302-pfepyvaw	8	34	aid	aid	VB
cord-011302-pfepyvaw	8	35	treatment	treatment	NN
cord-011302-pfepyvaw	8	36	decisions	decision	NNS
cord-011302-pfepyvaw	8	37	in	in	IN
cord-011302-pfepyvaw	8	38	the	the	DT
cord-011302-pfepyvaw	8	39	future	future	NN
cord-011302-pfepyvaw	8	40	.	.	.
cord-011302-pfepyvaw	9	1	Increased	increase	VBN
cord-011302-pfepyvaw	9	2	life	life	NN
cord-011302-pfepyvaw	9	3	expectancy	expectancy	NN
cord-011302-pfepyvaw	9	4	,	,	,
cord-011302-pfepyvaw	9	5	lower	low	JJR
cord-011302-pfepyvaw	9	6	operative	operative	JJ
cord-011302-pfepyvaw	9	7	morbidities	morbidity	NNS
cord-011302-pfepyvaw	9	8	,	,	,
cord-011302-pfepyvaw	9	9	and	and	CC
cord-011302-pfepyvaw	9	10	enhanced	enhanced	JJ
cord-011302-pfepyvaw	9	11	expectations	expectation	NNS
cord-011302-pfepyvaw	9	12	from	from	IN
cord-011302-pfepyvaw	9	13	patients	patient	NNS
cord-011302-pfepyvaw	9	14	and	and	CC
cord-011302-pfepyvaw	9	15	their	-PRON-	PRP$
cord-011302-pfepyvaw	9	16	families	family	NNS
cord-011302-pfepyvaw	9	17	has	have	VBZ
cord-011302-pfepyvaw	9	18	led	lead	VBN
cord-011302-pfepyvaw	9	19	to	to	IN
cord-011302-pfepyvaw	9	20	an	an	DT
cord-011302-pfepyvaw	9	21	increasing	increase	VBG
cord-011302-pfepyvaw	9	22	population	population	NN
cord-011302-pfepyvaw	9	23	of	of	IN
cord-011302-pfepyvaw	9	24	older	old	JJR
cord-011302-pfepyvaw	9	25	patients	patient	NNS
cord-011302-pfepyvaw	9	26	with	with	IN
cord-011302-pfepyvaw	9	27	pathology	pathology	NN
cord-011302-pfepyvaw	9	28	that	that	WDT
cord-011302-pfepyvaw	9	29	may	may	MD
cord-011302-pfepyvaw	9	30	be	be	VB
cord-011302-pfepyvaw	9	31	amenable	amenable	JJ
cord-011302-pfepyvaw	9	32	to	to	IN
cord-011302-pfepyvaw	9	33	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	9	34	treatment	treatment	NN
cord-011302-pfepyvaw	9	35	.	.	.
cord-011302-pfepyvaw	10	1	In	in	IN
cord-011302-pfepyvaw	10	2	2010	2010	CD
cord-011302-pfepyvaw	10	3	,	,	,
cord-011302-pfepyvaw	10	4	Chibbaro	Chibbaro	NNP
cord-011302-pfepyvaw	10	5	showed	show	VBD
cord-011302-pfepyvaw	10	6	that	that	IN
cord-011302-pfepyvaw	10	7	the	the	DT
cord-011302-pfepyvaw	10	8	proportion	proportion	NN
cord-011302-pfepyvaw	10	9	of	of	IN
cord-011302-pfepyvaw	10	10	patients	patient	NNS
cord-011302-pfepyvaw	10	11	aged	age	VBN
cord-011302-pfepyvaw	10	12	70	70	CD
cord-011302-pfepyvaw	10	13	and	and	CC
cord-011302-pfepyvaw	10	14	over	over	IN
cord-011302-pfepyvaw	10	15	admitted	admit	VBN
cord-011302-pfepyvaw	10	16	to	to	IN
cord-011302-pfepyvaw	10	17	a	a	DT
cord-011302-pfepyvaw	10	18	Parisian	parisian	JJ
cord-011302-pfepyvaw	10	19	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	10	20	unit	unit	NN
cord-011302-pfepyvaw	10	21	increased	increase	VBD
cord-011302-pfepyvaw	10	22	from	from	IN
cord-011302-pfepyvaw	10	23	11	11	CD
cord-011302-pfepyvaw	10	24	%	%	NN
cord-011302-pfepyvaw	10	25	in	in	IN
cord-011302-pfepyvaw	10	26	1983	1983	CD
cord-011302-pfepyvaw	10	27	to	to	IN
cord-011302-pfepyvaw	10	28	25	25	CD
cord-011302-pfepyvaw	10	29	%	%	NN
cord-011302-pfepyvaw	10	30	in	in	IN
cord-011302-pfepyvaw	10	31	2007	2007	CD
cord-011302-pfepyvaw	10	32	[	[	-LRB-
cord-011302-pfepyvaw	10	33	6	6	CD
cord-011302-pfepyvaw	10	34	]	]	-RRB-
cord-011302-pfepyvaw	10	35	.	.	.
cord-011302-pfepyvaw	11	1	Surgical	surgical	JJ
cord-011302-pfepyvaw	11	2	interventions	intervention	NNS
cord-011302-pfepyvaw	11	3	also	also	RB
cord-011302-pfepyvaw	11	4	increased	increase	VBD
cord-011302-pfepyvaw	11	5	from	from	IN
cord-011302-pfepyvaw	11	6	77	77	CD
cord-011302-pfepyvaw	11	7	%	%	NN
cord-011302-pfepyvaw	11	8	to	to	IN
cord-011302-pfepyvaw	11	9	93	93	CD
cord-011302-pfepyvaw	11	10	%	%	NN
cord-011302-pfepyvaw	11	11	in	in	IN
cord-011302-pfepyvaw	11	12	this	this	DT
cord-011302-pfepyvaw	11	13	group	group	NN
cord-011302-pfepyvaw	11	14	,	,	,
cord-011302-pfepyvaw	11	15	with	with	IN
cord-011302-pfepyvaw	11	16	a	a	DT
cord-011302-pfepyvaw	11	17	particular	particular	JJ
cord-011302-pfepyvaw	11	18	rise	rise	NN
cord-011302-pfepyvaw	11	19	in	in	IN
cord-011302-pfepyvaw	11	20	brain	brain	NN
cord-011302-pfepyvaw	11	21	tumour	tumour	NN
cord-011302-pfepyvaw	11	22	surgery	surgery	NN
cord-011302-pfepyvaw	11	23	.	.	.
cord-011302-pfepyvaw	12	1	Such	such	JJ
cord-011302-pfepyvaw	12	2	trends	trend	NNS
cord-011302-pfepyvaw	12	3	are	be	VBP
cord-011302-pfepyvaw	12	4	set	set	VBN
cord-011302-pfepyvaw	12	5	to	to	TO
cord-011302-pfepyvaw	12	6	continue	continue	VB
cord-011302-pfepyvaw	12	7	and	and	CC
cord-011302-pfepyvaw	12	8	a	a	DT
cord-011302-pfepyvaw	12	9	recent	recent	JJ
cord-011302-pfepyvaw	12	10	report	report	NN
cord-011302-pfepyvaw	12	11	from	from	IN
cord-011302-pfepyvaw	12	12	a	a	DT
cord-011302-pfepyvaw	12	13	UK	UK	NNP
cord-011302-pfepyvaw	12	14	regional	regional	JJ
cord-011302-pfepyvaw	12	15	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	12	16	centre	centre	NN
cord-011302-pfepyvaw	12	17	showed	show	VBD
cord-011302-pfepyvaw	12	18	continued	continued	JJ
cord-011302-pfepyvaw	12	19	increases	increase	NNS
cord-011302-pfepyvaw	12	20	in	in	IN
cord-011302-pfepyvaw	12	21	elderly	elderly	JJ
cord-011302-pfepyvaw	12	22	admissions	admission	NNS
cord-011302-pfepyvaw	12	23	from	from	IN
cord-011302-pfepyvaw	12	24	2000	2000	CD
cord-011302-pfepyvaw	12	25	to	to	IN
cord-011302-pfepyvaw	12	26	2013	2013	CD
cord-011302-pfepyvaw	12	27	,	,	,
cord-011302-pfepyvaw	12	28	particularly	particularly	RB
cord-011302-pfepyvaw	12	29	in	in	IN
cord-011302-pfepyvaw	12	30	emergency	emergency	NN
cord-011302-pfepyvaw	12	31	conditions	condition	NNS
cord-011302-pfepyvaw	12	32	such	such	JJ
cord-011302-pfepyvaw	12	33	as	as	IN
cord-011302-pfepyvaw	12	34	traumatic	traumatic	JJ
cord-011302-pfepyvaw	12	35	head	head	NN
cord-011302-pfepyvaw	12	36	injury	injury	NN
cord-011302-pfepyvaw	12	37	and	and	CC
cord-011302-pfepyvaw	12	38	spontaneous	spontaneous	JJ
cord-011302-pfepyvaw	12	39	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	12	40	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	12	41	[	[	-LRB-
cord-011302-pfepyvaw	12	42	42	42	CD
cord-011302-pfepyvaw	12	43	]	]	-RRB-
cord-011302-pfepyvaw	12	44	.	.	.
cord-011302-pfepyvaw	13	1	An	an	DT
cord-011302-pfepyvaw	13	2	important	important	JJ
cord-011302-pfepyvaw	13	3	driver	driver	NN
cord-011302-pfepyvaw	13	4	of	of	IN
cord-011302-pfepyvaw	13	5	increased	increase	VBN
cord-011302-pfepyvaw	13	6	admissions	admission	NNS
cord-011302-pfepyvaw	13	7	is	be	VBZ
cord-011302-pfepyvaw	13	8	the	the	DT
cord-011302-pfepyvaw	13	9	perceived	perceive	VBN
cord-011302-pfepyvaw	13	10	improvement	improvement	NN
cord-011302-pfepyvaw	13	11	in	in	IN
cord-011302-pfepyvaw	13	12	outcomes	outcome	NNS
cord-011302-pfepyvaw	13	13	in	in	IN
cord-011302-pfepyvaw	13	14	older	old	JJR
cord-011302-pfepyvaw	13	15	patients	patient	NNS
cord-011302-pfepyvaw	13	16	.	.	.
cord-011302-pfepyvaw	14	1	Chibbaro	Chibbaro	NNP
cord-011302-pfepyvaw	14	2	showed	show	VBD
cord-011302-pfepyvaw	14	3	a	a	DT
cord-011302-pfepyvaw	14	4	dramatic	dramatic	JJ
cord-011302-pfepyvaw	14	5	drop	drop	NN
cord-011302-pfepyvaw	14	6	in	in	IN
cord-011302-pfepyvaw	14	7	the	the	DT
cord-011302-pfepyvaw	14	8	immediate	immediate	JJ
cord-011302-pfepyvaw	14	9	mortality	mortality	NN
cord-011302-pfepyvaw	14	10	rate	rate	NN
cord-011302-pfepyvaw	14	11	,	,	,
cord-011302-pfepyvaw	14	12	from	from	IN
cord-011302-pfepyvaw	14	13	12	12	CD
cord-011302-pfepyvaw	14	14	to	to	TO
cord-011302-pfepyvaw	14	15	0.3	0.3	CD
cord-011302-pfepyvaw	14	16	%	%	NN
cord-011302-pfepyvaw	14	17	in	in	IN
cord-011302-pfepyvaw	14	18	older	old	JJR
cord-011302-pfepyvaw	14	19	patients	patient	NNS
cord-011302-pfepyvaw	14	20	[	[	-LRB-
cord-011302-pfepyvaw	14	21	6	6	CD
cord-011302-pfepyvaw	14	22	]	]	-RRB-
cord-011302-pfepyvaw	14	23	.	.	.
cord-011302-pfepyvaw	15	1	Shifting	shift	VBG
cord-011302-pfepyvaw	15	2	treatment	treatment	NN
cord-011302-pfepyvaw	15	3	algorithms	algorithm	NNS
cord-011302-pfepyvaw	15	4	,	,	,
cord-011302-pfepyvaw	15	5	such	such	JJ
cord-011302-pfepyvaw	15	6	as	as	IN
cord-011302-pfepyvaw	15	7	endovascular	endovascular	JJ
cord-011302-pfepyvaw	15	8	coiling	coiling	NN
cord-011302-pfepyvaw	15	9	rather	rather	RB
cord-011302-pfepyvaw	15	10	than	than	IN
cord-011302-pfepyvaw	15	11	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	15	12	clipping	clipping	NN
cord-011302-pfepyvaw	15	13	,	,	,
cord-011302-pfepyvaw	15	14	account	account	NN
cord-011302-pfepyvaw	15	15	,	,	,
cord-011302-pfepyvaw	15	16	in	in	IN
cord-011302-pfepyvaw	15	17	part	part	NN
cord-011302-pfepyvaw	15	18	,	,	,
cord-011302-pfepyvaw	15	19	for	for	IN
cord-011302-pfepyvaw	15	20	improved	improved	JJ
cord-011302-pfepyvaw	15	21	outcomes	outcome	NNS
cord-011302-pfepyvaw	15	22	.	.	.
cord-011302-pfepyvaw	16	1	However	however	RB
cord-011302-pfepyvaw	16	2	,	,	,
cord-011302-pfepyvaw	16	3	poor	poor	JJ
cord-011302-pfepyvaw	16	4	outcomes	outcome	NNS
cord-011302-pfepyvaw	16	5	still	still	RB
cord-011302-pfepyvaw	16	6	prevail	prevail	VBP
cord-011302-pfepyvaw	16	7	in	in	IN
cord-011302-pfepyvaw	16	8	older	old	JJR
cord-011302-pfepyvaw	16	9	patients	patient	NNS
cord-011302-pfepyvaw	16	10	with	with	IN
cord-011302-pfepyvaw	16	11	emergency	emergency	NN
cord-011302-pfepyvaw	16	12	presentations	presentation	NNS
cord-011302-pfepyvaw	16	13	:	:	:
cord-011302-pfepyvaw	16	14	Whitehouse	Whitehouse	NNP
cord-011302-pfepyvaw	16	15	reported	report	VBD
cord-011302-pfepyvaw	16	16	5-year	5-year	CD
cord-011302-pfepyvaw	16	17	mortality	mortality	NN
cord-011302-pfepyvaw	16	18	of	of	IN
cord-011302-pfepyvaw	16	19	around	around	IN
cord-011302-pfepyvaw	16	20	55	55	CD
cord-011302-pfepyvaw	16	21	%	%	NN
cord-011302-pfepyvaw	16	22	in	in	IN
cord-011302-pfepyvaw	16	23	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	16	24	patients	patient	NNS
cord-011302-pfepyvaw	16	25	over	over	IN
cord-011302-pfepyvaw	16	26	65	65	CD
cord-011302-pfepyvaw	16	27	admitted	admit	VBD
cord-011302-pfepyvaw	16	28	as	as	IN
cord-011302-pfepyvaw	16	29	an	an	DT
cord-011302-pfepyvaw	16	30	emergency	emergency	NN
cord-011302-pfepyvaw	16	31	compared	compare	VBN
cord-011302-pfepyvaw	16	32	with	with	IN
cord-011302-pfepyvaw	16	33	less	less	JJR
cord-011302-pfepyvaw	16	34	than	than	IN
cord-011302-pfepyvaw	16	35	20	20	CD
cord-011302-pfepyvaw	16	36	%	%	NN
cord-011302-pfepyvaw	16	37	in	in	IN
cord-011302-pfepyvaw	16	38	elective	elective	JJ
cord-011302-pfepyvaw	16	39	patients	patient	NNS
cord-011302-pfepyvaw	16	40	[	[	-LRB-
cord-011302-pfepyvaw	16	41	42	42	CD
cord-011302-pfepyvaw	16	42	]	]	-RRB-
cord-011302-pfepyvaw	16	43	.	.	.
cord-011302-pfepyvaw	17	1	Mortality	mortality	NN
cord-011302-pfepyvaw	17	2	is	be	VBZ
cord-011302-pfepyvaw	17	3	particularly	particularly	RB
cord-011302-pfepyvaw	17	4	increased	increase	VBN
cord-011302-pfepyvaw	17	5	within	within	IN
cord-011302-pfepyvaw	17	6	6	6	CD
cord-011302-pfepyvaw	17	7	months	month	NNS
cord-011302-pfepyvaw	17	8	of	of	IN
cord-011302-pfepyvaw	17	9	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	17	10	treatment	treatment	NN
cord-011302-pfepyvaw	17	11	and	and	CC
cord-011302-pfepyvaw	17	12	,	,	,
cord-011302-pfepyvaw	17	13	therefore	therefore	RB
cord-011302-pfepyvaw	17	14	,	,	,
cord-011302-pfepyvaw	17	15	surgical	surgical	JJ
cord-011302-pfepyvaw	17	16	approaches	approach	NNS
cord-011302-pfepyvaw	17	17	and	and	CC
cord-011302-pfepyvaw	17	18	their	-PRON-	PRP$
cord-011302-pfepyvaw	17	19	associated	associate	VBN
cord-011302-pfepyvaw	17	20	complications	complication	NNS
cord-011302-pfepyvaw	17	21	need	need	VBP
cord-011302-pfepyvaw	17	22	to	to	TO
cord-011302-pfepyvaw	17	23	be	be	VB
cord-011302-pfepyvaw	17	24	carefully	carefully	RB
cord-011302-pfepyvaw	17	25	considered	consider	VBN
cord-011302-pfepyvaw	17	26	to	to	TO
cord-011302-pfepyvaw	17	27	improve	improve	VB
cord-011302-pfepyvaw	17	28	outcomes	outcome	NNS
cord-011302-pfepyvaw	17	29	.	.	.
cord-011302-pfepyvaw	18	1	In	in	IN
cord-011302-pfepyvaw	18	2	this	this	DT
cord-011302-pfepyvaw	18	3	review	review	NN
cord-011302-pfepyvaw	18	4	,	,	,
cord-011302-pfepyvaw	18	5	we	-PRON-	PRP
cord-011302-pfepyvaw	18	6	consider	consider	VBP
cord-011302-pfepyvaw	18	7	changes	change	NNS
cord-011302-pfepyvaw	18	8	in	in	IN
cord-011302-pfepyvaw	18	9	practice	practice	NN
cord-011302-pfepyvaw	18	10	and	and	CC
cord-011302-pfepyvaw	18	11	current	current	JJ
cord-011302-pfepyvaw	18	12	treatment	treatment	NN
cord-011302-pfepyvaw	18	13	outcomes	outcome	NNS
cord-011302-pfepyvaw	18	14	in	in	IN
cord-011302-pfepyvaw	18	15	older	old	JJR
cord-011302-pfepyvaw	18	16	patients	patient	NNS
cord-011302-pfepyvaw	18	17	with	with	IN
cord-011302-pfepyvaw	18	18	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	18	19	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	18	20	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	18	21	,	,	,
cord-011302-pfepyvaw	18	22	traumatic	traumatic	JJ
cord-011302-pfepyvaw	18	23	head	head	NN
cord-011302-pfepyvaw	18	24	injury	injury	NN
cord-011302-pfepyvaw	18	25	,	,	,
cord-011302-pfepyvaw	18	26	and	and	CC
cord-011302-pfepyvaw	18	27	haemorrhagic	haemorrhagic	JJ
cord-011302-pfepyvaw	18	28	strokes	stroke	NNS
cord-011302-pfepyvaw	18	29	.	.	.
cord-011302-pfepyvaw	19	1	We	-PRON-	PRP
cord-011302-pfepyvaw	19	2	focus	focus	VBP
cord-011302-pfepyvaw	19	3	on	on	IN
cord-011302-pfepyvaw	19	4	the	the	DT
cord-011302-pfepyvaw	19	5	assessment	assessment	NN
cord-011302-pfepyvaw	19	6	of	of	IN
cord-011302-pfepyvaw	19	7	frailty	frailty	NN
cord-011302-pfepyvaw	19	8	in	in	IN
cord-011302-pfepyvaw	19	9	older	old	JJR
cord-011302-pfepyvaw	19	10	patients	patient	NNS
cord-011302-pfepyvaw	19	11	and	and	CC
cord-011302-pfepyvaw	19	12	how	how	WRB
cord-011302-pfepyvaw	19	13	this	this	DT
cord-011302-pfepyvaw	19	14	can	can	MD
cord-011302-pfepyvaw	19	15	help	help	VB
cord-011302-pfepyvaw	19	16	to	to	TO
cord-011302-pfepyvaw	19	17	inform	inform	VB
cord-011302-pfepyvaw	19	18	future	future	JJ
cord-011302-pfepyvaw	19	19	treatment	treatment	NN
cord-011302-pfepyvaw	19	20	planning	planning	NN
cord-011302-pfepyvaw	19	21	.	.	.
cord-011302-pfepyvaw	20	1	Incidental	incidental	JJ
cord-011302-pfepyvaw	20	2	,	,	,
cord-011302-pfepyvaw	20	3	unruptured	unruptured	JJ
cord-011302-pfepyvaw	20	4	cerebral	cerebral	JJ
cord-011302-pfepyvaw	20	5	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	20	6	pose	pose	VBP
cord-011302-pfepyvaw	20	7	a	a	DT
cord-011302-pfepyvaw	20	8	risk	risk	NN
cord-011302-pfepyvaw	20	9	of	of	IN
cord-011302-pfepyvaw	20	10	rupture	rupture	NN
cord-011302-pfepyvaw	20	11	over	over	IN
cord-011302-pfepyvaw	20	12	time	time	NN
cord-011302-pfepyvaw	20	13	;	;	:
cord-011302-pfepyvaw	20	14	factors	factor	NNS
cord-011302-pfepyvaw	20	15	including	include	VBG
cord-011302-pfepyvaw	20	16	size	size	NN
cord-011302-pfepyvaw	20	17	and	and	CC
cord-011302-pfepyvaw	20	18	location	location	NN
cord-011302-pfepyvaw	20	19	influence	influence	NN
cord-011302-pfepyvaw	20	20	this	this	DT
cord-011302-pfepyvaw	20	21	risk	risk	NN
cord-011302-pfepyvaw	20	22	[	[	-LRB-
cord-011302-pfepyvaw	20	23	43	43	CD
cord-011302-pfepyvaw	20	24	]	]	-RRB-
cord-011302-pfepyvaw	20	25	.	.	.
cord-011302-pfepyvaw	21	1	It	-PRON-	PRP
cord-011302-pfepyvaw	21	2	is	be	VBZ
cord-011302-pfepyvaw	21	3	logical	logical	JJ
cord-011302-pfepyvaw	21	4	,	,	,
cord-011302-pfepyvaw	21	5	that	that	IN
cord-011302-pfepyvaw	21	6	as	as	IN
cord-011302-pfepyvaw	21	7	people	people	NNS
cord-011302-pfepyvaw	21	8	live	live	VBP
cord-011302-pfepyvaw	21	9	longer	long	RBR
cord-011302-pfepyvaw	21	10	,	,	,
cord-011302-pfepyvaw	21	11	there	there	EX
cord-011302-pfepyvaw	21	12	is	be	VBZ
cord-011302-pfepyvaw	21	13	a	a	DT
cord-011302-pfepyvaw	21	14	greater	great	JJR
cord-011302-pfepyvaw	21	15	lifetime	lifetime	NN
cord-011302-pfepyvaw	21	16	risk	risk	NN
cord-011302-pfepyvaw	21	17	of	of	IN
cord-011302-pfepyvaw	21	18	incidental	incidental	JJ
cord-011302-pfepyvaw	21	19	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	21	20	rupture	rupture	NN
cord-011302-pfepyvaw	21	21	and	and	CC
cord-011302-pfepyvaw	21	22	presentation	presentation	NN
cord-011302-pfepyvaw	21	23	with	with	IN
cord-011302-pfepyvaw	21	24	a	a	DT
cord-011302-pfepyvaw	21	25	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	21	26	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	21	27	(	(	-LRB-
cord-011302-pfepyvaw	21	28	SAH	SAH	NNP
cord-011302-pfepyvaw	21	29	)	)	-RRB-
cord-011302-pfepyvaw	21	30	.	.	.
cord-011302-pfepyvaw	22	1	Conversely	conversely	RB
cord-011302-pfepyvaw	22	2	,	,	,
cord-011302-pfepyvaw	22	3	the	the	DT
cord-011302-pfepyvaw	22	4	first	first	JJ
cord-011302-pfepyvaw	22	5	detection	detection	NN
cord-011302-pfepyvaw	22	6	of	of	IN
cord-011302-pfepyvaw	22	7	an	an	DT
cord-011302-pfepyvaw	22	8	incidental	incidental	JJ
cord-011302-pfepyvaw	22	9	cerebral	cerebral	JJ
cord-011302-pfepyvaw	22	10	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	22	11	in	in	IN
cord-011302-pfepyvaw	22	12	later	later	JJ
cord-011302-pfepyvaw	22	13	life	life	NN
cord-011302-pfepyvaw	22	14	means	mean	VBZ
cord-011302-pfepyvaw	22	15	that	that	IN
cord-011302-pfepyvaw	22	16	there	there	EX
cord-011302-pfepyvaw	22	17	is	be	VBZ
cord-011302-pfepyvaw	22	18	a	a	DT
cord-011302-pfepyvaw	22	19	reduced	reduce	VBN
cord-011302-pfepyvaw	22	20	effect	effect	NN
cord-011302-pfepyvaw	22	21	of	of	IN
cord-011302-pfepyvaw	22	22	any	any	DT
cord-011302-pfepyvaw	22	23	preventative	preventative	JJ
cord-011302-pfepyvaw	22	24	treatment	treatment	NN
cord-011302-pfepyvaw	22	25	due	due	IN
cord-011302-pfepyvaw	22	26	to	to	IN
cord-011302-pfepyvaw	22	27	the	the	DT
cord-011302-pfepyvaw	22	28	deceased	deceased	JJ
cord-011302-pfepyvaw	22	29	remaining	remain	VBG
cord-011302-pfepyvaw	22	30	life	life	NN
cord-011302-pfepyvaw	22	31	expectancy	expectancy	NN
cord-011302-pfepyvaw	22	32	in	in	IN
cord-011302-pfepyvaw	22	33	the	the	DT
cord-011302-pfepyvaw	22	34	elderly	elderly	JJ
cord-011302-pfepyvaw	22	35	.	.	.
cord-011302-pfepyvaw	23	1	In	in	IN
cord-011302-pfepyvaw	23	2	addition	addition	NN
cord-011302-pfepyvaw	23	3	,	,	,
cord-011302-pfepyvaw	23	4	the	the	DT
cord-011302-pfepyvaw	23	5	outcomes	outcome	NNS
cord-011302-pfepyvaw	23	6	,	,	,
cord-011302-pfepyvaw	23	7	in	in	IN
cord-011302-pfepyvaw	23	8	terms	term	NNS
cord-011302-pfepyvaw	23	9	of	of	IN
cord-011302-pfepyvaw	23	10	quality	quality	NN
cord-011302-pfepyvaw	23	11	of	of	IN
cord-011302-pfepyvaw	23	12	life	life	NN
cord-011302-pfepyvaw	23	13	and	and	CC
cord-011302-pfepyvaw	23	14	mortality	mortality	NN
cord-011302-pfepyvaw	23	15	,	,	,
cord-011302-pfepyvaw	23	16	from	from	IN
cord-011302-pfepyvaw	23	17	treated	treat	VBN
cord-011302-pfepyvaw	23	18	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	23	19	SAH	SAH	NNP
cord-011302-pfepyvaw	23	20	in	in	IN
cord-011302-pfepyvaw	23	21	older	old	JJR
cord-011302-pfepyvaw	23	22	patients	patient	NNS
cord-011302-pfepyvaw	23	23	are	be	VBP
cord-011302-pfepyvaw	23	24	variable	variable	JJ
cord-011302-pfepyvaw	23	25	.	.	.
cord-011302-pfepyvaw	24	1	As	as	IN
cord-011302-pfepyvaw	24	2	such	such	JJ
cord-011302-pfepyvaw	24	3	,	,	,
cord-011302-pfepyvaw	24	4	it	-PRON-	PRP
cord-011302-pfepyvaw	24	5	is	be	VBZ
cord-011302-pfepyvaw	24	6	important	important	JJ
cord-011302-pfepyvaw	24	7	that	that	IN
cord-011302-pfepyvaw	24	8	we	-PRON-	PRP
cord-011302-pfepyvaw	24	9	have	have	VBP
cord-011302-pfepyvaw	24	10	robust	robust	JJ
cord-011302-pfepyvaw	24	11	data	datum	NNS
cord-011302-pfepyvaw	24	12	on	on	IN
cord-011302-pfepyvaw	24	13	all	all	PDT
cord-011302-pfepyvaw	24	14	these	these	DT
cord-011302-pfepyvaw	24	15	aspects	aspect	NNS
cord-011302-pfepyvaw	24	16	,	,	,
cord-011302-pfepyvaw	24	17	to	to	TO
cord-011302-pfepyvaw	24	18	guide	guide	VB
cord-011302-pfepyvaw	24	19	the	the	DT
cord-011302-pfepyvaw	24	20	management	management	NN
cord-011302-pfepyvaw	24	21	of	of	IN
cord-011302-pfepyvaw	24	22	both	both	CC
cord-011302-pfepyvaw	24	23	ruptured	ruptured	JJ
cord-011302-pfepyvaw	24	24	and	and	CC
cord-011302-pfepyvaw	24	25	unruptured	unruptured	JJ
cord-011302-pfepyvaw	24	26	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	24	27	in	in	IN
cord-011302-pfepyvaw	24	28	the	the	DT
cord-011302-pfepyvaw	24	29	older	old	JJR
cord-011302-pfepyvaw	24	30	person	person	NN
cord-011302-pfepyvaw	24	31	.	.	.
cord-011302-pfepyvaw	25	1	In	in	IN
cord-011302-pfepyvaw	25	2	2006	2006	CD
cord-011302-pfepyvaw	25	3	,	,	,
cord-011302-pfepyvaw	25	4	Nieuwkamp	Nieuwkamp	NNP
cord-011302-pfepyvaw	25	5	et	et	NNP
cord-011302-pfepyvaw	25	6	al	al	NNP
cord-011302-pfepyvaw	25	7	.	.	NNP
cord-011302-pfepyvaw	25	8	reported	report	VBD
cord-011302-pfepyvaw	25	9	outcomes	outcome	NNS
cord-011302-pfepyvaw	25	10	in	in	IN
cord-011302-pfepyvaw	25	11	170	170	CD
cord-011302-pfepyvaw	25	12	patients	patient	NNS
cord-011302-pfepyvaw	25	13	aged	age	VBN
cord-011302-pfepyvaw	25	14	≥	≥	CD
cord-011302-pfepyvaw	25	15	75	75	CD
cord-011302-pfepyvaw	25	16	years	year	NNS
cord-011302-pfepyvaw	25	17	presenting	present	VBG
cord-011302-pfepyvaw	25	18	with	with	IN
cord-011302-pfepyvaw	25	19	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	25	20	SAH	SAH	NNP
cord-011302-pfepyvaw	25	21	,	,	,
cord-011302-pfepyvaw	25	22	where	where	WRB
cord-011302-pfepyvaw	25	23	only	only	RB
cord-011302-pfepyvaw	25	24	20	20	CD
cord-011302-pfepyvaw	25	25	%	%	NN
cord-011302-pfepyvaw	25	26	of	of	IN
cord-011302-pfepyvaw	25	27	patients	patient	NNS
cord-011302-pfepyvaw	25	28	were	be	VBD
cord-011302-pfepyvaw	25	29	clipped	clip	VBN
cord-011302-pfepyvaw	25	30	and	and	CC
cord-011302-pfepyvaw	25	31	8	8	CD
cord-011302-pfepyvaw	25	32	%	%	NN
cord-011302-pfepyvaw	25	33	coiled	coil	VBN
cord-011302-pfepyvaw	25	34	[	[	-LRB-
cord-011302-pfepyvaw	25	35	27	27	CD
cord-011302-pfepyvaw	25	36	]	]	-RRB-
cord-011302-pfepyvaw	25	37	.	.	.
cord-011302-pfepyvaw	26	1	Overall	overall	RB
cord-011302-pfepyvaw	26	2	,	,	,
cord-011302-pfepyvaw	26	3	half	half	PDT
cord-011302-pfepyvaw	26	4	the	the	DT
cord-011302-pfepyvaw	26	5	patients	patient	NNS
cord-011302-pfepyvaw	26	6	died	die	VBD
cord-011302-pfepyvaw	26	7	and	and	CC
cord-011302-pfepyvaw	26	8	only	only	RB
cord-011302-pfepyvaw	26	9	one	one	CD
cord-011302-pfepyvaw	26	10	in	in	IN
cord-011302-pfepyvaw	26	11	six	six	CD
cord-011302-pfepyvaw	26	12	returned	return	VBN
cord-011302-pfepyvaw	26	13	to	to	IN
cord-011302-pfepyvaw	26	14	independent	independent	JJ
cord-011302-pfepyvaw	26	15	function	function	NN
cord-011302-pfepyvaw	26	16	by	by	IN
cord-011302-pfepyvaw	26	17	discharge	discharge	NN
cord-011302-pfepyvaw	26	18	.	.	.
cord-011302-pfepyvaw	27	1	Of	of	IN
cord-011302-pfepyvaw	27	2	their	-PRON-	PRP$
cord-011302-pfepyvaw	27	3	60	60	CD
cord-011302-pfepyvaw	27	4	patients	patient	NNS
cord-011302-pfepyvaw	27	5	admitted	admit	VBN
cord-011302-pfepyvaw	27	6	in	in	IN
cord-011302-pfepyvaw	27	7	a	a	DT
cord-011302-pfepyvaw	27	8	poor	poor	JJ
cord-011302-pfepyvaw	27	9	condition	condition	NN
cord-011302-pfepyvaw	27	10	(	(	-LRB-
cord-011302-pfepyvaw	27	11	those	those	DT
cord-011302-pfepyvaw	27	12	with	with	IN
cord-011302-pfepyvaw	27	13	a	a	DT
cord-011302-pfepyvaw	27	14	Glasgow	Glasgow	NNP
cord-011302-pfepyvaw	27	15	Coma	Coma	NNP
cord-011302-pfepyvaw	27	16	Score	Score	NNP
cord-011302-pfepyvaw	27	17	of	of	IN
cord-011302-pfepyvaw	27	18	12	12	CD
cord-011302-pfepyvaw	27	19	or	or	CC
cord-011302-pfepyvaw	27	20	less	less	JJR
cord-011302-pfepyvaw	27	21	)	)	-RRB-
cord-011302-pfepyvaw	27	22	,	,	,
cord-011302-pfepyvaw	27	23	none	none	NN
cord-011302-pfepyvaw	27	24	were	be	VBD
cord-011302-pfepyvaw	27	25	independent	independent	JJ
cord-011302-pfepyvaw	27	26	at	at	IN
cord-011302-pfepyvaw	27	27	discharge	discharge	NN
cord-011302-pfepyvaw	27	28	.	.	.
cord-011302-pfepyvaw	28	1	The	the	DT
cord-011302-pfepyvaw	28	2	strongest	strong	JJS
cord-011302-pfepyvaw	28	3	predictor	predictor	NN
cord-011302-pfepyvaw	28	4	of	of	IN
cord-011302-pfepyvaw	28	5	poor	poor	JJ
cord-011302-pfepyvaw	28	6	outcome	outcome	NN
cord-011302-pfepyvaw	28	7	in	in	IN
cord-011302-pfepyvaw	28	8	good	good	JJ
cord-011302-pfepyvaw	28	9	-	-	HYPH
cord-011302-pfepyvaw	28	10	grade	grade	NN
cord-011302-pfepyvaw	28	11	admissions	admission	NNS
cord-011302-pfepyvaw	28	12	was	be	VBD
cord-011302-pfepyvaw	28	13	re	re	VBN
cord-011302-pfepyvaw	28	14	-	-	NN
cord-011302-pfepyvaw	28	15	bleeding	bleeding	JJ
cord-011302-pfepyvaw	28	16	.	.	.
cord-011302-pfepyvaw	29	1	Compared	compare	VBN
cord-011302-pfepyvaw	29	2	to	to	IN
cord-011302-pfepyvaw	29	3	younger	young	JJR
cord-011302-pfepyvaw	29	4	SAH	SAH	NNP
cord-011302-pfepyvaw	29	5	patients	patient	NNS
cord-011302-pfepyvaw	29	6	,	,	,
cord-011302-pfepyvaw	29	7	those	those	DT
cord-011302-pfepyvaw	29	8	aged	age	VBN
cord-011302-pfepyvaw	29	9	75	75	CD
cord-011302-pfepyvaw	29	10	and	and	CC
cord-011302-pfepyvaw	29	11	over	over	RB
cord-011302-pfepyvaw	29	12	were	be	VBD
cord-011302-pfepyvaw	29	13	more	more	RBR
cord-011302-pfepyvaw	29	14	likely	likely	JJ
cord-011302-pfepyvaw	29	15	to	to	TO
cord-011302-pfepyvaw	29	16	be	be	VB
cord-011302-pfepyvaw	29	17	female	female	JJ
cord-011302-pfepyvaw	29	18	(	(	-LRB-
cord-011302-pfepyvaw	29	19	perhaps	perhaps	RB
cord-011302-pfepyvaw	29	20	due	due	IN
cord-011302-pfepyvaw	29	21	to	to	IN
cord-011302-pfepyvaw	29	22	greater	great	JJR
cord-011302-pfepyvaw	29	23	life	life	NN
cord-011302-pfepyvaw	29	24	expectancy	expectancy	NN
cord-011302-pfepyvaw	29	25	)	)	-RRB-
cord-011302-pfepyvaw	29	26	and	and	CC
cord-011302-pfepyvaw	29	27	suffer	suffer	VB
cord-011302-pfepyvaw	29	28	with	with	IN
cord-011302-pfepyvaw	29	29	medical	medical	JJ
cord-011302-pfepyvaw	29	30	complications	complication	NNS
cord-011302-pfepyvaw	29	31	and	and	CC
cord-011302-pfepyvaw	29	32	hydrocephalus	hydrocephalus	NN
cord-011302-pfepyvaw	29	33	.	.	.
cord-011302-pfepyvaw	30	1	The	the	DT
cord-011302-pfepyvaw	30	2	authors	author	NNS
cord-011302-pfepyvaw	30	3	suggested	suggest	VBD
cord-011302-pfepyvaw	30	4	that	that	IN
cord-011302-pfepyvaw	30	5	the	the	DT
cord-011302-pfepyvaw	30	6	early	early	JJ
cord-011302-pfepyvaw	30	7	treatment	treatment	NN
cord-011302-pfepyvaw	30	8	of	of	IN
cord-011302-pfepyvaw	30	9	patients	patient	NNS
cord-011302-pfepyvaw	30	10	in	in	IN
cord-011302-pfepyvaw	30	11	a	a	DT
cord-011302-pfepyvaw	30	12	good	good	JJ
cord-011302-pfepyvaw	30	13	condition	condition	NN
cord-011302-pfepyvaw	30	14	may	may	MD
cord-011302-pfepyvaw	30	15	prevent	prevent	VB
cord-011302-pfepyvaw	30	16	re	re	NN
cord-011302-pfepyvaw	30	17	-	-	NN
cord-011302-pfepyvaw	30	18	bleeding	bleeding	JJ
cord-011302-pfepyvaw	30	19	and	and	CC
cord-011302-pfepyvaw	30	20	thus	thus	RB
cord-011302-pfepyvaw	30	21	improve	improve	VB
cord-011302-pfepyvaw	30	22	outcomes	outcome	NNS
cord-011302-pfepyvaw	30	23	.	.	.
cord-011302-pfepyvaw	31	1	In	in	IN
cord-011302-pfepyvaw	31	2	2013	2013	CD
cord-011302-pfepyvaw	31	3	,	,	,
cord-011302-pfepyvaw	31	4	Scholler	Scholler	NNP
cord-011302-pfepyvaw	31	5	analysed	analyse	VBD
cord-011302-pfepyvaw	31	6	265	265	CD
cord-011302-pfepyvaw	31	7	patients	patient	NNS
cord-011302-pfepyvaw	31	8	over	over	IN
cord-011302-pfepyvaw	31	9	the	the	DT
cord-011302-pfepyvaw	31	10	age	age	NN
cord-011302-pfepyvaw	31	11	of	of	IN
cord-011302-pfepyvaw	31	12	60	60	CD
cord-011302-pfepyvaw	31	13	with	with	IN
cord-011302-pfepyvaw	31	14	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	31	15	SAH	SAH	NNP
cord-011302-pfepyvaw	31	16	,	,	,
cord-011302-pfepyvaw	31	17	with	with	IN
cord-011302-pfepyvaw	31	18	36	36	CD
cord-011302-pfepyvaw	31	19	%	%	NN
cord-011302-pfepyvaw	31	20	aged	age	VBN
cord-011302-pfepyvaw	31	21	between	between	IN
cord-011302-pfepyvaw	31	22	70	70	CD
cord-011302-pfepyvaw	31	23	and	and	CC
cord-011302-pfepyvaw	31	24	79	79	CD
cord-011302-pfepyvaw	31	25	and	and	CC
cord-011302-pfepyvaw	31	26	only	only	RB
cord-011302-pfepyvaw	31	27	10	10	CD
cord-011302-pfepyvaw	31	28	%	%	NN
cord-011302-pfepyvaw	31	29	over	over	IN
cord-011302-pfepyvaw	31	30	80	80	CD
cord-011302-pfepyvaw	31	31	[	[	-LRB-
cord-011302-pfepyvaw	31	32	33	33	CD
cord-011302-pfepyvaw	31	33	]	]	-RRB-
cord-011302-pfepyvaw	31	34	.	.	.
cord-011302-pfepyvaw	32	1	Challenges	challenge	NNS
cord-011302-pfepyvaw	32	2	identified	identify	VBN
cord-011302-pfepyvaw	32	3	in	in	IN
cord-011302-pfepyvaw	32	4	this	this	DT
cord-011302-pfepyvaw	32	5	older	old	JJR
cord-011302-pfepyvaw	32	6	population	population	NN
cord-011302-pfepyvaw	32	7	included	include	VBD
cord-011302-pfepyvaw	32	8	increased	increase	VBN
cord-011302-pfepyvaw	32	9	co	co	NNS
cord-011302-pfepyvaw	32	10	-	-	NNS
cord-011302-pfepyvaw	32	11	morbidities	morbidity	NNS
cord-011302-pfepyvaw	32	12	(	(	-LRB-
cord-011302-pfepyvaw	32	13	92	92	CD
cord-011302-pfepyvaw	32	14	%	%	NN
cord-011302-pfepyvaw	32	15	had	have	VBD
cord-011302-pfepyvaw	32	16	at	at	RB
cord-011302-pfepyvaw	32	17	least	least	JJS
cord-011302-pfepyvaw	32	18	one	one	CD
cord-011302-pfepyvaw	32	19	)	)	-RRB-
cord-011302-pfepyvaw	32	20	,	,	,
cord-011302-pfepyvaw	32	21	the	the	DT
cord-011302-pfepyvaw	32	22	use	use	NN
cord-011302-pfepyvaw	32	23	of	of	IN
cord-011302-pfepyvaw	32	24	anti	anti	JJ
cord-011302-pfepyvaw	32	25	-	-	JJ
cord-011302-pfepyvaw	32	26	thrombotic	thrombotic	JJ
cord-011302-pfepyvaw	32	27	drugs	drug	NNS
cord-011302-pfepyvaw	32	28	(	(	-LRB-
cord-011302-pfepyvaw	32	29	in	in	IN
cord-011302-pfepyvaw	32	30	29	29	CD
cord-011302-pfepyvaw	32	31	%	%	NN
cord-011302-pfepyvaw	32	32	)	)	-RRB-
cord-011302-pfepyvaw	32	33	and	and	CC
cord-011302-pfepyvaw	32	34	increased	increase	VBN
cord-011302-pfepyvaw	32	35	prevalence	prevalence	NN
cord-011302-pfepyvaw	32	36	of	of	IN
cord-011302-pfepyvaw	32	37	hydrocephalus	hydrocephalus	NN
cord-011302-pfepyvaw	32	38	requiring	require	VBG
cord-011302-pfepyvaw	32	39	an	an	DT
cord-011302-pfepyvaw	32	40	EVD	evd	NN
cord-011302-pfepyvaw	32	41	in	in	IN
cord-011302-pfepyvaw	32	42	those	those	DT
cord-011302-pfepyvaw	32	43	aged	age	VBN
cord-011302-pfepyvaw	32	44	70	70	CD
cord-011302-pfepyvaw	32	45	-	-	SYM
cord-011302-pfepyvaw	32	46	80	80	CD
cord-011302-pfepyvaw	32	47	years	year	NNS
cord-011302-pfepyvaw	32	48	(	(	-LRB-
cord-011302-pfepyvaw	32	49	77	77	CD
cord-011302-pfepyvaw	32	50	%	%	NN
cord-011302-pfepyvaw	32	51	)	)	-RRB-
cord-011302-pfepyvaw	32	52	compared	compare	VBN
cord-011302-pfepyvaw	32	53	to	to	IN
cord-011302-pfepyvaw	32	54	60	60	CD
cord-011302-pfepyvaw	32	55	-	-	HYPH
cord-011302-pfepyvaw	32	56	70-year	70-year	JJ
cord-011302-pfepyvaw	32	57	-	-	HYPH
cord-011302-pfepyvaw	32	58	olds	old	NNS
cord-011302-pfepyvaw	32	59	(	(	-LRB-
cord-011302-pfepyvaw	32	60	61	61	CD
cord-011302-pfepyvaw	32	61	%	%	NN
cord-011302-pfepyvaw	32	62	)	)	-RRB-
cord-011302-pfepyvaw	32	63	.	.	.
cord-011302-pfepyvaw	33	1	Interventional	interventional	JJ
cord-011302-pfepyvaw	33	2	treatment	treatment	NN
cord-011302-pfepyvaw	33	3	was	be	VBD
cord-011302-pfepyvaw	33	4	undertaken	undertake	VBN
cord-011302-pfepyvaw	33	5	in	in	IN
cord-011302-pfepyvaw	33	6	85	85	CD
cord-011302-pfepyvaw	33	7	%	%	NN
cord-011302-pfepyvaw	33	8	of	of	IN
cord-011302-pfepyvaw	33	9	cases	case	NNS
cord-011302-pfepyvaw	33	10	,	,	,
cord-011302-pfepyvaw	33	11	with	with	IN
cord-011302-pfepyvaw	33	12	clipping	clip	VBG
cord-011302-pfepyvaw	33	13	in	in	IN
cord-011302-pfepyvaw	33	14	48	48	CD
cord-011302-pfepyvaw	33	15	%	%	NN
cord-011302-pfepyvaw	33	16	and	and	CC
cord-011302-pfepyvaw	33	17	coiling	coil	VBG
cord-011302-pfepyvaw	33	18	in	in	IN
cord-011302-pfepyvaw	33	19	37	37	CD
cord-011302-pfepyvaw	33	20	%	%	NN
cord-011302-pfepyvaw	33	21	,	,	,
cord-011302-pfepyvaw	33	22	the	the	DT
cord-011302-pfepyvaw	33	23	latter	latter	JJ
cord-011302-pfepyvaw	33	24	more	more	RBR
cord-011302-pfepyvaw	33	25	commonly	commonly	RB
cord-011302-pfepyvaw	33	26	in	in	IN
cord-011302-pfepyvaw	33	27	those	those	DT
cord-011302-pfepyvaw	33	28	aged	age	VBN
cord-011302-pfepyvaw	33	29	over	over	IN
cord-011302-pfepyvaw	33	30	80	80	CD
cord-011302-pfepyvaw	33	31	.	.	.
cord-011302-pfepyvaw	34	1	Outcome	outcome	NN
cord-011302-pfepyvaw	34	2	was	be	VBD
cord-011302-pfepyvaw	34	3	clearly	clearly	RB
cord-011302-pfepyvaw	34	4	associated	associate	VBN
cord-011302-pfepyvaw	34	5	with	with	IN
cord-011302-pfepyvaw	34	6	age	age	NN
cord-011302-pfepyvaw	34	7	;	;	:
cord-011302-pfepyvaw	34	8	death	death	NN
cord-011302-pfepyvaw	34	9	or	or	CC
cord-011302-pfepyvaw	34	10	poor	poor	JJ
cord-011302-pfepyvaw	34	11	outcome	outcome	NN
cord-011302-pfepyvaw	34	12	at	at	IN
cord-011302-pfepyvaw	34	13	discharge	discharge	NN
cord-011302-pfepyvaw	34	14	occurred	occur	VBD
cord-011302-pfepyvaw	34	15	in	in	IN
cord-011302-pfepyvaw	34	16	73	73	CD
cord-011302-pfepyvaw	34	17	%	%	NN
cord-011302-pfepyvaw	34	18	of	of	IN
cord-011302-pfepyvaw	34	19	over	over	IN
cord-011302-pfepyvaw	34	20	70	70	CD
cord-011302-pfepyvaw	34	21	years	year	NNS
cord-011302-pfepyvaw	34	22	old	old	JJ
cord-011302-pfepyvaw	34	23	compared	compare	VBN
cord-011302-pfepyvaw	34	24	with	with	IN
cord-011302-pfepyvaw	34	25	51	51	CD
cord-011302-pfepyvaw	34	26	%	%	NN
cord-011302-pfepyvaw	34	27	of	of	IN
cord-011302-pfepyvaw	34	28	60	60	CD
cord-011302-pfepyvaw	34	29	-	-	SYM
cord-011302-pfepyvaw	34	30	70	70	CD
cord-011302-pfepyvaw	34	31	years	year	NNS
cord-011302-pfepyvaw	34	32	old	old	JJ
cord-011302-pfepyvaw	34	33	.	.	.
cord-011302-pfepyvaw	35	1	Condition	condition	NN
cord-011302-pfepyvaw	35	2	at	at	IN
cord-011302-pfepyvaw	35	3	presentation	presentation	NN
cord-011302-pfepyvaw	35	4	was	be	VBD
cord-011302-pfepyvaw	35	5	also	also	RB
cord-011302-pfepyvaw	35	6	important	important	JJ
cord-011302-pfepyvaw	35	7	with	with	IN
cord-011302-pfepyvaw	35	8	no	no	DT
cord-011302-pfepyvaw	35	9	poor	poor	JJ
cord-011302-pfepyvaw	35	10	grade	grade	NN
cord-011302-pfepyvaw	35	11	at	at	IN
cord-011302-pfepyvaw	35	12	presentation	presentation	NN
cord-011302-pfepyvaw	35	13	patients	patient	NNS
cord-011302-pfepyvaw	35	14	(	(	-LRB-
cord-011302-pfepyvaw	35	15	WFNS	WFNS	NNP
cord-011302-pfepyvaw	35	16	4	4	CD
cord-011302-pfepyvaw	35	17	-	-	SYM
cord-011302-pfepyvaw	35	18	5	5	CD
cord-011302-pfepyvaw	35	19	)	)	-RRB-
cord-011302-pfepyvaw	35	20	aged	age	VBN
cord-011302-pfepyvaw	35	21	over	over	IN
cord-011302-pfepyvaw	35	22	80	80	CD
cord-011302-pfepyvaw	35	23	experiencing	experience	VBG
cord-011302-pfepyvaw	35	24	a	a	DT
cord-011302-pfepyvaw	35	25	good	good	JJ
cord-011302-pfepyvaw	35	26	outcome	outcome	NN
cord-011302-pfepyvaw	35	27	at	at	IN
cord-011302-pfepyvaw	35	28	discharge	discharge	NN
cord-011302-pfepyvaw	35	29	.	.	.
cord-011302-pfepyvaw	36	1	It	-PRON-	PRP
cord-011302-pfepyvaw	36	2	is	be	VBZ
cord-011302-pfepyvaw	36	3	important	important	JJ
cord-011302-pfepyvaw	36	4	to	to	TO
cord-011302-pfepyvaw	36	5	note	note	VB
cord-011302-pfepyvaw	36	6	that	that	IN
cord-011302-pfepyvaw	36	7	although	although	IN
cord-011302-pfepyvaw	36	8	70	70	CD
cord-011302-pfepyvaw	36	9	%	%	NN
cord-011302-pfepyvaw	36	10	of	of	IN
cord-011302-pfepyvaw	36	11	conservatively	conservatively	RB
cord-011302-pfepyvaw	36	12	managed	manage	VBN
cord-011302-pfepyvaw	36	13	patients	patient	NNS
cord-011302-pfepyvaw	36	14	died	die	VBD
cord-011302-pfepyvaw	36	15	,	,	,
cord-011302-pfepyvaw	36	16	none	none	NN
cord-011302-pfepyvaw	36	17	were	be	VBD
cord-011302-pfepyvaw	36	18	due	due	JJ
cord-011302-pfepyvaw	36	19	to	to	IN
cord-011302-pfepyvaw	36	20	re	re	VB
cord-011302-pfepyvaw	36	21	-	-	VB
cord-011302-pfepyvaw	36	22	bleed	bleed	VB
cord-011302-pfepyvaw	36	23	,	,	,
cord-011302-pfepyvaw	36	24	suggesting	suggest	VBG
cord-011302-pfepyvaw	36	25	that	that	IN
cord-011302-pfepyvaw	36	26	it	-PRON-	PRP
cord-011302-pfepyvaw	36	27	is	be	VBZ
cord-011302-pfepyvaw	36	28	the	the	DT
cord-011302-pfepyvaw	36	29	nature	nature	NN
cord-011302-pfepyvaw	36	30	of	of	IN
cord-011302-pfepyvaw	36	31	the	the	DT
cord-011302-pfepyvaw	36	32	initial	initial	JJ
cord-011302-pfepyvaw	36	33	bleed	bleed	NN
cord-011302-pfepyvaw	36	34	and	and	CC
cord-011302-pfepyvaw	36	35	not	not	RB
cord-011302-pfepyvaw	36	36	any	any	DT
cord-011302-pfepyvaw	36	37	failure	failure	NN
cord-011302-pfepyvaw	36	38	to	to	TO
cord-011302-pfepyvaw	36	39	treat	treat	VB
cord-011302-pfepyvaw	36	40	,	,	,
cord-011302-pfepyvaw	36	41	that	that	IN
cord-011302-pfepyvaw	36	42	results	result	VBZ
cord-011302-pfepyvaw	36	43	in	in	IN
cord-011302-pfepyvaw	36	44	the	the	DT
cord-011302-pfepyvaw	36	45	poor	poor	JJ
cord-011302-pfepyvaw	36	46	outcome	outcome	NN
cord-011302-pfepyvaw	36	47	.	.	.
cord-011302-pfepyvaw	37	1	There	there	EX
cord-011302-pfepyvaw	37	2	has	have	VBZ
cord-011302-pfepyvaw	37	3	also	also	RB
cord-011302-pfepyvaw	37	4	been	be	VBN
cord-011302-pfepyvaw	37	5	a	a	DT
cord-011302-pfepyvaw	37	6	significant	significant	JJ
cord-011302-pfepyvaw	37	7	shift	shift	NN
cord-011302-pfepyvaw	37	8	in	in	IN
cord-011302-pfepyvaw	37	9	practice	practice	NN
cord-011302-pfepyvaw	37	10	in	in	IN
cord-011302-pfepyvaw	37	11	the	the	DT
cord-011302-pfepyvaw	37	12	last	last	JJ
cord-011302-pfepyvaw	37	13	15	15	CD
cord-011302-pfepyvaw	37	14	years	year	NNS
cord-011302-pfepyvaw	37	15	towards	towards	IN
cord-011302-pfepyvaw	37	16	coiling	coil	VBG
cord-011302-pfepyvaw	37	17	,	,	,
cord-011302-pfepyvaw	37	18	rather	rather	RB
cord-011302-pfepyvaw	37	19	than	than	IN
cord-011302-pfepyvaw	37	20	clipping	clip	VBG
cord-011302-pfepyvaw	37	21	since	since	IN
cord-011302-pfepyvaw	37	22	the	the	DT
cord-011302-pfepyvaw	37	23	International	International	NNP
cord-011302-pfepyvaw	37	24	Subarachnoid	Subarachnoid	NNP
cord-011302-pfepyvaw	37	25	Aneurysm	Aneurysm	NNP
cord-011302-pfepyvaw	37	26	Trial	Trial	NNP
cord-011302-pfepyvaw	37	27	(	(	-LRB-
cord-011302-pfepyvaw	37	28	ISAT	ISAT	NNP
cord-011302-pfepyvaw	37	29	)	)	-RRB-
cord-011302-pfepyvaw	37	30	[	[	-LRB-
cord-011302-pfepyvaw	37	31	25	25	CD
cord-011302-pfepyvaw	37	32	]	]	-RRB-
cord-011302-pfepyvaw	37	33	.	.	.
cord-011302-pfepyvaw	38	1	Subsequent	subsequent	JJ
cord-011302-pfepyvaw	38	2	sub	sub	JJ
cord-011302-pfepyvaw	38	3	-	-	JJ
cord-011302-pfepyvaw	38	4	group	group	JJ
cord-011302-pfepyvaw	38	5	analysis	analysis	NN
cord-011302-pfepyvaw	38	6	of	of	IN
cord-011302-pfepyvaw	38	7	patients	patient	NNS
cord-011302-pfepyvaw	38	8	aged	age	VBN
cord-011302-pfepyvaw	38	9	65	65	CD
cord-011302-pfepyvaw	38	10	years	year	NNS
cord-011302-pfepyvaw	38	11	and	and	CC
cord-011302-pfepyvaw	38	12	over	over	RB
cord-011302-pfepyvaw	38	13	suggested	suggest	VBD
cord-011302-pfepyvaw	38	14	a	a	DT
cord-011302-pfepyvaw	38	15	trend	trend	NN
cord-011302-pfepyvaw	38	16	towards	towards	IN
cord-011302-pfepyvaw	38	17	better	well	JJR
cord-011302-pfepyvaw	38	18	outcomes	outcome	NNS
cord-011302-pfepyvaw	38	19	with	with	IN
cord-011302-pfepyvaw	38	20	endovascular	endovascular	JJ
cord-011302-pfepyvaw	38	21	treatment	treatment	NN
cord-011302-pfepyvaw	38	22	compared	compare	VBN
cord-011302-pfepyvaw	38	23	to	to	IN
cord-011302-pfepyvaw	38	24	clipping	clip	VBG
cord-011302-pfepyvaw	38	25	,	,	,
cord-011302-pfepyvaw	38	26	although	although	IN
cord-011302-pfepyvaw	38	27	this	this	DT
cord-011302-pfepyvaw	38	28	was	be	VBD
cord-011302-pfepyvaw	38	29	subject	subject	JJ
cord-011302-pfepyvaw	38	30	to	to	IN
cord-011302-pfepyvaw	38	31	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	38	32	location	location	NN
cord-011302-pfepyvaw	38	33	[	[	-LRB-
cord-011302-pfepyvaw	38	34	30	30	CD
cord-011302-pfepyvaw	38	35	]	]	-RRB-
cord-011302-pfepyvaw	38	36	.	.	.
cord-011302-pfepyvaw	39	1	Lower	low	JJR
cord-011302-pfepyvaw	39	2	rates	rate	NNS
cord-011302-pfepyvaw	39	3	of	of	IN
cord-011302-pfepyvaw	39	4	infectious	infectious	JJ
cord-011302-pfepyvaw	39	5	and	and	CC
cord-011302-pfepyvaw	39	6	pulmonary	pulmonary	JJ
cord-011302-pfepyvaw	39	7	complications	complication	NNS
cord-011302-pfepyvaw	39	8	and	and	CC
cord-011302-pfepyvaw	39	9	epilepsy	epilepsy	NN
cord-011302-pfepyvaw	39	10	occurred	occur	VBD
cord-011302-pfepyvaw	39	11	in	in	IN
cord-011302-pfepyvaw	39	12	the	the	DT
cord-011302-pfepyvaw	39	13	endovascular	endovascular	JJ
cord-011302-pfepyvaw	39	14	group	group	NN
cord-011302-pfepyvaw	39	15	.	.	.
cord-011302-pfepyvaw	40	1	This	this	DT
cord-011302-pfepyvaw	40	2	was	be	VBD
cord-011302-pfepyvaw	40	3	supported	support	VBN
cord-011302-pfepyvaw	40	4	by	by	IN
cord-011302-pfepyvaw	40	5	the	the	DT
cord-011302-pfepyvaw	40	6	Barrow	Barrow	NNP
cord-011302-pfepyvaw	40	7	Ruptured	rupture	VBD
cord-011302-pfepyvaw	40	8	Aneurysm	Aneurysm	NNP
cord-011302-pfepyvaw	40	9	Trial	Trial	NNP
cord-011302-pfepyvaw	40	10	(	(	-LRB-
cord-011302-pfepyvaw	40	11	BRAT	BRAT	NNP
cord-011302-pfepyvaw	40	12	)	)	-RRB-
cord-011302-pfepyvaw	40	13	which	which	WDT
cord-011302-pfepyvaw	40	14	showed	show	VBD
cord-011302-pfepyvaw	40	15	significantly	significantly	RB
cord-011302-pfepyvaw	40	16	poorer	poor	JJR
cord-011302-pfepyvaw	40	17	outcomes	outcome	NNS
cord-011302-pfepyvaw	40	18	at	at	IN
cord-011302-pfepyvaw	40	19	1	1	CD
cord-011302-pfepyvaw	40	20	year	year	NN
cord-011302-pfepyvaw	40	21	in	in	IN
cord-011302-pfepyvaw	40	22	patients	patient	NNS
cord-011302-pfepyvaw	40	23	over	over	IN
cord-011302-pfepyvaw	40	24	50	50	CD
cord-011302-pfepyvaw	40	25	years	year	NNS
cord-011302-pfepyvaw	40	26	old	old	JJ
cord-011302-pfepyvaw	40	27	treated	treat	VBN
cord-011302-pfepyvaw	40	28	with	with	IN
cord-011302-pfepyvaw	40	29	clipping	clip	VBG
cord-011302-pfepyvaw	40	30	[	[	-LRB-
cord-011302-pfepyvaw	40	31	21	21	CD
cord-011302-pfepyvaw	40	32	]	]	-RRB-
cord-011302-pfepyvaw	40	33	.	.	.
cord-011302-pfepyvaw	41	1	A	a	DT
cord-011302-pfepyvaw	41	2	recent	recent	JJ
cord-011302-pfepyvaw	41	3	systematic	systematic	JJ
cord-011302-pfepyvaw	41	4	review	review	NN
cord-011302-pfepyvaw	41	5	of	of	IN
cord-011302-pfepyvaw	41	6	endovascular	endovascular	JJ
cord-011302-pfepyvaw	41	7	treatment	treatment	NN
cord-011302-pfepyvaw	41	8	of	of	IN
cord-011302-pfepyvaw	41	9	ruptured	ruptured	JJ
cord-011302-pfepyvaw	41	10	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	41	11	in	in	IN
cord-011302-pfepyvaw	41	12	patients	patient	NNS
cord-011302-pfepyvaw	41	13	aged	age	VBN
cord-011302-pfepyvaw	41	14	over	over	IN
cord-011302-pfepyvaw	41	15	65	65	CD
cord-011302-pfepyvaw	41	16	reported	report	VBD
cord-011302-pfepyvaw	41	17	good	good	JJ
cord-011302-pfepyvaw	41	18	outcomes	outcome	NNS
cord-011302-pfepyvaw	41	19	in	in	IN
cord-011302-pfepyvaw	41	20	66	66	CD
cord-011302-pfepyvaw	41	21	%	%	NN
cord-011302-pfepyvaw	41	22	,	,	,
cord-011302-pfepyvaw	41	23	with	with	IN
cord-011302-pfepyvaw	41	24	a	a	DT
cord-011302-pfepyvaw	41	25	mortality	mortality	NN
cord-011302-pfepyvaw	41	26	rate	rate	NN
cord-011302-pfepyvaw	41	27	of	of	IN
cord-011302-pfepyvaw	41	28	around	around	IN
cord-011302-pfepyvaw	41	29	26	26	CD
cord-011302-pfepyvaw	41	30	%	%	NN
cord-011302-pfepyvaw	41	31	at	at	IN
cord-011302-pfepyvaw	41	32	1	1	CD
cord-011302-pfepyvaw	41	33	year	year	NN
cord-011302-pfepyvaw	41	34	[	[	-LRB-
cord-011302-pfepyvaw	41	35	36	36	CD
cord-011302-pfepyvaw	41	36	]	]	-RRB-
cord-011302-pfepyvaw	41	37	.	.	.
cord-011302-pfepyvaw	42	1	With	with	IN
cord-011302-pfepyvaw	42	2	an	an	DT
cord-011302-pfepyvaw	42	3	86	86	CD
cord-011302-pfepyvaw	42	4	%	%	NN
cord-011302-pfepyvaw	42	5	complete	complete	JJ
cord-011302-pfepyvaw	42	6	or	or	CC
cord-011302-pfepyvaw	42	7	near	near	RB
cord-011302-pfepyvaw	42	8	-	-	HYPH
cord-011302-pfepyvaw	42	9	complete	complete	JJ
cord-011302-pfepyvaw	42	10	occlusion	occlusion	NN
cord-011302-pfepyvaw	42	11	rate	rate	NN
cord-011302-pfepyvaw	42	12	at	at	IN
cord-011302-pfepyvaw	42	13	long	long	JJ
cord-011302-pfepyvaw	42	14	-	-	HYPH
cord-011302-pfepyvaw	42	15	term	term	NN
cord-011302-pfepyvaw	42	16	follow	follow	NN
cord-011302-pfepyvaw	42	17	-	-	HYPH
cord-011302-pfepyvaw	42	18	up	up	NN
cord-011302-pfepyvaw	42	19	,	,	,
cord-011302-pfepyvaw	42	20	endovascular	endovascular	JJ
cord-011302-pfepyvaw	42	21	treatment	treatment	NN
cord-011302-pfepyvaw	42	22	is	be	VBZ
cord-011302-pfepyvaw	42	23	preferred	prefer	VBN
cord-011302-pfepyvaw	42	24	to	to	IN
cord-011302-pfepyvaw	42	25	clipping	clip	VBG
cord-011302-pfepyvaw	42	26	and	and	CC
cord-011302-pfepyvaw	42	27	probably	probably	RB
cord-011302-pfepyvaw	42	28	reduces	reduce	VBZ
cord-011302-pfepyvaw	42	29	risks	risk	NNS
cord-011302-pfepyvaw	42	30	for	for	IN
cord-011302-pfepyvaw	42	31	older	old	JJR
cord-011302-pfepyvaw	42	32	patients	patient	NNS
cord-011302-pfepyvaw	42	33	.	.	.
cord-011302-pfepyvaw	43	1	Koffijberg	Koffijberg	NNP
cord-011302-pfepyvaw	43	2	analysed	analyse	VBD
cord-011302-pfepyvaw	43	3	the	the	DT
cord-011302-pfepyvaw	43	4	cost	cost	NN
cord-011302-pfepyvaw	43	5	-	-	HYPH
cord-011302-pfepyvaw	43	6	effectiveness	effectiveness	NN
cord-011302-pfepyvaw	43	7	of	of	IN
cord-011302-pfepyvaw	43	8	treating	treat	VBG
cord-011302-pfepyvaw	43	9	ruptured	rupture	VBN
cord-011302-pfepyvaw	43	10	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	43	11	in	in	IN
cord-011302-pfepyvaw	43	12	patients	patient	NNS
cord-011302-pfepyvaw	43	13	aged	age	VBN
cord-011302-pfepyvaw	43	14	over	over	IN
cord-011302-pfepyvaw	43	15	70	70	CD
cord-011302-pfepyvaw	43	16	,	,	,
cord-011302-pfepyvaw	43	17	identifying	identify	VBG
cord-011302-pfepyvaw	43	18	key	key	JJ
cord-011302-pfepyvaw	43	19	parameters	parameter	NNS
cord-011302-pfepyvaw	43	20	including	include	VBG
cord-011302-pfepyvaw	43	21	patient	patient	JJ
cord-011302-pfepyvaw	43	22	age	age	NN
cord-011302-pfepyvaw	43	23	(	(	-LRB-
cord-011302-pfepyvaw	43	24	and	and	CC
cord-011302-pfepyvaw	43	25	thus	thus	RB
cord-011302-pfepyvaw	43	26	life	life	NN
cord-011302-pfepyvaw	43	27	expectancy	expectancy	NN
cord-011302-pfepyvaw	43	28	)	)	-RRB-
cord-011302-pfepyvaw	43	29	,	,	,
cord-011302-pfepyvaw	43	30	good	good	JJ
cord-011302-pfepyvaw	43	31	or	or	CC
cord-011302-pfepyvaw	43	32	poor	poor	JJ
cord-011302-pfepyvaw	43	33	clinical	clinical	JJ
cord-011302-pfepyvaw	43	34	condition	condition	NN
cord-011302-pfepyvaw	43	35	on	on	IN
cord-011302-pfepyvaw	43	36	presentation	presentation	NN
cord-011302-pfepyvaw	43	37	,	,	,
cord-011302-pfepyvaw	43	38	conservative	conservative	JJ
cord-011302-pfepyvaw	43	39	or	or	CC
cord-011302-pfepyvaw	43	40	occlusive	occlusive	JJ
cord-011302-pfepyvaw	43	41	treatment	treatment	NN
cord-011302-pfepyvaw	43	42	(	(	-LRB-
cord-011302-pfepyvaw	43	43	clipping	clip	VBG
cord-011302-pfepyvaw	43	44	or	or	CC
cord-011302-pfepyvaw	43	45	coiling	coil	VBG
cord-011302-pfepyvaw	43	46	)	)	-RRB-
cord-011302-pfepyvaw	43	47	and	and	CC
cord-011302-pfepyvaw	43	48	good	good	JJ
cord-011302-pfepyvaw	43	49	or	or	CC
cord-011302-pfepyvaw	43	50	poor	poor	JJ
cord-011302-pfepyvaw	43	51	outcomes	outcome	NNS
cord-011302-pfepyvaw	43	52	[	[	-LRB-
cord-011302-pfepyvaw	43	53	18	18	CD
cord-011302-pfepyvaw	43	54	]	]	-RRB-
cord-011302-pfepyvaw	43	55	.	.	.
cord-011302-pfepyvaw	44	1	Perhaps	perhaps	RB
cord-011302-pfepyvaw	44	2	surprisingly	surprisingly	RB
cord-011302-pfepyvaw	44	3	,	,	,
cord-011302-pfepyvaw	44	4	occlusive	occlusive	JJ
cord-011302-pfepyvaw	44	5	treatment	treatment	NN
cord-011302-pfepyvaw	44	6	of	of	IN
cord-011302-pfepyvaw	44	7	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	44	8	translated	translate	VBN
cord-011302-pfepyvaw	44	9	into	into	IN
cord-011302-pfepyvaw	44	10	a	a	DT
cord-011302-pfepyvaw	44	11	health	health	NN
cord-011302-pfepyvaw	44	12	benefit	benefit	NN
cord-011302-pfepyvaw	44	13	for	for	IN
cord-011302-pfepyvaw	44	14	all	all	DT
cord-011302-pfepyvaw	44	15	older	old	JJR
cord-011302-pfepyvaw	44	16	patients	patient	NNS
cord-011302-pfepyvaw	44	17	presenting	present	VBG
cord-011302-pfepyvaw	44	18	within	within	IN
cord-011302-pfepyvaw	44	19	4	4	CD
cord-011302-pfepyvaw	44	20	days	day	NNS
cord-011302-pfepyvaw	44	21	of	of	IN
cord-011302-pfepyvaw	44	22	SAH	SAH	NNP
cord-011302-pfepyvaw	44	23	,	,	,
cord-011302-pfepyvaw	44	24	regardless	regardless	RB
cord-011302-pfepyvaw	44	25	of	of	IN
cord-011302-pfepyvaw	44	26	the	the	DT
cord-011302-pfepyvaw	44	27	good	good	JJ
cord-011302-pfepyvaw	44	28	or	or	CC
cord-011302-pfepyvaw	44	29	poor	poor	JJ
cord-011302-pfepyvaw	44	30	condition	condition	NN
cord-011302-pfepyvaw	44	31	at	at	IN
cord-011302-pfepyvaw	44	32	presentation	presentation	NN
cord-011302-pfepyvaw	44	33	.	.	.
cord-011302-pfepyvaw	45	1	A	a	DT
cord-011302-pfepyvaw	45	2	later	later	JJ
cord-011302-pfepyvaw	45	3	presentation	presentation	NN
cord-011302-pfepyvaw	45	4	,	,	,
cord-011302-pfepyvaw	45	5	particularly	particularly	RB
cord-011302-pfepyvaw	45	6	10	10	CD
cord-011302-pfepyvaw	45	7	days	day	NNS
cord-011302-pfepyvaw	45	8	or	or	CC
cord-011302-pfepyvaw	45	9	more	more	JJR
cord-011302-pfepyvaw	45	10	after	after	IN
cord-011302-pfepyvaw	45	11	SAH	SAH	NNP
cord-011302-pfepyvaw	45	12	,	,	,
cord-011302-pfepyvaw	45	13	was	be	VBD
cord-011302-pfepyvaw	45	14	more	more	RBR
cord-011302-pfepyvaw	45	15	likely	likely	JJ
cord-011302-pfepyvaw	45	16	to	to	TO
cord-011302-pfepyvaw	45	17	result	result	VB
cord-011302-pfepyvaw	45	18	in	in	IN
cord-011302-pfepyvaw	45	19	no	no	DT
cord-011302-pfepyvaw	45	20	or	or	CC
cord-011302-pfepyvaw	45	21	minimal	minimal	JJ
cord-011302-pfepyvaw	45	22	treatment	treatment	NN
cord-011302-pfepyvaw	45	23	benefits	benefit	NNS
cord-011302-pfepyvaw	45	24	.	.	.
cord-011302-pfepyvaw	46	1	However	however	RB
cord-011302-pfepyvaw	46	2	,	,	,
cord-011302-pfepyvaw	46	3	occlusive	occlusive	JJ
cord-011302-pfepyvaw	46	4	treatment	treatment	NN
cord-011302-pfepyvaw	46	5	was	be	VBD
cord-011302-pfepyvaw	46	6	only	only	RB
cord-011302-pfepyvaw	46	7	found	find	VBN
cord-011302-pfepyvaw	46	8	to	to	TO
cord-011302-pfepyvaw	46	9	be	be	VB
cord-011302-pfepyvaw	46	10	cost	cost	NN
cord-011302-pfepyvaw	46	11	-	-	HYPH
cord-011302-pfepyvaw	46	12	effective	effective	JJ
cord-011302-pfepyvaw	46	13	in	in	IN
cord-011302-pfepyvaw	46	14	women	woman	NNS
cord-011302-pfepyvaw	46	15	aged	age	VBN
cord-011302-pfepyvaw	46	16	70	70	CD
cord-011302-pfepyvaw	46	17	-	-	SYM
cord-011302-pfepyvaw	46	18	79	79	CD
cord-011302-pfepyvaw	46	19	,	,	,
cord-011302-pfepyvaw	46	20	and	and	CC
cord-011302-pfepyvaw	46	21	men	man	NNS
cord-011302-pfepyvaw	46	22	aged	age	VBD
cord-011302-pfepyvaw	46	23	70	70	CD
cord-011302-pfepyvaw	46	24	-	-	SYM
cord-011302-pfepyvaw	46	25	74	74	CD
cord-011302-pfepyvaw	46	26	presenting	present	VBG
cord-011302-pfepyvaw	46	27	in	in	IN
cord-011302-pfepyvaw	46	28	a	a	DT
cord-011302-pfepyvaw	46	29	good	good	JJ
cord-011302-pfepyvaw	46	30	condition	condition	NN
cord-011302-pfepyvaw	46	31	,	,	,
cord-011302-pfepyvaw	46	32	within	within	IN
cord-011302-pfepyvaw	46	33	4	4	CD
cord-011302-pfepyvaw	46	34	days	day	NNS
cord-011302-pfepyvaw	46	35	of	of	IN
cord-011302-pfepyvaw	46	36	SAH	SAH	NNP
cord-011302-pfepyvaw	46	37	.	.	.
cord-011302-pfepyvaw	47	1	Thus	thus	RB
cord-011302-pfepyvaw	47	2	,	,	,
cord-011302-pfepyvaw	47	3	although	although	IN
cord-011302-pfepyvaw	47	4	potentially	potentially	RB
cord-011302-pfepyvaw	47	5	offering	offer	VBG
cord-011302-pfepyvaw	47	6	some	some	DT
cord-011302-pfepyvaw	47	7	clinical	clinical	JJ
cord-011302-pfepyvaw	47	8	benefit	benefit	NN
cord-011302-pfepyvaw	47	9	,	,	,
cord-011302-pfepyvaw	47	10	occlusive	occlusive	JJ
cord-011302-pfepyvaw	47	11	treatment	treatment	NN
cord-011302-pfepyvaw	47	12	is	be	VBZ
cord-011302-pfepyvaw	47	13	clearly	clearly	RB
cord-011302-pfepyvaw	47	14	more	more	RBR
cord-011302-pfepyvaw	47	15	costly	costly	JJ
cord-011302-pfepyvaw	47	16	than	than	IN
cord-011302-pfepyvaw	47	17	conservative	conservative	JJ
cord-011302-pfepyvaw	47	18	management	management	NN
cord-011302-pfepyvaw	47	19	and	and	CC
cord-011302-pfepyvaw	47	20	may	may	MD
cord-011302-pfepyvaw	47	21	be	be	VB
cord-011302-pfepyvaw	47	22	particularly	particularly	RB
cord-011302-pfepyvaw	47	23	difficult	difficult	JJ
cord-011302-pfepyvaw	47	24	to	to	TO
cord-011302-pfepyvaw	47	25	justify	justify	VB
cord-011302-pfepyvaw	47	26	in	in	IN
cord-011302-pfepyvaw	47	27	those	those	DT
cord-011302-pfepyvaw	47	28	aged	age	VBN
cord-011302-pfepyvaw	47	29	80	80	CD
cord-011302-pfepyvaw	47	30	years	year	NNS
cord-011302-pfepyvaw	47	31	and	and	CC
cord-011302-pfepyvaw	47	32	over	over	IN
cord-011302-pfepyvaw	47	33	presenting	present	VBG
cord-011302-pfepyvaw	47	34	in	in	IN
cord-011302-pfepyvaw	47	35	a	a	DT
cord-011302-pfepyvaw	47	36	poor	poor	JJ
cord-011302-pfepyvaw	47	37	condition	condition	NN
cord-011302-pfepyvaw	47	38	.	.	.
cord-011302-pfepyvaw	48	1	It	-PRON-	PRP
cord-011302-pfepyvaw	48	2	is	be	VBZ
cord-011302-pfepyvaw	48	3	,	,	,
cord-011302-pfepyvaw	48	4	however	however	RB
cord-011302-pfepyvaw	48	5	,	,	,
cord-011302-pfepyvaw	48	6	also	also	RB
cord-011302-pfepyvaw	48	7	important	important	JJ
cord-011302-pfepyvaw	48	8	to	to	TO
cord-011302-pfepyvaw	48	9	highlight	highlight	VB
cord-011302-pfepyvaw	48	10	that	that	IN
cord-011302-pfepyvaw	48	11	studies	study	NNS
cord-011302-pfepyvaw	48	12	assessing	assess	VBG
cord-011302-pfepyvaw	48	13	interventions	intervention	NNS
cord-011302-pfepyvaw	48	14	such	such	JJ
cord-011302-pfepyvaw	48	15	as	as	IN
cord-011302-pfepyvaw	48	16	this	this	DT
cord-011302-pfepyvaw	48	17	will	will	MD
cord-011302-pfepyvaw	48	18	contain	contain	VB
cord-011302-pfepyvaw	48	19	inherent	inherent	JJ
cord-011302-pfepyvaw	48	20	selection	selection	NN
cord-011302-pfepyvaw	48	21	bias	bias	NN
cord-011302-pfepyvaw	48	22	,	,	,
cord-011302-pfepyvaw	48	23	by	by	IN
cord-011302-pfepyvaw	48	24	virtue	virtue	NN
cord-011302-pfepyvaw	48	25	of	of	IN
cord-011302-pfepyvaw	48	26	the	the	DT
cord-011302-pfepyvaw	48	27	fact	fact	NN
cord-011302-pfepyvaw	48	28	that	that	IN
cord-011302-pfepyvaw	48	29	the	the	DT
cord-011302-pfepyvaw	48	30	patients	patient	NNS
cord-011302-pfepyvaw	48	31	undergoing	undergo	VBG
cord-011302-pfepyvaw	48	32	intervention	intervention	NN
cord-011302-pfepyvaw	48	33	differ	differ	VBP
cord-011302-pfepyvaw	48	34	from	from	IN
cord-011302-pfepyvaw	48	35	those	those	DT
cord-011302-pfepyvaw	48	36	that	that	WDT
cord-011302-pfepyvaw	48	37	were	be	VBD
cord-011302-pfepyvaw	48	38	not	not	RB
cord-011302-pfepyvaw	48	39	.	.	.
cord-011302-pfepyvaw	49	1	Such	such	JJ
cord-011302-pfepyvaw	49	2	results	result	NNS
cord-011302-pfepyvaw	49	3	should	should	MD
cord-011302-pfepyvaw	49	4	be	be	VB
cord-011302-pfepyvaw	49	5	treated	treat	VBN
cord-011302-pfepyvaw	49	6	with	with	IN
cord-011302-pfepyvaw	49	7	caution	caution	NN
cord-011302-pfepyvaw	49	8	until	until	IN
cord-011302-pfepyvaw	49	9	clear	clear	JJ
cord-011302-pfepyvaw	49	10	,	,	,
cord-011302-pfepyvaw	49	11	prospective	prospective	JJ
cord-011302-pfepyvaw	49	12	,	,	,
cord-011302-pfepyvaw	49	13	evidence	evidence	NN
cord-011302-pfepyvaw	49	14	is	be	VBZ
cord-011302-pfepyvaw	49	15	available	available	JJ
cord-011302-pfepyvaw	49	16	.	.	.
cord-011302-pfepyvaw	50	1	It	-PRON-	PRP
cord-011302-pfepyvaw	50	2	is	be	VBZ
cord-011302-pfepyvaw	50	3	apparent	apparent	JJ
cord-011302-pfepyvaw	50	4	that	that	IN
cord-011302-pfepyvaw	50	5	patients	patient	NNS
cord-011302-pfepyvaw	50	6	presenting	present	VBG
cord-011302-pfepyvaw	50	7	in	in	IN
cord-011302-pfepyvaw	50	8	a	a	DT
cord-011302-pfepyvaw	50	9	poor	poor	JJ
cord-011302-pfepyvaw	50	10	condition	condition	NN
cord-011302-pfepyvaw	50	11	and	and	CC
cord-011302-pfepyvaw	50	12	aged	age	VBN
cord-011302-pfepyvaw	50	13	over	over	IN
cord-011302-pfepyvaw	50	14	70	70	CD
cord-011302-pfepyvaw	50	15	are	be	VBP
cord-011302-pfepyvaw	50	16	likely	likely	JJ
cord-011302-pfepyvaw	50	17	to	to	TO
cord-011302-pfepyvaw	50	18	have	have	VB
cord-011302-pfepyvaw	50	19	a	a	DT
cord-011302-pfepyvaw	50	20	poor	poor	JJ
cord-011302-pfepyvaw	50	21	outcome	outcome	NN
cord-011302-pfepyvaw	50	22	,	,	,
cord-011302-pfepyvaw	50	23	and	and	CC
cord-011302-pfepyvaw	50	24	a	a	DT
cord-011302-pfepyvaw	50	25	conservative	conservative	JJ
cord-011302-pfepyvaw	50	26	approach	approach	NN
cord-011302-pfepyvaw	50	27	may	may	MD
cord-011302-pfepyvaw	50	28	be	be	VB
cord-011302-pfepyvaw	50	29	appropriate	appropriate	JJ
cord-011302-pfepyvaw	50	30	in	in	IN
cord-011302-pfepyvaw	50	31	these	these	DT
cord-011302-pfepyvaw	50	32	patients	patient	NNS
cord-011302-pfepyvaw	50	33	.	.	.
cord-011302-pfepyvaw	51	1	More	More	JJR
cord-011302-pfepyvaw	51	2	prospective	prospective	JJ
cord-011302-pfepyvaw	51	3	research	research	NN
cord-011302-pfepyvaw	51	4	is	be	VBZ
cord-011302-pfepyvaw	51	5	needed	need	VBN
cord-011302-pfepyvaw	51	6	to	to	TO
cord-011302-pfepyvaw	51	7	understand	understand	VB
cord-011302-pfepyvaw	51	8	the	the	DT
cord-011302-pfepyvaw	51	9	risk	risk	NN
cord-011302-pfepyvaw	51	10	-	-	HYPH
cord-011302-pfepyvaw	51	11	benefit	benefit	NN
cord-011302-pfepyvaw	51	12	profile	profile	NN
cord-011302-pfepyvaw	51	13	of	of	IN
cord-011302-pfepyvaw	51	14	treating	treat	VBG
cord-011302-pfepyvaw	51	15	well	well	NN
cord-011302-pfepyvaw	51	16	patients	patient	NNS
cord-011302-pfepyvaw	51	17	,	,	,
cord-011302-pfepyvaw	51	18	particularly	particularly	RB
cord-011302-pfepyvaw	51	19	those	those	DT
cord-011302-pfepyvaw	51	20	aged	age	VBN
cord-011302-pfepyvaw	51	21	over	over	IN
cord-011302-pfepyvaw	51	22	80	80	CD
cord-011302-pfepyvaw	51	23	.	.	.
cord-011302-pfepyvaw	52	1	The	the	DT
cord-011302-pfepyvaw	52	2	current	current	JJ
cord-011302-pfepyvaw	52	3	literature	literature	NN
cord-011302-pfepyvaw	52	4	supports	support	VBZ
cord-011302-pfepyvaw	52	5	active	active	JJ
cord-011302-pfepyvaw	52	6	intervention	intervention	NN
cord-011302-pfepyvaw	52	7	for	for	IN
cord-011302-pfepyvaw	52	8	those	those	DT
cord-011302-pfepyvaw	52	9	under	under	IN
cord-011302-pfepyvaw	52	10	80	80	CD
cord-011302-pfepyvaw	52	11	,	,	,
cord-011302-pfepyvaw	52	12	with	with	IN
cord-011302-pfepyvaw	52	13	an	an	DT
cord-011302-pfepyvaw	52	14	awareness	awareness	NN
cord-011302-pfepyvaw	52	15	of	of	IN
cord-011302-pfepyvaw	52	16	the	the	DT
cord-011302-pfepyvaw	52	17	increased	increase	VBN
cord-011302-pfepyvaw	52	18	risk	risk	NN
cord-011302-pfepyvaw	52	19	of	of	IN
cord-011302-pfepyvaw	52	20	complications	complication	NNS
cord-011302-pfepyvaw	52	21	,	,	,
cord-011302-pfepyvaw	52	22	but	but	CC
cord-011302-pfepyvaw	52	23	more	more	JJR
cord-011302-pfepyvaw	52	24	data	datum	NNS
cord-011302-pfepyvaw	52	25	are	be	VBP
cord-011302-pfepyvaw	52	26	needed	need	VBN
cord-011302-pfepyvaw	52	27	specifically	specifically	RB
cord-011302-pfepyvaw	52	28	in	in	IN
cord-011302-pfepyvaw	52	29	relation	relation	NN
cord-011302-pfepyvaw	52	30	to	to	IN
cord-011302-pfepyvaw	52	31	outcomes	outcome	NNS
cord-011302-pfepyvaw	52	32	with	with	IN
cord-011302-pfepyvaw	52	33	endovascular	endovascular	JJ
cord-011302-pfepyvaw	52	34	intervention	intervention	NN
cord-011302-pfepyvaw	52	35	.	.	.
cord-011302-pfepyvaw	53	1	The	the	DT
cord-011302-pfepyvaw	53	2	vast	vast	JJ
cord-011302-pfepyvaw	53	3	majority	majority	NN
cord-011302-pfepyvaw	53	4	of	of	IN
cord-011302-pfepyvaw	53	5	older	old	JJR
cord-011302-pfepyvaw	53	6	patients	patient	NNS
cord-011302-pfepyvaw	53	7	admitted	admit	VBN
cord-011302-pfepyvaw	53	8	to	to	IN
cord-011302-pfepyvaw	53	9	a	a	DT
cord-011302-pfepyvaw	53	10	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	53	11	unit	unit	NN
cord-011302-pfepyvaw	53	12	with	with	IN
cord-011302-pfepyvaw	53	13	head	head	NN
cord-011302-pfepyvaw	53	14	injury	injury	NN
cord-011302-pfepyvaw	53	15	have	have	VBP
cord-011302-pfepyvaw	53	16	a	a	DT
cord-011302-pfepyvaw	53	17	subdural	subdural	JJ
cord-011302-pfepyvaw	53	18	haematoma	haematoma	NN
cord-011302-pfepyvaw	53	19	,	,	,
cord-011302-pfepyvaw	53	20	most	most	RBS
cord-011302-pfepyvaw	53	21	commonly	commonly	RB
cord-011302-pfepyvaw	53	22	chronic	chronic	JJ
cord-011302-pfepyvaw	53	23	subdural	subdural	JJ
cord-011302-pfepyvaw	53	24	haematoma	haematoma	NN
cord-011302-pfepyvaw	53	25	(	(	-LRB-
cord-011302-pfepyvaw	53	26	CSDH	CSDH	NNP
cord-011302-pfepyvaw	53	27	)	)	-RRB-
cord-011302-pfepyvaw	53	28	,	,	,
cord-011302-pfepyvaw	53	29	followed	follow	VBN
cord-011302-pfepyvaw	53	30	by	by	IN
cord-011302-pfepyvaw	53	31	mixed	mixed	JJ
cord-011302-pfepyvaw	53	32	and	and	CC
cord-011302-pfepyvaw	53	33	then	then	RB
cord-011302-pfepyvaw	53	34	acute	acute	JJ
cord-011302-pfepyvaw	53	35	subdural	subdural	JJ
cord-011302-pfepyvaw	53	36	haematoma	haematoma	NN
cord-011302-pfepyvaw	53	37	(	(	-LRB-
cord-011302-pfepyvaw	53	38	ASDH	ASDH	NNP
cord-011302-pfepyvaw	53	39	)	)	-RRB-
cord-011302-pfepyvaw	53	40	[	[	-LRB-
cord-011302-pfepyvaw	53	41	41	41	CD
cord-011302-pfepyvaw	53	42	]	]	-RRB-
cord-011302-pfepyvaw	53	43	.	.	.
cord-011302-pfepyvaw	54	1	A	a	DT
cord-011302-pfepyvaw	54	2	CSDH	CSDH	NNP
cord-011302-pfepyvaw	54	3	is	be	VBZ
cord-011302-pfepyvaw	54	4	a	a	DT
cord-011302-pfepyvaw	54	5	condition	condition	NN
cord-011302-pfepyvaw	54	6	almost	almost	RB
cord-011302-pfepyvaw	54	7	exclusively	exclusively	RB
cord-011302-pfepyvaw	54	8	confined	confine	VBN
cord-011302-pfepyvaw	54	9	to	to	IN
cord-011302-pfepyvaw	54	10	the	the	DT
cord-011302-pfepyvaw	54	11	elderly	elderly	JJ
cord-011302-pfepyvaw	54	12	,	,	,
cord-011302-pfepyvaw	54	13	with	with	IN
cord-011302-pfepyvaw	54	14	a	a	DT
cord-011302-pfepyvaw	54	15	median	median	JJ
cord-011302-pfepyvaw	54	16	age	age	NN
cord-011302-pfepyvaw	54	17	of	of	IN
cord-011302-pfepyvaw	54	18	77	77	CD
cord-011302-pfepyvaw	54	19	in	in	IN
cord-011302-pfepyvaw	54	20	the	the	DT
cord-011302-pfepyvaw	54	21	UK	UK	NNP
cord-011302-pfepyvaw	54	22	[	[	-LRB-
cord-011302-pfepyvaw	54	23	4	4	CD
cord-011302-pfepyvaw	54	24	]	]	-RRB-
cord-011302-pfepyvaw	54	25	.	.	.
cord-011302-pfepyvaw	55	1	The	the	DT
cord-011302-pfepyvaw	55	2	post	post	JJ
cord-011302-pfepyvaw	55	3	-	-	JJ
cord-011302-pfepyvaw	55	4	traumatic	traumatic	JJ
cord-011302-pfepyvaw	55	5	pathophysiology	pathophysiology	NN
cord-011302-pfepyvaw	55	6	is	be	VBZ
cord-011302-pfepyvaw	55	7	complex	complex	JJ
cord-011302-pfepyvaw	55	8	;	;	:
cord-011302-pfepyvaw	55	9	it	-PRON-	PRP
cord-011302-pfepyvaw	55	10	takes	take	VBZ
cord-011302-pfepyvaw	55	11	weeks	week	NNS
cord-011302-pfepyvaw	55	12	to	to	IN
cord-011302-pfepyvaw	55	13	months	month	NNS
cord-011302-pfepyvaw	55	14	for	for	IN
cord-011302-pfepyvaw	55	15	the	the	DT
cord-011302-pfepyvaw	55	16	collection	collection	NN
cord-011302-pfepyvaw	55	17	of	of	IN
cord-011302-pfepyvaw	55	18	blood	blood	NN
cord-011302-pfepyvaw	55	19	and	and	CC
cord-011302-pfepyvaw	55	20	fluid	fluid	NN
cord-011302-pfepyvaw	55	21	to	to	TO
cord-011302-pfepyvaw	55	22	expand	expand	VB
cord-011302-pfepyvaw	55	23	:	:	:
cord-011302-pfepyvaw	56	1	evidences	evidence	NNS
cord-011302-pfepyvaw	56	2	support	support	VBP
cord-011302-pfepyvaw	56	3	the	the	DT
cord-011302-pfepyvaw	56	4	theory	theory	NN
cord-011302-pfepyvaw	56	5	that	that	IN
cord-011302-pfepyvaw	56	6	this	this	DT
cord-011302-pfepyvaw	56	7	is	be	VBZ
cord-011302-pfepyvaw	56	8	,	,	,
cord-011302-pfepyvaw	56	9	at	at	IN
cord-011302-pfepyvaw	56	10	least	least	JJS
cord-011302-pfepyvaw	56	11	in	in	IN
cord-011302-pfepyvaw	56	12	part	part	NN
cord-011302-pfepyvaw	56	13	,	,	,
cord-011302-pfepyvaw	56	14	due	due	IN
cord-011302-pfepyvaw	56	15	to	to	IN
cord-011302-pfepyvaw	56	16	an	an	DT
cord-011302-pfepyvaw	56	17	escalating	escalate	VBG
cord-011302-pfepyvaw	56	18	inflammatory	inflammatory	JJ
cord-011302-pfepyvaw	56	19	process	process	NN
cord-011302-pfepyvaw	56	20	[	[	-LRB-
cord-011302-pfepyvaw	56	21	8	8	CD
cord-011302-pfepyvaw	56	22	]	]	-RRB-
cord-011302-pfepyvaw	56	23	.	.	.
cord-011302-pfepyvaw	57	1	Many	many	JJ
cord-011302-pfepyvaw	57	2	patients	patient	NNS
cord-011302-pfepyvaw	57	3	have	have	VBP
cord-011302-pfepyvaw	57	4	no	no	DT
cord-011302-pfepyvaw	57	5	recollection	recollection	NN
cord-011302-pfepyvaw	57	6	of	of	IN
cord-011302-pfepyvaw	57	7	significant	significant	JJ
cord-011302-pfepyvaw	57	8	trauma	trauma	NN
cord-011302-pfepyvaw	57	9	and	and	CC
cord-011302-pfepyvaw	57	10	presentation	presentation	NN
cord-011302-pfepyvaw	57	11	is	be	VBZ
cord-011302-pfepyvaw	57	12	usually	usually	RB
cord-011302-pfepyvaw	57	13	with	with	IN
cord-011302-pfepyvaw	57	14	cognitive	cognitive	JJ
cord-011302-pfepyvaw	57	15	impairment	impairment	NN
cord-011302-pfepyvaw	57	16	,	,	,
cord-011302-pfepyvaw	57	17	gait	gait	JJ
cord-011302-pfepyvaw	57	18	disturbance	disturbance	NN
cord-011302-pfepyvaw	57	19	,	,	,
cord-011302-pfepyvaw	57	20	limb	limb	NN
cord-011302-pfepyvaw	57	21	weakness	weakness	NN
cord-011302-pfepyvaw	57	22	,	,	,
cord-011302-pfepyvaw	57	23	or	or	CC
cord-011302-pfepyvaw	57	24	headache	headache	NN
cord-011302-pfepyvaw	57	25	.	.	.
cord-011302-pfepyvaw	58	1	The	the	DT
cord-011302-pfepyvaw	58	2	mainstay	mainstay	NN
cord-011302-pfepyvaw	58	3	of	of	IN
cord-011302-pfepyvaw	58	4	treatment	treatment	NN
cord-011302-pfepyvaw	58	5	has	have	VBZ
cord-011302-pfepyvaw	58	6	been	be	VBN
cord-011302-pfepyvaw	58	7	surgical	surgical	JJ
cord-011302-pfepyvaw	58	8	drainage	drainage	NN
cord-011302-pfepyvaw	58	9	[	[	-LRB-
cord-011302-pfepyvaw	58	10	4	4	CD
cord-011302-pfepyvaw	58	11	,	,	,
cord-011302-pfepyvaw	58	12	31	31	CD
cord-011302-pfepyvaw	58	13	]	]	-RRB-
cord-011302-pfepyvaw	58	14	.	.	.
cord-011302-pfepyvaw	59	1	However	however	RB
cord-011302-pfepyvaw	59	2	,	,	,
cord-011302-pfepyvaw	59	3	recent	recent	JJ
cord-011302-pfepyvaw	59	4	trials	trial	NNS
cord-011302-pfepyvaw	59	5	have	have	VBP
cord-011302-pfepyvaw	59	6	focused	focus	VBN
cord-011302-pfepyvaw	59	7	on	on	IN
cord-011302-pfepyvaw	59	8	medical	medical	JJ
cord-011302-pfepyvaw	59	9	treatments	treatment	NNS
cord-011302-pfepyvaw	59	10	,	,	,
cord-011302-pfepyvaw	59	11	such	such	JJ
cord-011302-pfepyvaw	59	12	as	as	IN
cord-011302-pfepyvaw	59	13	steroids	steroid	NNS
cord-011302-pfepyvaw	59	14	,	,	,
cord-011302-pfepyvaw	59	15	for	for	IN
cord-011302-pfepyvaw	59	16	controlling	control	VBG
cord-011302-pfepyvaw	59	17	the	the	DT
cord-011302-pfepyvaw	59	18	inflammatory	inflammatory	JJ
cord-011302-pfepyvaw	59	19	response	response	NN
cord-011302-pfepyvaw	59	20	in	in	IN
cord-011302-pfepyvaw	59	21	CSDH	CSDH	NNP
cord-011302-pfepyvaw	59	22	,	,	,
cord-011302-pfepyvaw	59	23	and	and	CC
cord-011302-pfepyvaw	59	24	,	,	,
cord-011302-pfepyvaw	59	25	therefore	therefore	RB
cord-011302-pfepyvaw	59	26	,	,	,
cord-011302-pfepyvaw	59	27	either	either	CC
cord-011302-pfepyvaw	59	28	reducing	reduce	VBG
cord-011302-pfepyvaw	59	29	CSDH	CSDH	NNP
cord-011302-pfepyvaw	59	30	recurrence	recurrence	NN
cord-011302-pfepyvaw	59	31	following	follow	VBG
cord-011302-pfepyvaw	59	32	surgery	surgery	NN
cord-011302-pfepyvaw	59	33	or	or	CC
cord-011302-pfepyvaw	59	34	even	even	RB
cord-011302-pfepyvaw	59	35	as	as	IN
cord-011302-pfepyvaw	59	36	a	a	DT
cord-011302-pfepyvaw	59	37	first	first	JJ
cord-011302-pfepyvaw	59	38	-	-	HYPH
cord-011302-pfepyvaw	59	39	line	line	NN
cord-011302-pfepyvaw	59	40	treatment	treatment	NN
cord-011302-pfepyvaw	59	41	[	[	-LRB-
cord-011302-pfepyvaw	59	42	9	9	CD
cord-011302-pfepyvaw	59	43	,	,	,
cord-011302-pfepyvaw	59	44	15	15	CD
cord-011302-pfepyvaw	59	45	,	,	,
cord-011302-pfepyvaw	59	46	19	19	CD
cord-011302-pfepyvaw	59	47	,	,	,
cord-011302-pfepyvaw	59	48	24	24	CD
cord-011302-pfepyvaw	59	49	]	]	-RRB-
cord-011302-pfepyvaw	59	50	.	.	.
cord-011302-pfepyvaw	60	1	Any	any	DT
cord-011302-pfepyvaw	60	2	treatment	treatment	NN
cord-011302-pfepyvaw	60	3	which	which	WDT
cord-011302-pfepyvaw	60	4	reduces	reduce	VBZ
cord-011302-pfepyvaw	60	5	CSDH	CSDH	NNP
cord-011302-pfepyvaw	60	6	recurrence	recurrence	NN
cord-011302-pfepyvaw	60	7	has	have	VBZ
cord-011302-pfepyvaw	60	8	the	the	DT
cord-011302-pfepyvaw	60	9	potential	potential	NN
cord-011302-pfepyvaw	60	10	to	to	TO
cord-011302-pfepyvaw	60	11	reduce	reduce	VB
cord-011302-pfepyvaw	60	12	mortality	mortality	NN
cord-011302-pfepyvaw	60	13	,	,	,
cord-011302-pfepyvaw	60	14	which	which	WDT
cord-011302-pfepyvaw	60	15	can	can	MD
cord-011302-pfepyvaw	60	16	be	be	VB
cord-011302-pfepyvaw	60	17	as	as	RB
cord-011302-pfepyvaw	60	18	high	high	JJ
cord-011302-pfepyvaw	60	19	as	as	IN
cord-011302-pfepyvaw	60	20	18	18	CD
cord-011302-pfepyvaw	60	21	%	%	NN
cord-011302-pfepyvaw	60	22	at	at	IN
cord-011302-pfepyvaw	60	23	6	6	CD
cord-011302-pfepyvaw	60	24	months	month	NNS
cord-011302-pfepyvaw	60	25	[	[	-LRB-
cord-011302-pfepyvaw	60	26	31	31	CD
cord-011302-pfepyvaw	60	27	]	]	-RRB-
cord-011302-pfepyvaw	60	28	.	.	.
cord-011302-pfepyvaw	61	1	The	the	DT
cord-011302-pfepyvaw	61	2	outcome	outcome	NN
cord-011302-pfepyvaw	61	3	of	of	IN
cord-011302-pfepyvaw	61	4	these	these	DT
cord-011302-pfepyvaw	61	5	steroid	steroid	NN
cord-011302-pfepyvaw	61	6	trials	trial	NNS
cord-011302-pfepyvaw	61	7	is	be	VBZ
cord-011302-pfepyvaw	61	8	still	still	RB
cord-011302-pfepyvaw	61	9	awaited	await	VBN
cord-011302-pfepyvaw	61	10	,	,	,
cord-011302-pfepyvaw	61	11	but	but	CC
cord-011302-pfepyvaw	61	12	a	a	DT
cord-011302-pfepyvaw	61	13	move	move	NN
cord-011302-pfepyvaw	61	14	to	to	IN
cord-011302-pfepyvaw	61	15	more	more	JJR
cord-011302-pfepyvaw	61	16	conservative	conservative	JJ
cord-011302-pfepyvaw	61	17	treatments	treatment	NNS
cord-011302-pfepyvaw	61	18	of	of	IN
cord-011302-pfepyvaw	61	19	CSDH	CSDH	NNP
cord-011302-pfepyvaw	61	20	could	could	MD
cord-011302-pfepyvaw	61	21	benefit	benefit	VB
cord-011302-pfepyvaw	61	22	older	old	JJR
cord-011302-pfepyvaw	61	23	patients	patient	NNS
cord-011302-pfepyvaw	61	24	with	with	IN
cord-011302-pfepyvaw	61	25	multiple	multiple	JJ
cord-011302-pfepyvaw	61	26	co	co	NNS
cord-011302-pfepyvaw	61	27	-	-	NNS
cord-011302-pfepyvaw	61	28	morbidities	morbidity	NNS
cord-011302-pfepyvaw	61	29	who	who	WP
cord-011302-pfepyvaw	61	30	are	be	VBP
cord-011302-pfepyvaw	61	31	at	at	IN
cord-011302-pfepyvaw	61	32	increased	increase	VBN
cord-011302-pfepyvaw	61	33	risk	risk	NN
cord-011302-pfepyvaw	61	34	from	from	IN
cord-011302-pfepyvaw	61	35	anaesthesia	anaesthesia	NN
cord-011302-pfepyvaw	61	36	and	and	CC
cord-011302-pfepyvaw	61	37	surgical	surgical	JJ
cord-011302-pfepyvaw	61	38	treatment	treatment	NN
cord-011302-pfepyvaw	61	39	.	.	.
cord-011302-pfepyvaw	62	1	ASDHs	asdh	NNS
cord-011302-pfepyvaw	62	2	are	be	VBP
cord-011302-pfepyvaw	62	3	traditionally	traditionally	RB
cord-011302-pfepyvaw	62	4	considered	consider	VBN
cord-011302-pfepyvaw	62	5	to	to	TO
cord-011302-pfepyvaw	62	6	occur	occur	VB
cord-011302-pfepyvaw	62	7	in	in	IN
cord-011302-pfepyvaw	62	8	higher	high	JJR
cord-011302-pfepyvaw	62	9	impact	impact	NN
cord-011302-pfepyvaw	62	10	trauma	trauma	NN
cord-011302-pfepyvaw	62	11	,	,	,
cord-011302-pfepyvaw	62	12	leading	lead	VBG
cord-011302-pfepyvaw	62	13	to	to	IN
cord-011302-pfepyvaw	62	14	coma	coma	NN
cord-011302-pfepyvaw	62	15	and	and	CC
cord-011302-pfepyvaw	62	16	hence	hence	RB
cord-011302-pfepyvaw	62	17	a	a	DT
cord-011302-pfepyvaw	62	18	poorer	poor	JJR
cord-011302-pfepyvaw	62	19	prognosis	prognosis	NN
cord-011302-pfepyvaw	62	20	,	,	,
cord-011302-pfepyvaw	62	21	particularly	particularly	RB
cord-011302-pfepyvaw	62	22	in	in	IN
cord-011302-pfepyvaw	62	23	the	the	DT
cord-011302-pfepyvaw	62	24	elderly	elderly	JJ
cord-011302-pfepyvaw	62	25	.	.	.
cord-011302-pfepyvaw	63	1	However	however	RB
cord-011302-pfepyvaw	63	2	,	,	,
cord-011302-pfepyvaw	63	3	due	due	IN
cord-011302-pfepyvaw	63	4	to	to	IN
cord-011302-pfepyvaw	63	5	co	co	JJ
cord-011302-pfepyvaw	63	6	-	-	JJ
cord-011302-pfepyvaw	63	7	existent	existent	JJ
cord-011302-pfepyvaw	63	8	cerebral	cerebral	JJ
cord-011302-pfepyvaw	63	9	atrophy	atrophy	NN
cord-011302-pfepyvaw	63	10	in	in	IN
cord-011302-pfepyvaw	63	11	older	old	JJR
cord-011302-pfepyvaw	63	12	patients	patient	NNS
cord-011302-pfepyvaw	63	13	,	,	,
cord-011302-pfepyvaw	63	14	lower	lower	VB
cord-011302-pfepyvaw	63	15	energy	energy	NN
cord-011302-pfepyvaw	63	16	forces	force	NNS
cord-011302-pfepyvaw	63	17	(	(	-LRB-
cord-011302-pfepyvaw	63	18	falls	fall	VBZ
cord-011302-pfepyvaw	63	19	)	)	-RRB-
cord-011302-pfepyvaw	63	20	cause	cause	VB
cord-011302-pfepyvaw	63	21	most	most	JJS
cord-011302-pfepyvaw	63	22	traumatic	traumatic	JJ
cord-011302-pfepyvaw	63	23	brain	brain	NN
cord-011302-pfepyvaw	63	24	injuries	injury	NNS
cord-011302-pfepyvaw	63	25	in	in	IN
cord-011302-pfepyvaw	63	26	this	this	DT
cord-011302-pfepyvaw	63	27	age	age	NN
cord-011302-pfepyvaw	63	28	group	group	NN
cord-011302-pfepyvaw	63	29	,	,	,
cord-011302-pfepyvaw	63	30	and	and	CC
cord-011302-pfepyvaw	63	31	the	the	DT
cord-011302-pfepyvaw	63	32	onset	onset	NN
cord-011302-pfepyvaw	63	33	of	of	IN
cord-011302-pfepyvaw	63	34	neurological	neurological	JJ
cord-011302-pfepyvaw	63	35	deterioration	deterioration	NN
cord-011302-pfepyvaw	63	36	secondary	secondary	JJ
cord-011302-pfepyvaw	63	37	to	to	IN
cord-011302-pfepyvaw	63	38	an	an	DT
cord-011302-pfepyvaw	63	39	ASDH	ASDH	NNP
cord-011302-pfepyvaw	63	40	may	may	MD
cord-011302-pfepyvaw	63	41	be	be	VB
cord-011302-pfepyvaw	63	42	delayed	delay	VBN
cord-011302-pfepyvaw	63	43	.	.	.
cord-011302-pfepyvaw	64	1	This	this	DT
cord-011302-pfepyvaw	64	2	provides	provide	VBZ
cord-011302-pfepyvaw	64	3	an	an	DT
cord-011302-pfepyvaw	64	4	opportunity	opportunity	NN
cord-011302-pfepyvaw	64	5	for	for	IN
cord-011302-pfepyvaw	64	6	definitive	definitive	JJ
cord-011302-pfepyvaw	64	7	management	management	NN
cord-011302-pfepyvaw	64	8	,	,	,
cord-011302-pfepyvaw	64	9	following	follow	VBG
cord-011302-pfepyvaw	64	10	an	an	DT
cord-011302-pfepyvaw	64	11	early	early	JJ
cord-011302-pfepyvaw	64	12	CT	CT	NNP
cord-011302-pfepyvaw	64	13	scan	scan	NN
cord-011302-pfepyvaw	64	14	,	,	,
cord-011302-pfepyvaw	64	15	as	as	IN
cord-011302-pfepyvaw	64	16	recommended	recommend	VBN
cord-011302-pfepyvaw	64	17	by	by	IN
cord-011302-pfepyvaw	64	18	NICE	nice	JJ
cord-011302-pfepyvaw	64	19	guidelines	guideline	NNS
cord-011302-pfepyvaw	64	20	[	[	-LRB-
cord-011302-pfepyvaw	64	21	26	26	CD
cord-011302-pfepyvaw	64	22	]	]	-RRB-
cord-011302-pfepyvaw	64	23	.	.	.
cord-011302-pfepyvaw	65	1	ASDH	ASDH	NNP
cord-011302-pfepyvaw	65	2	following	follow	VBG
cord-011302-pfepyvaw	65	3	a	a	DT
cord-011302-pfepyvaw	65	4	minor	minor	JJ
cord-011302-pfepyvaw	65	5	fall	fall	NN
cord-011302-pfepyvaw	65	6	is	be	VBZ
cord-011302-pfepyvaw	65	7	often	often	RB
cord-011302-pfepyvaw	65	8	exacerbated	exacerbate	VBN
cord-011302-pfepyvaw	65	9	by	by	IN
cord-011302-pfepyvaw	65	10	the	the	DT
cord-011302-pfepyvaw	65	11	fact	fact	NN
cord-011302-pfepyvaw	65	12	that	that	IN
cord-011302-pfepyvaw	65	13	nearly	nearly	RB
cord-011302-pfepyvaw	65	14	two	two	CD
cord-011302-pfepyvaw	65	15	-	-	HYPH
cord-011302-pfepyvaw	65	16	third	third	NN
cord-011302-pfepyvaw	65	17	of	of	IN
cord-011302-pfepyvaw	65	18	these	these	DT
cord-011302-pfepyvaw	65	19	patients	patient	NNS
cord-011302-pfepyvaw	65	20	are	be	VBP
cord-011302-pfepyvaw	65	21	on	on	IN
cord-011302-pfepyvaw	65	22	anti	anti	JJ
cord-011302-pfepyvaw	65	23	-	-	JJ
cord-011302-pfepyvaw	65	24	thrombotic	thrombotic	JJ
cord-011302-pfepyvaw	65	25	medications	medication	NNS
cord-011302-pfepyvaw	65	26	[	[	-LRB-
cord-011302-pfepyvaw	65	27	20	20	CD
cord-011302-pfepyvaw	65	28	]	]	-RRB-
cord-011302-pfepyvaw	65	29	.	.	.
cord-011302-pfepyvaw	66	1	The	the	DT
cord-011302-pfepyvaw	66	2	increased	increase	VBN
cord-011302-pfepyvaw	66	3	use	use	NN
cord-011302-pfepyvaw	66	4	of	of	IN
cord-011302-pfepyvaw	66	5	these	these	DT
cord-011302-pfepyvaw	66	6	medications	medication	NNS
cord-011302-pfepyvaw	66	7	and	and	CC
cord-011302-pfepyvaw	66	8	an	an	DT
cord-011302-pfepyvaw	66	9	aging	age	VBG
cord-011302-pfepyvaw	66	10	population	population	NN
cord-011302-pfepyvaw	66	11	are	be	VBP
cord-011302-pfepyvaw	66	12	probably	probably	RB
cord-011302-pfepyvaw	66	13	contributing	contribute	VBG
cord-011302-pfepyvaw	66	14	to	to	IN
cord-011302-pfepyvaw	66	15	growing	grow	VBG
cord-011302-pfepyvaw	66	16	rates	rate	NNS
cord-011302-pfepyvaw	66	17	of	of	IN
cord-011302-pfepyvaw	66	18	ASDH	ASDH	NNP
cord-011302-pfepyvaw	66	19	in	in	IN
cord-011302-pfepyvaw	66	20	the	the	DT
cord-011302-pfepyvaw	66	21	elderly	elderly	JJ
cord-011302-pfepyvaw	66	22	.	.	.
cord-011302-pfepyvaw	67	1	A	a	DT
cord-011302-pfepyvaw	67	2	recent	recent	JJ
cord-011302-pfepyvaw	67	3	review	review	NN
cord-011302-pfepyvaw	67	4	of	of	IN
cord-011302-pfepyvaw	67	5	165	165	CD
cord-011302-pfepyvaw	67	6	ASDHs	asdh	NNS
cord-011302-pfepyvaw	67	7	in	in	IN
cord-011302-pfepyvaw	67	8	a	a	DT
cord-011302-pfepyvaw	67	9	German	german	JJ
cord-011302-pfepyvaw	67	10	hospital	hospital	NN
cord-011302-pfepyvaw	67	11	reported	report	VBD
cord-011302-pfepyvaw	67	12	41.2	41.2	CD
cord-011302-pfepyvaw	67	13	%	%	NN
cord-011302-pfepyvaw	67	14	of	of	IN
cord-011302-pfepyvaw	67	15	them	-PRON-	PRP
cord-011302-pfepyvaw	67	16	occurring	occur	VBG
cord-011302-pfepyvaw	67	17	in	in	IN
cord-011302-pfepyvaw	67	18	patients	patient	NNS
cord-011302-pfepyvaw	67	19	aged	age	VBN
cord-011302-pfepyvaw	67	20	80	80	CD
cord-011302-pfepyvaw	67	21	or	or	CC
cord-011302-pfepyvaw	67	22	over	over	IN
cord-011302-pfepyvaw	67	23	[	[	-LRB-
cord-011302-pfepyvaw	67	24	44	44	CD
cord-011302-pfepyvaw	67	25	]	]	-RRB-
cord-011302-pfepyvaw	67	26	.	.	.
cord-011302-pfepyvaw	68	1	Importantly	importantly	RB
cord-011302-pfepyvaw	68	2	,	,	,
cord-011302-pfepyvaw	68	3	although	although	IN
cord-011302-pfepyvaw	68	4	90	90	CD
cord-011302-pfepyvaw	68	5	%	%	NN
cord-011302-pfepyvaw	68	6	of	of	IN
cord-011302-pfepyvaw	68	7	the	the	DT
cord-011302-pfepyvaw	68	8	patients	patient	NNS
cord-011302-pfepyvaw	68	9	aged	age	VBN
cord-011302-pfepyvaw	68	10	≥	≥	CD
cord-011302-pfepyvaw	68	11	80	80	CD
cord-011302-pfepyvaw	68	12	years	year	NNS
cord-011302-pfepyvaw	68	13	of	of	IN
cord-011302-pfepyvaw	68	14	age	age	NN
cord-011302-pfepyvaw	68	15	underwent	undergo	VBD
cord-011302-pfepyvaw	68	16	surgery	surgery	NN
cord-011302-pfepyvaw	68	17	,	,	,
cord-011302-pfepyvaw	68	18	only	only	RB
cord-011302-pfepyvaw	68	19	24	24	CD
cord-011302-pfepyvaw	68	20	%	%	NN
cord-011302-pfepyvaw	68	21	experienced	experience	VBD
cord-011302-pfepyvaw	68	22	a	a	DT
cord-011302-pfepyvaw	68	23	favourable	favourable	JJ
cord-011302-pfepyvaw	68	24	outcome	outcome	NN
cord-011302-pfepyvaw	68	25	at	at	IN
cord-011302-pfepyvaw	68	26	discharge	discharge	NN
cord-011302-pfepyvaw	68	27	(	(	-LRB-
cord-011302-pfepyvaw	68	28	Glasgow	Glasgow	NNP
cord-011302-pfepyvaw	68	29	outcome	outcome	NN
cord-011302-pfepyvaw	68	30	scale	scale	NN
cord-011302-pfepyvaw	68	31	4	4	CD
cord-011302-pfepyvaw	68	32	-	-	SYM
cord-011302-pfepyvaw	68	33	5	5	CD
cord-011302-pfepyvaw	68	34	)	)	-RRB-
cord-011302-pfepyvaw	68	35	,	,	,
cord-011302-pfepyvaw	68	36	increasing	increase	VBG
cord-011302-pfepyvaw	68	37	to	to	IN
cord-011302-pfepyvaw	68	38	36	36	CD
cord-011302-pfepyvaw	68	39	%	%	NN
cord-011302-pfepyvaw	68	40	at	at	IN
cord-011302-pfepyvaw	68	41	3-months	3-months	CD
cord-011302-pfepyvaw	68	42	.	.	.
cord-011302-pfepyvaw	69	1	The	the	DT
cord-011302-pfepyvaw	69	2	mortality	mortality	NN
cord-011302-pfepyvaw	69	3	rate	rate	NN
cord-011302-pfepyvaw	69	4	was	be	VBD
cord-011302-pfepyvaw	69	5	high	high	JJ
cord-011302-pfepyvaw	69	6	,	,	,
cord-011302-pfepyvaw	69	7	48	48	CD
cord-011302-pfepyvaw	69	8	%	%	NN
cord-011302-pfepyvaw	69	9	at	at	IN
cord-011302-pfepyvaw	69	10	3	3	CD
cord-011302-pfepyvaw	69	11	months	month	NNS
cord-011302-pfepyvaw	69	12	,	,	,
cord-011302-pfepyvaw	69	13	and	and	CC
cord-011302-pfepyvaw	69	14	predictors	predictor	NNS
cord-011302-pfepyvaw	69	15	of	of	IN
cord-011302-pfepyvaw	69	16	an	an	DT
cord-011302-pfepyvaw	69	17	unfavourable	unfavourable	JJ
cord-011302-pfepyvaw	69	18	outcome	outcome	NN
cord-011302-pfepyvaw	69	19	included	include	VBD
cord-011302-pfepyvaw	69	20	>	>	XX
cord-011302-pfepyvaw	69	21	5	5	CD
cord-011302-pfepyvaw	69	22	co	co	NNS
cord-011302-pfepyvaw	69	23	-	-	NNS
cord-011302-pfepyvaw	69	24	morbidities	morbidity	NNS
cord-011302-pfepyvaw	69	25	,	,	,
cord-011302-pfepyvaw	69	26	GCS	GCS	NNP
cord-011302-pfepyvaw	69	27	≤	≤	NNP
cord-011302-pfepyvaw	69	28	8	8	CD
cord-011302-pfepyvaw	69	29	at	at	IN
cord-011302-pfepyvaw	69	30	admission	admission	NN
cord-011302-pfepyvaw	69	31	and	and	CC
cord-011302-pfepyvaw	69	32	24	24	CD
cord-011302-pfepyvaw	69	33	hours	hour	NNS
cord-011302-pfepyvaw	69	34	,	,	,
cord-011302-pfepyvaw	69	35	re	re	NN
cord-011302-pfepyvaw	69	36	-	-	NN
cord-011302-pfepyvaw	69	37	bleeding	bleeding	JJ
cord-011302-pfepyvaw	69	38	,	,	,
cord-011302-pfepyvaw	69	39	and	and	CC
cord-011302-pfepyvaw	69	40	pneumonia	pneumonia	NN
cord-011302-pfepyvaw	69	41	.	.	.
cord-011302-pfepyvaw	70	1	The	the	DT
cord-011302-pfepyvaw	70	2	use	use	NN
cord-011302-pfepyvaw	70	3	of	of	IN
cord-011302-pfepyvaw	70	4	anti	anti	JJ
cord-011302-pfepyvaw	70	5	-	-	JJ
cord-011302-pfepyvaw	70	6	thrombotic	thrombotic	JJ
cord-011302-pfepyvaw	70	7	medications	medication	NNS
cord-011302-pfepyvaw	70	8	at	at	IN
cord-011302-pfepyvaw	70	9	presentation	presentation	NN
cord-011302-pfepyvaw	70	10	is	be	VBZ
cord-011302-pfepyvaw	70	11	also	also	RB
cord-011302-pfepyvaw	70	12	clearly	clearly	RB
cord-011302-pfepyvaw	70	13	a	a	DT
cord-011302-pfepyvaw	70	14	risk	risk	NN
cord-011302-pfepyvaw	70	15	factor	factor	NN
cord-011302-pfepyvaw	70	16	for	for	IN
cord-011302-pfepyvaw	70	17	poor	poor	JJ
cord-011302-pfepyvaw	70	18	outcome	outcome	NN
cord-011302-pfepyvaw	70	19	in	in	IN
cord-011302-pfepyvaw	70	20	all	all	DT
cord-011302-pfepyvaw	70	21	patients	patient	NNS
cord-011302-pfepyvaw	70	22	[	[	-LRB-
cord-011302-pfepyvaw	70	23	45	45	CD
cord-011302-pfepyvaw	70	24	]	]	-RRB-
cord-011302-pfepyvaw	70	25	.	.	.
cord-011302-pfepyvaw	71	1	Another	another	DT
cord-011302-pfepyvaw	71	2	series	series	NN
cord-011302-pfepyvaw	71	3	reported	report	VBD
cord-011302-pfepyvaw	71	4	no	no	DT
cord-011302-pfepyvaw	71	5	survivors	survivor	NNS
cord-011302-pfepyvaw	71	6	in	in	IN
cord-011302-pfepyvaw	71	7	patients	patient	NNS
cord-011302-pfepyvaw	71	8	with	with	IN
cord-011302-pfepyvaw	71	9	an	an	DT
cord-011302-pfepyvaw	71	10	ASDH	ASDH	NNP
cord-011302-pfepyvaw	71	11	aged	age	VBN
cord-011302-pfepyvaw	71	12	over	over	IN
cord-011302-pfepyvaw	71	13	90	90	CD
cord-011302-pfepyvaw	71	14	and	and	CC
cord-011302-pfepyvaw	71	15	only	only	RB
cord-011302-pfepyvaw	71	16	one	one	CD
cord-011302-pfepyvaw	71	17	survivor	survivor	NN
cord-011302-pfepyvaw	71	18	out	out	IN
cord-011302-pfepyvaw	71	19	of	of	IN
cord-011302-pfepyvaw	71	20	8	8	CD
cord-011302-pfepyvaw	71	21	aged	age	VBN
cord-011302-pfepyvaw	71	22	over	over	IN
cord-011302-pfepyvaw	71	23	65	65	CD
cord-011302-pfepyvaw	71	24	presenting	present	VBG
cord-011302-pfepyvaw	71	25	with	with	IN
cord-011302-pfepyvaw	71	26	a	a	DT
cord-011302-pfepyvaw	71	27	GCS	GCS	NNP
cord-011302-pfepyvaw	71	28	of	of	IN
cord-011302-pfepyvaw	71	29	less	less	JJR
cord-011302-pfepyvaw	71	30	than	than	IN
cord-011302-pfepyvaw	71	31	10	10	CD
cord-011302-pfepyvaw	71	32	[	[	-LRB-
cord-011302-pfepyvaw	71	33	41	41	CD
cord-011302-pfepyvaw	71	34	]	]	-RRB-
cord-011302-pfepyvaw	71	35	.	.	.
cord-011302-pfepyvaw	72	1	A	a	DT
cord-011302-pfepyvaw	72	2	recent	recent	JJ
cord-011302-pfepyvaw	72	3	systematic	systematic	JJ
cord-011302-pfepyvaw	72	4	review	review	NN
cord-011302-pfepyvaw	72	5	of	of	IN
cord-011302-pfepyvaw	72	6	ASDH	ASDH	NNP
cord-011302-pfepyvaw	72	7	in	in	IN
cord-011302-pfepyvaw	72	8	the	the	DT
cord-011302-pfepyvaw	72	9	elderly	elderly	JJ
cord-011302-pfepyvaw	72	10	reported	report	VBN
cord-011302-pfepyvaw	72	11	on	on	IN
cord-011302-pfepyvaw	72	12	only	only	RB
cord-011302-pfepyvaw	72	13	seven	seven	CD
cord-011302-pfepyvaw	72	14	eligible	eligible	JJ
cord-011302-pfepyvaw	72	15	studies	study	NNS
cord-011302-pfepyvaw	72	16	with	with	IN
cord-011302-pfepyvaw	72	17	the	the	DT
cord-011302-pfepyvaw	72	18	mean	mean	JJ
cord-011302-pfepyvaw	72	19	patient	patient	JJ
cord-011302-pfepyvaw	72	20	age	age	NN
cord-011302-pfepyvaw	72	21	ranging	range	VBG
cord-011302-pfepyvaw	72	22	from	from	IN
cord-011302-pfepyvaw	72	23	73	73	CD
cord-011302-pfepyvaw	72	24	to	to	TO
cord-011302-pfepyvaw	72	25	85	85	CD
cord-011302-pfepyvaw	72	26	years	year	NNS
cord-011302-pfepyvaw	72	27	[	[	-LRB-
cord-011302-pfepyvaw	72	28	10	10	CD
cord-011302-pfepyvaw	72	29	]	]	-RRB-
cord-011302-pfepyvaw	72	30	.	.	.
cord-011302-pfepyvaw	73	1	Outcomes	outcome	NNS
cord-011302-pfepyvaw	73	2	varied	varied	JJ
cord-011302-pfepyvaw	73	3	with	with	IN
cord-011302-pfepyvaw	73	4	a	a	DT
cord-011302-pfepyvaw	73	5	mortality	mortality	NN
cord-011302-pfepyvaw	73	6	rate	rate	NN
cord-011302-pfepyvaw	73	7	ranging	range	VBG
cord-011302-pfepyvaw	73	8	from	from	IN
cord-011302-pfepyvaw	73	9	27	27	CD
cord-011302-pfepyvaw	73	10	to	to	TO
cord-011302-pfepyvaw	73	11	70	70	CD
cord-011302-pfepyvaw	73	12	%	%	NN
cord-011302-pfepyvaw	73	13	,	,	,
cord-011302-pfepyvaw	73	14	and	and	CC
cord-011302-pfepyvaw	73	15	a	a	DT
cord-011302-pfepyvaw	73	16	good	good	JJ
cord-011302-pfepyvaw	73	17	functional	functional	JJ
cord-011302-pfepyvaw	73	18	outcome	outcome	NN
cord-011302-pfepyvaw	73	19	in	in	IN
cord-011302-pfepyvaw	73	20	10	10	CD
cord-011302-pfepyvaw	73	21	-	-	SYM
cord-011302-pfepyvaw	73	22	41	41	CD
cord-011302-pfepyvaw	73	23	%	%	NN
cord-011302-pfepyvaw	73	24	but	but	CC
cord-011302-pfepyvaw	73	25	with	with	IN
cord-011302-pfepyvaw	73	26	a	a	DT
cord-011302-pfepyvaw	73	27	presenting	present	VBG
cord-011302-pfepyvaw	73	28	GCS	GCS	NNP
cord-011302-pfepyvaw	73	29	≤	≤	NNP
cord-011302-pfepyvaw	73	30	8	8	CD
cord-011302-pfepyvaw	73	31	representing	represent	VBG
cord-011302-pfepyvaw	73	32	a	a	DT
cord-011302-pfepyvaw	73	33	poor	poor	JJ
cord-011302-pfepyvaw	73	34	prognostic	prognostic	JJ
cord-011302-pfepyvaw	73	35	factor	factor	NN
cord-011302-pfepyvaw	73	36	.	.	.
cord-011302-pfepyvaw	74	1	However	however	RB
cord-011302-pfepyvaw	74	2	,	,	,
cord-011302-pfepyvaw	74	3	overall	overall	RB
cord-011302-pfepyvaw	74	4	,	,	,
cord-011302-pfepyvaw	74	5	the	the	DT
cord-011302-pfepyvaw	74	6	studies	study	NNS
cord-011302-pfepyvaw	74	7	were	be	VBD
cord-011302-pfepyvaw	74	8	classified	classify	VBN
cord-011302-pfepyvaw	74	9	as	as	IN
cord-011302-pfepyvaw	74	10	low	low	JJ
cord-011302-pfepyvaw	74	11	quality	quality	NN
cord-011302-pfepyvaw	74	12	and	and	CC
cord-011302-pfepyvaw	74	13	were	be	VBD
cord-011302-pfepyvaw	74	14	particularly	particularly	RB
cord-011302-pfepyvaw	74	15	lacking	lack	VBG
cord-011302-pfepyvaw	74	16	in	in	IN
cord-011302-pfepyvaw	74	17	assessments	assessment	NNS
cord-011302-pfepyvaw	74	18	of	of	IN
cord-011302-pfepyvaw	74	19	patient	patient	NN
cord-011302-pfepyvaw	74	20	frailty	frailty	NN
cord-011302-pfepyvaw	74	21	which	which	WDT
cord-011302-pfepyvaw	74	22	may	may	MD
cord-011302-pfepyvaw	74	23	aid	aid	VB
cord-011302-pfepyvaw	74	24	future	future	JJ
cord-011302-pfepyvaw	74	25	research	research	NN
cord-011302-pfepyvaw	74	26	in	in	IN
cord-011302-pfepyvaw	74	27	this	this	DT
cord-011302-pfepyvaw	74	28	field	field	NN
cord-011302-pfepyvaw	74	29	.	.	.
cord-011302-pfepyvaw	75	1	It	-PRON-	PRP
cord-011302-pfepyvaw	75	2	is	be	VBZ
cord-011302-pfepyvaw	75	3	clear	clear	JJ
cord-011302-pfepyvaw	75	4	that	that	IN
cord-011302-pfepyvaw	75	5	poor	poor	JJ
cord-011302-pfepyvaw	75	6	neurology	neurology	NN
cord-011302-pfepyvaw	75	7	from	from	IN
cord-011302-pfepyvaw	75	8	the	the	DT
cord-011302-pfepyvaw	75	9	outset	outset	NN
cord-011302-pfepyvaw	75	10	is	be	VBZ
cord-011302-pfepyvaw	75	11	associated	associate	VBN
cord-011302-pfepyvaw	75	12	with	with	IN
cord-011302-pfepyvaw	75	13	poor	poor	JJ
cord-011302-pfepyvaw	75	14	outcome	outcome	NN
cord-011302-pfepyvaw	75	15	;	;	:
cord-011302-pfepyvaw	75	16	however	however	RB
cord-011302-pfepyvaw	75	17	,	,	,
cord-011302-pfepyvaw	75	18	as	as	IN
cord-011302-pfepyvaw	75	19	the	the	DT
cord-011302-pfepyvaw	75	20	incidence	incidence	NN
cord-011302-pfepyvaw	75	21	of	of	IN
cord-011302-pfepyvaw	75	22	this	this	DT
cord-011302-pfepyvaw	75	23	pathology	pathology	NN
cord-011302-pfepyvaw	75	24	appears	appear	VBZ
cord-011302-pfepyvaw	75	25	to	to	TO
cord-011302-pfepyvaw	75	26	be	be	VB
cord-011302-pfepyvaw	75	27	increasing	increase	VBG
cord-011302-pfepyvaw	75	28	in	in	IN
cord-011302-pfepyvaw	75	29	older	old	JJR
cord-011302-pfepyvaw	75	30	patients	patient	NNS
cord-011302-pfepyvaw	75	31	,	,	,
cord-011302-pfepyvaw	75	32	effective	effective	JJ
cord-011302-pfepyvaw	75	33	surgical	surgical	JJ
cord-011302-pfepyvaw	75	34	decision	decision	NN
cord-011302-pfepyvaw	75	35	-	-	HYPH
cord-011302-pfepyvaw	75	36	making	make	VBG
cord-011302-pfepyvaw	75	37	tools	tool	NNS
cord-011302-pfepyvaw	75	38	are	be	VBP
cord-011302-pfepyvaw	75	39	needed	need	VBN
cord-011302-pfepyvaw	75	40	.	.	.
cord-011302-pfepyvaw	76	1	In	in	IN
cord-011302-pfepyvaw	76	2	patients	patient	NNS
cord-011302-pfepyvaw	76	3	over	over	IN
cord-011302-pfepyvaw	76	4	80	80	CD
cord-011302-pfepyvaw	76	5	years	year	NNS
cord-011302-pfepyvaw	76	6	old	old	JJ
cord-011302-pfepyvaw	76	7	,	,	,
cord-011302-pfepyvaw	76	8	with	with	IN
cord-011302-pfepyvaw	76	9	multi	multi	JJ
cord-011302-pfepyvaw	76	10	-	-	JJ
cord-011302-pfepyvaw	76	11	morbidity	morbidity	JJ
cord-011302-pfepyvaw	76	12	and	and	CC
cord-011302-pfepyvaw	76	13	poor	poor	JJ
cord-011302-pfepyvaw	76	14	neurology	neurology	NN
cord-011302-pfepyvaw	76	15	,	,	,
cord-011302-pfepyvaw	76	16	caution	caution	NN
cord-011302-pfepyvaw	76	17	should	should	MD
cord-011302-pfepyvaw	76	18	be	be	VB
cord-011302-pfepyvaw	76	19	applied	apply	VBN
cord-011302-pfepyvaw	76	20	;	;	:
cord-011302-pfepyvaw	76	21	however	however	RB
cord-011302-pfepyvaw	76	22	,	,	,
cord-011302-pfepyvaw	76	23	it	-PRON-	PRP
cord-011302-pfepyvaw	76	24	could	could	MD
cord-011302-pfepyvaw	76	25	be	be	VB
cord-011302-pfepyvaw	76	26	advocated	advocate	VBN
cord-011302-pfepyvaw	76	27	that	that	IN
cord-011302-pfepyvaw	76	28	in	in	IN
cord-011302-pfepyvaw	76	29	all	all	DT
cord-011302-pfepyvaw	76	30	other	other	JJ
cord-011302-pfepyvaw	76	31	circumstances	circumstance	NNS
cord-011302-pfepyvaw	76	32	surgical	surgical	JJ
cord-011302-pfepyvaw	76	33	treatment	treatment	NN
cord-011302-pfepyvaw	76	34	should	should	MD
cord-011302-pfepyvaw	76	35	at	at	IN
cord-011302-pfepyvaw	76	36	least	least	JJS
cord-011302-pfepyvaw	76	37	be	be	VB
cord-011302-pfepyvaw	76	38	considered	consider	VBN
cord-011302-pfepyvaw	76	39	.	.	.
cord-011302-pfepyvaw	77	1	Attempts	attempt	NNS
cord-011302-pfepyvaw	77	2	have	have	VBP
cord-011302-pfepyvaw	77	3	been	be	VBN
cord-011302-pfepyvaw	77	4	made	make	VBN
cord-011302-pfepyvaw	77	5	at	at	IN
cord-011302-pfepyvaw	77	6	producing	produce	VBG
cord-011302-pfepyvaw	77	7	scoring	score	VBG
cord-011302-pfepyvaw	77	8	systems	system	NNS
cord-011302-pfepyvaw	77	9	to	to	TO
cord-011302-pfepyvaw	77	10	aid	aid	VB
cord-011302-pfepyvaw	77	11	prognostication	prognostication	NN
cord-011302-pfepyvaw	77	12	in	in	IN
cord-011302-pfepyvaw	77	13	elderly	elderly	JJ
cord-011302-pfepyvaw	77	14	patients	patient	NNS
cord-011302-pfepyvaw	77	15	with	with	IN
cord-011302-pfepyvaw	77	16	ASDH	ASDH	NNP
cord-011302-pfepyvaw	77	17	,	,	,
cord-011302-pfepyvaw	77	18	but	but	CC
cord-011302-pfepyvaw	77	19	more	more	RBR
cord-011302-pfepyvaw	77	20	widespread	widespread	JJ
cord-011302-pfepyvaw	77	21	validation	validation	NN
cord-011302-pfepyvaw	77	22	of	of	IN
cord-011302-pfepyvaw	77	23	this	this	DT
cord-011302-pfepyvaw	77	24	is	be	VBZ
cord-011302-pfepyvaw	77	25	required	require	VBN
cord-011302-pfepyvaw	77	26	[	[	-LRB-
cord-011302-pfepyvaw	77	27	1	1	CD
cord-011302-pfepyvaw	77	28	]	]	-RRB-
cord-011302-pfepyvaw	77	29	.	.	.
cord-011302-pfepyvaw	78	1	It	-PRON-	PRP
cord-011302-pfepyvaw	78	2	is	be	VBZ
cord-011302-pfepyvaw	78	3	notable	notable	JJ
cord-011302-pfepyvaw	78	4	that	that	IN
cord-011302-pfepyvaw	78	5	several	several	JJ
cord-011302-pfepyvaw	78	6	large	large	JJ
cord-011302-pfepyvaw	78	7	-	-	HYPH
cord-011302-pfepyvaw	78	8	scale	scale	NN
cord-011302-pfepyvaw	78	9	studies	study	NNS
cord-011302-pfepyvaw	78	10	assessing	assess	VBG
cord-011302-pfepyvaw	78	11	interventions	intervention	NNS
cord-011302-pfepyvaw	78	12	for	for	IN
cord-011302-pfepyvaw	78	13	severe	severe	JJ
cord-011302-pfepyvaw	78	14	traumatic	traumatic	JJ
cord-011302-pfepyvaw	78	15	brain	brain	NN
cord-011302-pfepyvaw	78	16	injury	injury	NN
cord-011302-pfepyvaw	78	17	(	(	-LRB-
cord-011302-pfepyvaw	78	18	TBI	TBI	NNP
cord-011302-pfepyvaw	78	19	)	)	-RRB-
cord-011302-pfepyvaw	78	20	in	in	IN
cord-011302-pfepyvaw	78	21	general	general	JJ
cord-011302-pfepyvaw	78	22	,	,	,
cord-011302-pfepyvaw	78	23	including	include	VBG
cord-011302-pfepyvaw	78	24	decompressive	decompressive	JJ
cord-011302-pfepyvaw	78	25	craniectomy	craniectomy	NNP
cord-011302-pfepyvaw	78	26	[	[	-LRB-
cord-011302-pfepyvaw	78	27	7	7	CD
cord-011302-pfepyvaw	78	28	,	,	,
cord-011302-pfepyvaw	78	29	16	16	CD
cord-011302-pfepyvaw	78	30	]	]	-RRB-
cord-011302-pfepyvaw	78	31	,	,	,
cord-011302-pfepyvaw	78	32	ICP	ICP	NNP
cord-011302-pfepyvaw	78	33	monitoring	monitor	VBG
cord-011302-pfepyvaw	78	34	[	[	-LRB-
cord-011302-pfepyvaw	78	35	5	5	CD
cord-011302-pfepyvaw	78	36	]	]	-RRB-
cord-011302-pfepyvaw	78	37	,	,	,
cord-011302-pfepyvaw	78	38	and	and	CC
cord-011302-pfepyvaw	78	39	cooling	cool	VBG
cord-011302-pfepyvaw	78	40	[	[	-LRB-
cord-011302-pfepyvaw	78	41	2	2	CD
cord-011302-pfepyvaw	78	42	]	]	-RRB-
cord-011302-pfepyvaw	78	43	,	,	,
cord-011302-pfepyvaw	78	44	have	have	VBP
cord-011302-pfepyvaw	78	45	either	either	CC
cord-011302-pfepyvaw	78	46	excluded	exclude	VBN
cord-011302-pfepyvaw	78	47	older	old	JJR
cord-011302-pfepyvaw	78	48	patients	patient	NNS
cord-011302-pfepyvaw	78	49	or	or	CC
cord-011302-pfepyvaw	78	50	had	have	VBD
cord-011302-pfepyvaw	78	51	minimal	minimal	JJ
cord-011302-pfepyvaw	78	52	numbers	number	NNS
cord-011302-pfepyvaw	78	53	of	of	IN
cord-011302-pfepyvaw	78	54	them	-PRON-	PRP
cord-011302-pfepyvaw	78	55	.	.	.
cord-011302-pfepyvaw	79	1	Whilst	whilst	IN
cord-011302-pfepyvaw	79	2	this	this	DT
cord-011302-pfepyvaw	79	3	makes	make	VBZ
cord-011302-pfepyvaw	79	4	understanding	understanding	NN
cord-011302-pfepyvaw	79	5	treatment	treatment	NN
cord-011302-pfepyvaw	79	6	in	in	IN
cord-011302-pfepyvaw	79	7	this	this	DT
cord-011302-pfepyvaw	79	8	age	age	NN
cord-011302-pfepyvaw	79	9	group	group	NN
cord-011302-pfepyvaw	79	10	challenging	challenge	VBG
cord-011302-pfepyvaw	79	11	,	,	,
cord-011302-pfepyvaw	79	12	it	-PRON-	PRP
cord-011302-pfepyvaw	79	13	may	may	MD
cord-011302-pfepyvaw	79	14	also	also	RB
cord-011302-pfepyvaw	79	15	just	just	RB
cord-011302-pfepyvaw	79	16	be	be	VB
cord-011302-pfepyvaw	79	17	a	a	DT
cord-011302-pfepyvaw	79	18	reflection	reflection	NN
cord-011302-pfepyvaw	79	19	of	of	IN
cord-011302-pfepyvaw	79	20	the	the	DT
cord-011302-pfepyvaw	79	21	reality	reality	NN
cord-011302-pfepyvaw	79	22	that	that	IN
cord-011302-pfepyvaw	79	23	fewer	few	JJR
cord-011302-pfepyvaw	79	24	older	old	JJR
cord-011302-pfepyvaw	79	25	patients	patient	NNS
cord-011302-pfepyvaw	79	26	are	be	VBP
cord-011302-pfepyvaw	79	27	considered	consider	VBN
cord-011302-pfepyvaw	79	28	likely	likely	JJ
cord-011302-pfepyvaw	79	29	to	to	TO
cord-011302-pfepyvaw	79	30	survive	survive	VB
cord-011302-pfepyvaw	79	31	intervention	intervention	NN
cord-011302-pfepyvaw	79	32	.	.	.
cord-011302-pfepyvaw	80	1	This	this	DT
cord-011302-pfepyvaw	80	2	is	be	VBZ
cord-011302-pfepyvaw	80	3	supported	support	VBN
cord-011302-pfepyvaw	80	4	by	by	IN
cord-011302-pfepyvaw	80	5	collaborations	collaboration	NNS
cord-011302-pfepyvaw	80	6	such	such	JJ
cord-011302-pfepyvaw	80	7	as	as	IN
cord-011302-pfepyvaw	80	8	IMPACT	IMPACT	NNP
cord-011302-pfepyvaw	80	9	(	(	-LRB-
cord-011302-pfepyvaw	80	10	International	International	NNP
cord-011302-pfepyvaw	80	11	Mission	Mission	NNP
cord-011302-pfepyvaw	80	12	for	for	IN
cord-011302-pfepyvaw	80	13	Prognosis	Prognosis	NNP
cord-011302-pfepyvaw	80	14	and	and	CC
cord-011302-pfepyvaw	80	15	Analysis	Analysis	NNP
cord-011302-pfepyvaw	80	16	of	of	IN
cord-011302-pfepyvaw	80	17	Clinical	Clinical	NNP
cord-011302-pfepyvaw	80	18	Trials	Trials	NNPS
cord-011302-pfepyvaw	80	19	in	in	IN
cord-011302-pfepyvaw	80	20	TBI	TBI	NNP
cord-011302-pfepyvaw	80	21	)	)	-RRB-
cord-011302-pfepyvaw	80	22	and	and	CC
cord-011302-pfepyvaw	80	23	CRASH	crash	NN
cord-011302-pfepyvaw	80	24	(	(	-LRB-
cord-011302-pfepyvaw	80	25	Corticosteroid	Corticosteroid	NNP
cord-011302-pfepyvaw	80	26	Randomisation	Randomisation	NNP
cord-011302-pfepyvaw	81	1	After	after	IN
cord-011302-pfepyvaw	81	2	Significant	significant	JJ
cord-011302-pfepyvaw	81	3	Head	Head	NNP
cord-011302-pfepyvaw	81	4	injury	injury	NN
cord-011302-pfepyvaw	81	5	)	)	-RRB-
cord-011302-pfepyvaw	81	6	,	,	,
cord-011302-pfepyvaw	81	7	who	who	WP
cord-011302-pfepyvaw	81	8	have	have	VBP
cord-011302-pfepyvaw	81	9	used	use	VBN
cord-011302-pfepyvaw	81	10	available	available	JJ
cord-011302-pfepyvaw	81	11	evidence	evidence	NN
cord-011302-pfepyvaw	81	12	to	to	TO
cord-011302-pfepyvaw	81	13	develop	develop	VB
cord-011302-pfepyvaw	81	14	prognostic	prognostic	JJ
cord-011302-pfepyvaw	81	15	calculators	calculator	NNS
cord-011302-pfepyvaw	81	16	for	for	IN
cord-011302-pfepyvaw	81	17	TBI	TBI	NNP
cord-011302-pfepyvaw	81	18	,	,	,
cord-011302-pfepyvaw	81	19	where	where	WRB
cord-011302-pfepyvaw	81	20	age	age	NN
cord-011302-pfepyvaw	81	21	is	be	VBZ
cord-011302-pfepyvaw	81	22	a	a	DT
cord-011302-pfepyvaw	81	23	corestratifying	corestratifye	VBG
cord-011302-pfepyvaw	81	24	component	component	NN
cord-011302-pfepyvaw	81	25	and	and	CC
cord-011302-pfepyvaw	81	26	significantly	significantly	RB
cord-011302-pfepyvaw	81	27	increases	increase	VBZ
cord-011302-pfepyvaw	81	28	chances	chance	NNS
cord-011302-pfepyvaw	81	29	of	of	IN
cord-011302-pfepyvaw	81	30	a	a	DT
cord-011302-pfepyvaw	81	31	poor	poor	JJ
cord-011302-pfepyvaw	81	32	outcome	outcome	NN
cord-011302-pfepyvaw	81	33	[	[	-LRB-
cord-011302-pfepyvaw	81	34	17	17	CD
cord-011302-pfepyvaw	81	35	,	,	,
cord-011302-pfepyvaw	81	36	38	38	CD
cord-011302-pfepyvaw	81	37	]	]	-RRB-
cord-011302-pfepyvaw	81	38	.	.	.
cord-011302-pfepyvaw	82	1	Overall	overall	RB
cord-011302-pfepyvaw	82	2	,	,	,
cord-011302-pfepyvaw	82	3	it	-PRON-	PRP
cord-011302-pfepyvaw	82	4	is	be	VBZ
cord-011302-pfepyvaw	82	5	recognised	recognise	VBN
cord-011302-pfepyvaw	82	6	that	that	IN
cord-011302-pfepyvaw	82	7	a	a	DT
cord-011302-pfepyvaw	82	8	lack	lack	NN
cord-011302-pfepyvaw	82	9	of	of	IN
cord-011302-pfepyvaw	82	10	evidence	evidence	NN
cord-011302-pfepyvaw	82	11	has	have	VBZ
cord-011302-pfepyvaw	82	12	led	lead	VBN
cord-011302-pfepyvaw	82	13	to	to	IN
cord-011302-pfepyvaw	82	14	varying	vary	VBG
cord-011302-pfepyvaw	82	15	practices	practice	NNS
cord-011302-pfepyvaw	82	16	and	and	CC
cord-011302-pfepyvaw	82	17	understanding	understanding	NN
cord-011302-pfepyvaw	82	18	about	about	IN
cord-011302-pfepyvaw	82	19	interventions	intervention	NNS
cord-011302-pfepyvaw	82	20	for	for	IN
cord-011302-pfepyvaw	82	21	TBI	TBI	NNP
cord-011302-pfepyvaw	82	22	in	in	IN
cord-011302-pfepyvaw	82	23	older	old	JJR
cord-011302-pfepyvaw	82	24	patients	patient	NNS
cord-011302-pfepyvaw	82	25	,	,	,
cord-011302-pfepyvaw	82	26	but	but	CC
cord-011302-pfepyvaw	82	27	it	-PRON-	PRP
cord-011302-pfepyvaw	82	28	is	be	VBZ
cord-011302-pfepyvaw	82	29	clear	clear	JJ
cord-011302-pfepyvaw	82	30	that	that	IN
cord-011302-pfepyvaw	82	31	functional	functional	JJ
cord-011302-pfepyvaw	82	32	and	and	CC
cord-011302-pfepyvaw	82	33	cognitive	cognitive	JJ
cord-011302-pfepyvaw	82	34	recovery	recovery	NN
cord-011302-pfepyvaw	82	35	is	be	VBZ
cord-011302-pfepyvaw	82	36	significantly	significantly	RB
cord-011302-pfepyvaw	82	37	worse	bad	JJR
cord-011302-pfepyvaw	82	38	in	in	IN
cord-011302-pfepyvaw	82	39	this	this	DT
cord-011302-pfepyvaw	82	40	age	age	NN
cord-011302-pfepyvaw	82	41	group	group	NN
cord-011302-pfepyvaw	82	42	[	[	-LRB-
cord-011302-pfepyvaw	82	43	13	13	CD
cord-011302-pfepyvaw	82	44	]	]	-RRB-
cord-011302-pfepyvaw	82	45	.	.	.
cord-011302-pfepyvaw	83	1	Understanding	understand	VBG
cord-011302-pfepyvaw	83	2	patient	patient	JJ
cord-011302-pfepyvaw	83	3	baseline	baseline	JJ
cord-011302-pfepyvaw	83	4	function	function	NN
cord-011302-pfepyvaw	83	5	and	and	CC
cord-011302-pfepyvaw	83	6	morbidity	morbidity	NN
cord-011302-pfepyvaw	83	7	is	be	VBZ
cord-011302-pfepyvaw	83	8	important	important	JJ
cord-011302-pfepyvaw	83	9	,	,	,
cord-011302-pfepyvaw	83	10	but	but	CC
cord-011302-pfepyvaw	83	11	recognising	recognise	VBG
cord-011302-pfepyvaw	83	12	the	the	DT
cord-011302-pfepyvaw	83	13	high	high	JJ
cord-011302-pfepyvaw	83	14	chance	chance	NN
cord-011302-pfepyvaw	83	15	of	of	IN
cord-011302-pfepyvaw	83	16	a	a	DT
cord-011302-pfepyvaw	83	17	poor	poor	JJ
cord-011302-pfepyvaw	83	18	outcome	outcome	NN
cord-011302-pfepyvaw	83	19	in	in	IN
cord-011302-pfepyvaw	83	20	this	this	DT
cord-011302-pfepyvaw	83	21	age	age	NN
cord-011302-pfepyvaw	83	22	group	group	NN
cord-011302-pfepyvaw	83	23	often	often	RB
cord-011302-pfepyvaw	83	24	leads	lead	VBZ
cord-011302-pfepyvaw	83	25	clinicians	clinician	NNS
cord-011302-pfepyvaw	83	26	to	to	TO
cord-011302-pfepyvaw	83	27	follow	follow	VB
cord-011302-pfepyvaw	83	28	a	a	DT
cord-011302-pfepyvaw	83	29	conservative	conservative	JJ
cord-011302-pfepyvaw	83	30	route	route	NN
cord-011302-pfepyvaw	83	31	,	,	,
cord-011302-pfepyvaw	83	32	avoiding	avoid	VBG
cord-011302-pfepyvaw	83	33	neurointensive	neurointensive	JJ
cord-011302-pfepyvaw	83	34	care	care	NN
cord-011302-pfepyvaw	83	35	.	.	.
cord-011302-pfepyvaw	84	1	Intracranial	intracranial	JJ
cord-011302-pfepyvaw	84	2	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	84	3	(	(	-LRB-
cord-011302-pfepyvaw	84	4	ICH	ICH	NNP
cord-011302-pfepyvaw	84	5	)	)	-RRB-
cord-011302-pfepyvaw	84	6	in	in	IN
cord-011302-pfepyvaw	84	7	older	old	JJR
cord-011302-pfepyvaw	84	8	people	people	NNS
cord-011302-pfepyvaw	84	9	is	be	VBZ
cord-011302-pfepyvaw	84	10	often	often	RB
cord-011302-pfepyvaw	84	11	the	the	DT
cord-011302-pfepyvaw	84	12	result	result	NN
cord-011302-pfepyvaw	84	13	of	of	IN
cord-011302-pfepyvaw	84	14	long	long	RB
cord-011302-pfepyvaw	84	15	-	-	HYPH
cord-011302-pfepyvaw	84	16	standing	stand	VBG
cord-011302-pfepyvaw	84	17	underlying	underlying	JJ
cord-011302-pfepyvaw	84	18	pathological	pathological	JJ
cord-011302-pfepyvaw	84	19	vascular	vascular	JJ
cord-011302-pfepyvaw	84	20	disease	disease	NN
cord-011302-pfepyvaw	84	21	.	.	.
cord-011302-pfepyvaw	85	1	A	a	DT
cord-011302-pfepyvaw	85	2	patient	patient	NN
cord-011302-pfepyvaw	85	3	,	,	,
cord-011302-pfepyvaw	85	4	therefore	therefore	RB
cord-011302-pfepyvaw	85	5	,	,	,
cord-011302-pfepyvaw	85	6	has	have	VBZ
cord-011302-pfepyvaw	85	7	the	the	DT
cord-011302-pfepyvaw	85	8	intracranial	intracranial	JJ
cord-011302-pfepyvaw	85	9	pressure	pressure	NN
cord-011302-pfepyvaw	85	10	effects	effect	NNS
cord-011302-pfepyvaw	85	11	and	and	CC
cord-011302-pfepyvaw	85	12	focal	focal	JJ
cord-011302-pfepyvaw	85	13	neurological	neurological	JJ
cord-011302-pfepyvaw	85	14	deficits	deficit	NNS
cord-011302-pfepyvaw	85	15	associated	associate	VBN
cord-011302-pfepyvaw	85	16	with	with	IN
cord-011302-pfepyvaw	85	17	the	the	DT
cord-011302-pfepyvaw	85	18	ICH	ICH	NNP
cord-011302-pfepyvaw	85	19	in	in	IN
cord-011302-pfepyvaw	85	20	addition	addition	NN
cord-011302-pfepyvaw	85	21	to	to	IN
cord-011302-pfepyvaw	85	22	the	the	DT
cord-011302-pfepyvaw	85	23	systemic	systemic	JJ
cord-011302-pfepyvaw	85	24	co	co	NNS
cord-011302-pfepyvaw	85	25	-	-	NNS
cord-011302-pfepyvaw	85	26	morbidities	morbidity	NNS
cord-011302-pfepyvaw	85	27	of	of	IN
cord-011302-pfepyvaw	85	28	cardiac	cardiac	JJ
cord-011302-pfepyvaw	85	29	,	,	,
cord-011302-pfepyvaw	85	30	peripheral	peripheral	JJ
cord-011302-pfepyvaw	85	31	vascular	vascular	JJ
cord-011302-pfepyvaw	85	32	disease	disease	NN
cord-011302-pfepyvaw	85	33	,	,	,
cord-011302-pfepyvaw	85	34	and	and	CC
cord-011302-pfepyvaw	85	35	often	often	RB
cord-011302-pfepyvaw	85	36	anti	anti	JJ
cord-011302-pfepyvaw	85	37	-	-	JJ
cord-011302-pfepyvaw	85	38	thrombotic	thrombotic	JJ
cord-011302-pfepyvaw	85	39	medication	medication	NN
cord-011302-pfepyvaw	85	40	use	use	NN
cord-011302-pfepyvaw	85	41	.	.	.
cord-011302-pfepyvaw	86	1	Furthermore	furthermore	RB
cord-011302-pfepyvaw	86	2	,	,	,
cord-011302-pfepyvaw	86	3	secondary	secondary	JJ
cord-011302-pfepyvaw	86	4	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	86	5	is	be	VBZ
cord-011302-pfepyvaw	86	6	always	always	RB
cord-011302-pfepyvaw	86	7	a	a	DT
cord-011302-pfepyvaw	86	8	concern	concern	NN
cord-011302-pfepyvaw	86	9	.	.	.
cord-011302-pfepyvaw	87	1	The	the	DT
cord-011302-pfepyvaw	87	2	STICH	STICH	NNP
cord-011302-pfepyvaw	87	3	I	I	NNP
cord-011302-pfepyvaw	87	4	and	and	CC
cord-011302-pfepyvaw	87	5	II	II	NNP
cord-011302-pfepyvaw	87	6	trials	trial	NNS
cord-011302-pfepyvaw	87	7	did	do	VBD
cord-011302-pfepyvaw	87	8	not	not	RB
cord-011302-pfepyvaw	87	9	demonstrate	demonstrate	VB
cord-011302-pfepyvaw	87	10	any	any	DT
cord-011302-pfepyvaw	87	11	overall	overall	JJ
cord-011302-pfepyvaw	87	12	benefit	benefit	NN
cord-011302-pfepyvaw	87	13	from	from	IN
cord-011302-pfepyvaw	87	14	early	early	JJ
cord-011302-pfepyvaw	87	15	surgery	surgery	NN
cord-011302-pfepyvaw	87	16	compared	compare	VBN
cord-011302-pfepyvaw	87	17	with	with	IN
cord-011302-pfepyvaw	87	18	initial	initial	JJ
cord-011302-pfepyvaw	87	19	conservative	conservative	JJ
cord-011302-pfepyvaw	87	20	management	management	NN
cord-011302-pfepyvaw	87	21	for	for	IN
cord-011302-pfepyvaw	87	22	supratentorial	supratentorial	NNP
cord-011302-pfepyvaw	87	23	(	(	-LRB-
cord-011302-pfepyvaw	87	24	including	include	VBG
cord-011302-pfepyvaw	87	25	lobar	lobar	NNP
cord-011302-pfepyvaw	87	26	)	)	-RRB-
cord-011302-pfepyvaw	87	27	ICH	ICH	NNP
cord-011302-pfepyvaw	87	28	.	.	.
cord-011302-pfepyvaw	88	1	[	[	-LRB-
cord-011302-pfepyvaw	88	2	22	22	CD
cord-011302-pfepyvaw	88	3	,	,	,
cord-011302-pfepyvaw	88	4	23	23	CD
cord-011302-pfepyvaw	88	5	]	]	-RRB-
cord-011302-pfepyvaw	88	6	.	.	.
cord-011302-pfepyvaw	89	1	The	the	DT
cord-011302-pfepyvaw	89	2	median	median	JJ
cord-011302-pfepyvaw	89	3	patient	patient	NN
cord-011302-pfepyvaw	89	4	age	age	NN
cord-011302-pfepyvaw	89	5	for	for	IN
cord-011302-pfepyvaw	89	6	STICH	STICH	NNP
cord-011302-pfepyvaw	90	1	I	-PRON-	PRP
cord-011302-pfepyvaw	90	2	was	be	VBD
cord-011302-pfepyvaw	90	3	62	62	CD
cord-011302-pfepyvaw	90	4	years	year	NNS
cord-011302-pfepyvaw	91	1	(	(	-LRB-
cord-011302-pfepyvaw	91	2	IQR	IQR	NNP
cord-011302-pfepyvaw	91	3	52	52	CD
cord-011302-pfepyvaw	91	4	-	-	SYM
cord-011302-pfepyvaw	91	5	70	70	CD
cord-011302-pfepyvaw	91	6	)	)	-RRB-
cord-011302-pfepyvaw	91	7	and	and	CC
cord-011302-pfepyvaw	91	8	65	65	CD
cord-011302-pfepyvaw	91	9	years	year	NNS
cord-011302-pfepyvaw	92	1	(	(	-LRB-
cord-011302-pfepyvaw	92	2	IQR	IQR	NNP
cord-011302-pfepyvaw	92	3	55	55	CD
cord-011302-pfepyvaw	92	4	-	-	SYM
cord-011302-pfepyvaw	92	5	74	74	CD
cord-011302-pfepyvaw	92	6	)	)	-RRB-
cord-011302-pfepyvaw	92	7	for	for	IN
cord-011302-pfepyvaw	92	8	STICH	STICH	NNP
cord-011302-pfepyvaw	92	9	II	II	NNP
cord-011302-pfepyvaw	92	10	.	.	.
cord-011302-pfepyvaw	93	1	The	the	DT
cord-011302-pfepyvaw	93	2	inference	inference	NN
cord-011302-pfepyvaw	93	3	from	from	IN
cord-011302-pfepyvaw	93	4	these	these	DT
cord-011302-pfepyvaw	93	5	studies	study	NNS
cord-011302-pfepyvaw	93	6	is	be	VBZ
cord-011302-pfepyvaw	93	7	that	that	IN
cord-011302-pfepyvaw	93	8	surgeons	surgeon	NNS
cord-011302-pfepyvaw	93	9	are	be	VBP
cord-011302-pfepyvaw	93	10	already	already	RB
cord-011302-pfepyvaw	93	11	appropriately	appropriately	RB
cord-011302-pfepyvaw	93	12	undertaking	undertake	VBG
cord-011302-pfepyvaw	93	13	selective	selective	JJ
cord-011302-pfepyvaw	93	14	,	,	,
cord-011302-pfepyvaw	93	15	targeted	target	VBN
cord-011302-pfepyvaw	93	16	surgery	surgery	NN
cord-011302-pfepyvaw	93	17	to	to	IN
cord-011302-pfepyvaw	93	18	the	the	DT
cord-011302-pfepyvaw	93	19	patients	patient	NNS
cord-011302-pfepyvaw	93	20	that	that	WDT
cord-011302-pfepyvaw	93	21	are	be	VBP
cord-011302-pfepyvaw	93	22	most	most	RBS
cord-011302-pfepyvaw	93	23	likely	likely	JJ
cord-011302-pfepyvaw	93	24	to	to	TO
cord-011302-pfepyvaw	93	25	benefit	benefit	VB
cord-011302-pfepyvaw	93	26	from	from	IN
cord-011302-pfepyvaw	93	27	it	-PRON-	PRP
cord-011302-pfepyvaw	93	28	.	.	.
cord-011302-pfepyvaw	94	1	When	when	WRB
cord-011302-pfepyvaw	94	2	there	there	EX
cord-011302-pfepyvaw	94	3	is	be	VBZ
cord-011302-pfepyvaw	94	4	equipoise	equipoise	NN
cord-011302-pfepyvaw	94	5	about	about	IN
cord-011302-pfepyvaw	94	6	whether	whether	IN
cord-011302-pfepyvaw	94	7	to	to	TO
cord-011302-pfepyvaw	94	8	operate	operate	VB
cord-011302-pfepyvaw	94	9	,	,	,
cord-011302-pfepyvaw	94	10	these	these	DT
cord-011302-pfepyvaw	94	11	studies	study	NNS
cord-011302-pfepyvaw	94	12	suggest	suggest	VBP
cord-011302-pfepyvaw	94	13	that	that	IN
cord-011302-pfepyvaw	94	14	it	-PRON-	PRP
cord-011302-pfepyvaw	94	15	is	be	VBZ
cord-011302-pfepyvaw	94	16	reasonable	reasonable	JJ
cord-011302-pfepyvaw	94	17	to	to	TO
cord-011302-pfepyvaw	94	18	manage	manage	VB
cord-011302-pfepyvaw	94	19	the	the	DT
cord-011302-pfepyvaw	94	20	patient	patient	NN
cord-011302-pfepyvaw	94	21	conservatively	conservatively	RB
cord-011302-pfepyvaw	94	22	in	in	IN
cord-011302-pfepyvaw	94	23	the	the	DT
cord-011302-pfepyvaw	94	24	first	first	JJ
cord-011302-pfepyvaw	94	25	instance	instance	NN
cord-011302-pfepyvaw	94	26	and	and	CC
cord-011302-pfepyvaw	94	27	then	then	RB
cord-011302-pfepyvaw	94	28	re	re	VB
cord-011302-pfepyvaw	94	29	-	-	VB
cord-011302-pfepyvaw	94	30	assess	assess	VB
cord-011302-pfepyvaw	94	31	.	.	.
cord-011302-pfepyvaw	95	1	More	more	RBR
cord-011302-pfepyvaw	95	2	recently	recently	RB
cord-011302-pfepyvaw	95	3	,	,	,
cord-011302-pfepyvaw	95	4	there	there	EX
cord-011302-pfepyvaw	95	5	has	have	VBZ
cord-011302-pfepyvaw	95	6	been	be	VBN
cord-011302-pfepyvaw	95	7	a	a	DT
cord-011302-pfepyvaw	95	8	move	move	NN
cord-011302-pfepyvaw	95	9	towards	towards	IN
cord-011302-pfepyvaw	95	10	minimallyinvasive	minimallyinvasive	JJ
cord-011302-pfepyvaw	95	11	surgery	surgery	NN
cord-011302-pfepyvaw	95	12	(	(	-LRB-
cord-011302-pfepyvaw	95	13	MIS	MIS	NNP
cord-011302-pfepyvaw	95	14	)	)	-RRB-
cord-011302-pfepyvaw	95	15	for	for	IN
cord-011302-pfepyvaw	95	16	ICH	ICH	NNP
cord-011302-pfepyvaw	95	17	,	,	,
cord-011302-pfepyvaw	95	18	with	with	IN
cord-011302-pfepyvaw	95	19	the	the	DT
cord-011302-pfepyvaw	95	20	potential	potential	JJ
cord-011302-pfepyvaw	95	21	benefits	benefit	NNS
cord-011302-pfepyvaw	95	22	of	of	IN
cord-011302-pfepyvaw	95	23	being	be	VBG
cord-011302-pfepyvaw	95	24	less	less	RBR
cord-011302-pfepyvaw	95	25	traumatic	traumatic	JJ
cord-011302-pfepyvaw	95	26	,	,	,
cord-011302-pfepyvaw	95	27	quicker	quick	RBR
cord-011302-pfepyvaw	95	28	,	,	,
cord-011302-pfepyvaw	95	29	and	and	CC
cord-011302-pfepyvaw	95	30	more	more	RBR
cord-011302-pfepyvaw	95	31	focused	focused	JJ
cord-011302-pfepyvaw	95	32	than	than	IN
cord-011302-pfepyvaw	95	33	a	a	DT
cord-011302-pfepyvaw	95	34	craniotomy	craniotomy	NN
cord-011302-pfepyvaw	95	35	.	.	.
cord-011302-pfepyvaw	96	1	However	however	RB
cord-011302-pfepyvaw	96	2	,	,	,
cord-011302-pfepyvaw	96	3	controversy	controversy	NN
cord-011302-pfepyvaw	96	4	exists	exist	VBZ
cord-011302-pfepyvaw	96	5	concerning	concern	VBG
cord-011302-pfepyvaw	96	6	the	the	DT
cord-011302-pfepyvaw	96	7	widespread	widespread	JJ
cord-011302-pfepyvaw	96	8	clinical	clinical	JJ
cord-011302-pfepyvaw	96	9	application	application	NN
cord-011302-pfepyvaw	96	10	of	of	IN
cord-011302-pfepyvaw	96	11	such	such	JJ
cord-011302-pfepyvaw	96	12	techniques	technique	NNS
cord-011302-pfepyvaw	96	13	.	.	.
cord-011302-pfepyvaw	97	1	A	a	DT
cord-011302-pfepyvaw	97	2	recent	recent	JJ
cord-011302-pfepyvaw	97	3	meta	meta	JJ
cord-011302-pfepyvaw	97	4	-	-	HYPH
cord-011302-pfepyvaw	97	5	analysis	analysis	NN
cord-011302-pfepyvaw	97	6	(	(	-LRB-
cord-011302-pfepyvaw	97	7	2018	2018	CD
cord-011302-pfepyvaw	97	8	)	)	-RRB-
cord-011302-pfepyvaw	97	9	on	on	IN
cord-011302-pfepyvaw	97	10	MIS	MIS	NNP
cord-011302-pfepyvaw	97	11	for	for	IN
cord-011302-pfepyvaw	97	12	hypertensive	hypertensive	JJ
cord-011302-pfepyvaw	97	13	ICH	ICH	NNP
cord-011302-pfepyvaw	97	14	(	(	-LRB-
cord-011302-pfepyvaw	97	15	the	the	DT
cord-011302-pfepyvaw	97	16	most	most	RBS
cord-011302-pfepyvaw	97	17	common	common	JJ
cord-011302-pfepyvaw	97	18	cause	cause	NN
cord-011302-pfepyvaw	97	19	of	of	IN
cord-011302-pfepyvaw	97	20	spontaneous	spontaneous	JJ
cord-011302-pfepyvaw	97	21	ICH	ICH	NNP
cord-011302-pfepyvaw	97	22	)	)	-RRB-
cord-011302-pfepyvaw	97	23	,	,	,
cord-011302-pfepyvaw	97	24	reported	report	VBD
cord-011302-pfepyvaw	97	25	a	a	DT
cord-011302-pfepyvaw	97	26	positive	positive	JJ
cord-011302-pfepyvaw	97	27	effect	effect	NN
cord-011302-pfepyvaw	97	28	on	on	IN
cord-011302-pfepyvaw	97	29	patient	patient	JJ
cord-011302-pfepyvaw	97	30	prognosis	prognosis	NN
cord-011302-pfepyvaw	97	31	(	(	-LRB-
cord-011302-pfepyvaw	97	32	using	use	VBG
cord-011302-pfepyvaw	97	33	GOS	GOS	NNP
cord-011302-pfepyvaw	97	34	)	)	-RRB-
cord-011302-pfepyvaw	97	35	compared	compare	VBN
cord-011302-pfepyvaw	97	36	to	to	IN
cord-011302-pfepyvaw	97	37	both	both	CC
cord-011302-pfepyvaw	97	38	craniotomy	craniotomy	NN
cord-011302-pfepyvaw	97	39	and	and	CC
cord-011302-pfepyvaw	97	40	conservative	conservative	JJ
cord-011302-pfepyvaw	97	41	treatment	treatment	NN
cord-011302-pfepyvaw	97	42	[	[	-LRB-
cord-011302-pfepyvaw	97	43	37	37	CD
cord-011302-pfepyvaw	97	44	]	]	-RRB-
cord-011302-pfepyvaw	97	45	.	.	.
cord-011302-pfepyvaw	98	1	Mortality	mortality	NN
cord-011302-pfepyvaw	98	2	rates	rate	NNS
cord-011302-pfepyvaw	98	3	were	be	VBD
cord-011302-pfepyvaw	98	4	lower	low	JJR
cord-011302-pfepyvaw	98	5	for	for	IN
cord-011302-pfepyvaw	98	6	MIS	mi	NNS
cord-011302-pfepyvaw	98	7	compared	compare	VBN
cord-011302-pfepyvaw	98	8	to	to	IN
cord-011302-pfepyvaw	98	9	conservative	conservative	JJ
cord-011302-pfepyvaw	98	10	treatment	treatment	NN
cord-011302-pfepyvaw	98	11	and	and	CC
cord-011302-pfepyvaw	98	12	post	post	JJ
cord-011302-pfepyvaw	98	13	-	-	JJ
cord-011302-pfepyvaw	98	14	operative	operative	JJ
cord-011302-pfepyvaw	98	15	re	re	NN
cord-011302-pfepyvaw	98	16	-	-	JJ
cord-011302-pfepyvaw	98	17	bleeding	bleeding	JJ
cord-011302-pfepyvaw	98	18	rates	rate	NNS
cord-011302-pfepyvaw	98	19	were	be	VBD
cord-011302-pfepyvaw	98	20	lower	low	JJR
cord-011302-pfepyvaw	98	21	for	for	IN
cord-011302-pfepyvaw	98	22	MIS	mi	NNS
cord-011302-pfepyvaw	98	23	compared	compare	VBN
cord-011302-pfepyvaw	98	24	to	to	IN
cord-011302-pfepyvaw	98	25	craniotomy	craniotomy	NN
cord-011302-pfepyvaw	98	26	.	.	.
cord-011302-pfepyvaw	99	1	As	as	IN
cord-011302-pfepyvaw	99	2	this	this	DT
cord-011302-pfepyvaw	99	3	review	review	NN
cord-011302-pfepyvaw	99	4	only	only	RB
cord-011302-pfepyvaw	99	5	included	include	VBD
cord-011302-pfepyvaw	99	6	eight	eight	CD
cord-011302-pfepyvaw	99	7	randomised	randomised	JJ
cord-011302-pfepyvaw	99	8	controlled	control	VBN
cord-011302-pfepyvaw	99	9	trials	trial	NNS
cord-011302-pfepyvaw	99	10	and	and	CC
cord-011302-pfepyvaw	99	11	most	most	JJS
cord-011302-pfepyvaw	99	12	studies	study	NNS
cord-011302-pfepyvaw	99	13	also	also	RB
cord-011302-pfepyvaw	99	14	excluded	exclude	VBD
cord-011302-pfepyvaw	99	15	patients	patient	NNS
cord-011302-pfepyvaw	99	16	that	that	WDT
cord-011302-pfepyvaw	99	17	were	be	VBD
cord-011302-pfepyvaw	99	18	>	>	NNS
cord-011302-pfepyvaw	99	19	80	80	CD
cord-011302-pfepyvaw	99	20	years	year	NNS
cord-011302-pfepyvaw	99	21	old	old	JJ
cord-011302-pfepyvaw	99	22	,	,	,
cord-011302-pfepyvaw	99	23	more	more	RBR
cord-011302-pfepyvaw	99	24	high	high	JJ
cord-011302-pfepyvaw	99	25	-	-	HYPH
cord-011302-pfepyvaw	99	26	quality	quality	NN
cord-011302-pfepyvaw	99	27	studies	study	NNS
cord-011302-pfepyvaw	99	28	and	and	CC
cord-011302-pfepyvaw	99	29	in	in	IN
cord-011302-pfepyvaw	99	30	a	a	DT
cord-011302-pfepyvaw	99	31	wider	wide	JJR
cord-011302-pfepyvaw	99	32	population	population	NN
cord-011302-pfepyvaw	99	33	of	of	IN
cord-011302-pfepyvaw	99	34	older	old	JJR
cord-011302-pfepyvaw	99	35	patients	patient	NNS
cord-011302-pfepyvaw	99	36	are	be	VBP
cord-011302-pfepyvaw	99	37	needed	need	VBN
cord-011302-pfepyvaw	99	38	before	before	IN
cord-011302-pfepyvaw	99	39	firm	firm	JJ
cord-011302-pfepyvaw	99	40	conclusions	conclusion	NNS
cord-011302-pfepyvaw	99	41	can	can	MD
cord-011302-pfepyvaw	99	42	be	be	VB
cord-011302-pfepyvaw	99	43	drawn	draw	VBN
cord-011302-pfepyvaw	99	44	.	.	.
cord-011302-pfepyvaw	100	1	This	this	DT
cord-011302-pfepyvaw	100	2	is	be	VBZ
cord-011302-pfepyvaw	100	3	particularly	particularly	RB
cord-011302-pfepyvaw	100	4	important	important	JJ
cord-011302-pfepyvaw	100	5	as	as	IN
cord-011302-pfepyvaw	100	6	29	29	CD
cord-011302-pfepyvaw	100	7	-	-	SYM
cord-011302-pfepyvaw	100	8	34	34	CD
cord-011302-pfepyvaw	100	9	%	%	NN
cord-011302-pfepyvaw	100	10	of	of	IN
cord-011302-pfepyvaw	100	11	patients	patient	NNS
cord-011302-pfepyvaw	100	12	diagnosed	diagnose	VBN
cord-011302-pfepyvaw	100	13	with	with	IN
cord-011302-pfepyvaw	100	14	an	an	DT
cord-011302-pfepyvaw	100	15	ICH	ICH	NNP
cord-011302-pfepyvaw	100	16	are	be	VBP
cord-011302-pfepyvaw	100	17	≥	≥	CD
cord-011302-pfepyvaw	100	18	80	80	CD
cord-011302-pfepyvaw	100	19	years	year	NNS
cord-011302-pfepyvaw	100	20	old	old	JJ
cord-011302-pfepyvaw	100	21	,	,	,
cord-011302-pfepyvaw	100	22	and	and	CC
cord-011302-pfepyvaw	100	23	this	this	DT
cord-011302-pfepyvaw	100	24	patient	patient	NN
cord-011302-pfepyvaw	100	25	group	group	NN
cord-011302-pfepyvaw	100	26	has	have	VBZ
cord-011302-pfepyvaw	100	27	significantly	significantly	RB
cord-011302-pfepyvaw	100	28	higher	high	JJR
cord-011302-pfepyvaw	100	29	rates	rate	NNS
cord-011302-pfepyvaw	100	30	of	of	IN
cord-011302-pfepyvaw	100	31	in	in	IN
cord-011302-pfepyvaw	100	32	-	-	HYPH
cord-011302-pfepyvaw	100	33	hospital	hospital	NN
cord-011302-pfepyvaw	100	34	mortality	mortality	NN
cord-011302-pfepyvaw	100	35	and	and	CC
cord-011302-pfepyvaw	100	36	unfavourable	unfavourable	JJ
cord-011302-pfepyvaw	100	37	outcome	outcome	NN
cord-011302-pfepyvaw	100	38	[	[	-LRB-
cord-011302-pfepyvaw	100	39	3	3	CD
cord-011302-pfepyvaw	100	40	,	,	,
cord-011302-pfepyvaw	100	41	35	35	CD
cord-011302-pfepyvaw	100	42	]	]	-RRB-
cord-011302-pfepyvaw	100	43	.	.	.
cord-011302-pfepyvaw	101	1	Scaggiante	Scaggiante	NNP
cord-011302-pfepyvaw	101	2	also	also	RB
cord-011302-pfepyvaw	101	3	published	publish	VBD
cord-011302-pfepyvaw	101	4	a	a	DT
cord-011302-pfepyvaw	101	5	meta	meta	NN
cord-011302-pfepyvaw	101	6	-	-	HYPH
cord-011302-pfepyvaw	101	7	analysis	analysis	NN
cord-011302-pfepyvaw	101	8	of	of	IN
cord-011302-pfepyvaw	101	9	MIS	MIS	NNP
cord-011302-pfepyvaw	101	10	in	in	IN
cord-011302-pfepyvaw	101	11	2018	2018	CD
cord-011302-pfepyvaw	101	12	,	,	,
cord-011302-pfepyvaw	101	13	assessing	assess	VBG
cord-011302-pfepyvaw	101	14	15	15	CD
cord-011302-pfepyvaw	101	15	RCTs	rct	NNS
cord-011302-pfepyvaw	101	16	that	that	WDT
cord-011302-pfepyvaw	101	17	mainly	mainly	RB
cord-011302-pfepyvaw	101	18	deployed	deploy	VBD
cord-011302-pfepyvaw	101	19	endoscopic	endoscopic	NNS
cord-011302-pfepyvaw	101	20	and/or	and/or	CC
cord-011302-pfepyvaw	101	21	stereotactic	stereotactic	JJ
cord-011302-pfepyvaw	101	22	thrombolytic	thrombolytic	NN
cord-011302-pfepyvaw	101	23	techniques	technique	NNS
cord-011302-pfepyvaw	101	24	[	[	-LRB-
cord-011302-pfepyvaw	101	25	32	32	CD
cord-011302-pfepyvaw	101	26	]	]	-RRB-
cord-011302-pfepyvaw	101	27	.	.	.
cord-011302-pfepyvaw	102	1	This	this	DT
cord-011302-pfepyvaw	102	2	consolidated	consolidate	VBD
cord-011302-pfepyvaw	102	3	the	the	DT
cord-011302-pfepyvaw	102	4	finding	finding	NN
cord-011302-pfepyvaw	102	5	that	that	IN
cord-011302-pfepyvaw	102	6	MIS	MIS	NNP
cord-011302-pfepyvaw	102	7	improved	improve	VBN
cord-011302-pfepyvaw	102	8	outcome	outcome	NN
cord-011302-pfepyvaw	102	9	compared	compare	VBN
cord-011302-pfepyvaw	102	10	to	to	IN
cord-011302-pfepyvaw	102	11	both	both	CC
cord-011302-pfepyvaw	102	12	craniotomy	craniotomy	NN
cord-011302-pfepyvaw	102	13	and	and	CC
cord-011302-pfepyvaw	102	14	conservative	conservative	JJ
cord-011302-pfepyvaw	102	15	treatment	treatment	NN
cord-011302-pfepyvaw	102	16	.	.	.
cord-011302-pfepyvaw	103	1	Different	different	JJ
cord-011302-pfepyvaw	103	2	MIS	MIS	NNP
cord-011302-pfepyvaw	103	3	techniques	technique	NNS
cord-011302-pfepyvaw	103	4	(	(	-LRB-
cord-011302-pfepyvaw	103	5	endoscopy	endoscopy	NN
cord-011302-pfepyvaw	103	6	and	and	CC
cord-011302-pfepyvaw	103	7	stereotactic	stereotactic	JJ
cord-011302-pfepyvaw	103	8	thrombolysis	thrombolysis	NN
cord-011302-pfepyvaw	103	9	)	)	-RRB-
cord-011302-pfepyvaw	103	10	both	both	DT
cord-011302-pfepyvaw	103	11	showed	show	VBD
cord-011302-pfepyvaw	103	12	significant	significant	JJ
cord-011302-pfepyvaw	103	13	improvements	improvement	NNS
cord-011302-pfepyvaw	103	14	,	,	,
cord-011302-pfepyvaw	103	15	but	but	CC
cord-011302-pfepyvaw	103	16	these	these	DT
cord-011302-pfepyvaw	103	17	techniques	technique	NNS
cord-011302-pfepyvaw	103	18	have	have	VBP
cord-011302-pfepyvaw	103	19	not	not	RB
cord-011302-pfepyvaw	103	20	been	be	VBN
cord-011302-pfepyvaw	103	21	compared	compare	VBN
cord-011302-pfepyvaw	103	22	directly	directly	RB
cord-011302-pfepyvaw	103	23	.	.	.
cord-011302-pfepyvaw	104	1	Earlier	early	JJR
cord-011302-pfepyvaw	104	2	MIS	MIS	NNP
cord-011302-pfepyvaw	104	3	evacuation	evacuation	NN
cord-011302-pfepyvaw	104	4	of	of	IN
cord-011302-pfepyvaw	104	5	an	an	DT
cord-011302-pfepyvaw	104	6	ICH	ICH	NNP
cord-011302-pfepyvaw	104	7	appeared	appear	VBD
cord-011302-pfepyvaw	104	8	to	to	TO
cord-011302-pfepyvaw	104	9	be	be	VB
cord-011302-pfepyvaw	104	10	associated	associate	VBN
cord-011302-pfepyvaw	104	11	with	with	IN
cord-011302-pfepyvaw	104	12	a	a	DT
cord-011302-pfepyvaw	104	13	better	well	JJR
cord-011302-pfepyvaw	104	14	chance	chance	NN
cord-011302-pfepyvaw	104	15	of	of	IN
cord-011302-pfepyvaw	104	16	achieving	achieve	VBG
cord-011302-pfepyvaw	104	17	functional	functional	JJ
cord-011302-pfepyvaw	104	18	independence	independence	NN
cord-011302-pfepyvaw	104	19	.	.	.
cord-011302-pfepyvaw	105	1	Conversely	conversely	RB
cord-011302-pfepyvaw	105	2	,	,	,
cord-011302-pfepyvaw	105	3	the	the	DT
cord-011302-pfepyvaw	105	4	final	final	JJ
cord-011302-pfepyvaw	105	5	results	result	NNS
cord-011302-pfepyvaw	105	6	of	of	IN
cord-011302-pfepyvaw	105	7	the	the	DT
cord-011302-pfepyvaw	105	8	MISTIE	MISTIE	NNP
cord-011302-pfepyvaw	105	9	3	3	CD
cord-011302-pfepyvaw	106	1	(	(	-LRB-
cord-011302-pfepyvaw	106	2	Minimially	Minimially	NNP
cord-011302-pfepyvaw	106	3	Invasive	invasive	JJ
cord-011302-pfepyvaw	106	4	Surgery	surgery	NN
cord-011302-pfepyvaw	106	5	with	with	IN
cord-011302-pfepyvaw	106	6	Thrombolysis	Thrombolysis	NNP
cord-011302-pfepyvaw	106	7	in	in	IN
cord-011302-pfepyvaw	106	8	ICH	ICH	NNP
cord-011302-pfepyvaw	106	9	Evacuation	Evacuation	NNP
cord-011302-pfepyvaw	106	10	)	)	-RRB-
cord-011302-pfepyvaw	106	11	trial	trial	NN
cord-011302-pfepyvaw	106	12	showed	show	VBD
cord-011302-pfepyvaw	106	13	that	that	IN
cord-011302-pfepyvaw	106	14	aspiration	aspiration	NN
cord-011302-pfepyvaw	106	15	and	and	CC
cord-011302-pfepyvaw	106	16	thrombolytic	thrombolytic	NN
cord-011302-pfepyvaw	106	17	irrigation	irrigation	NN
cord-011302-pfepyvaw	106	18	of	of	IN
cord-011302-pfepyvaw	106	19	an	an	DT
cord-011302-pfepyvaw	106	20	ICH	ICH	NNP
cord-011302-pfepyvaw	106	21	with	with	IN
cord-011302-pfepyvaw	106	22	alteplase	alteplase	NNP
cord-011302-pfepyvaw	106	23	via	via	IN
cord-011302-pfepyvaw	106	24	an	an	DT
cord-011302-pfepyvaw	106	25	image	image	NN
cord-011302-pfepyvaw	106	26	directed	direct	VBN
cord-011302-pfepyvaw	106	27	catheter	catheter	NN
cord-011302-pfepyvaw	106	28	did	do	VBD
cord-011302-pfepyvaw	106	29	not	not	RB
cord-011302-pfepyvaw	106	30	improve	improve	VB
cord-011302-pfepyvaw	106	31	functional	functional	JJ
cord-011302-pfepyvaw	106	32	outcomes	outcome	NNS
cord-011302-pfepyvaw	106	33	compared	compare	VBN
cord-011302-pfepyvaw	106	34	with	with	IN
cord-011302-pfepyvaw	106	35	standard	standard	JJ
cord-011302-pfepyvaw	106	36	care	care	NN
cord-011302-pfepyvaw	106	37	for	for	IN
cord-011302-pfepyvaw	106	38	large	large	JJ
cord-011302-pfepyvaw	106	39	ICHs	ich	NNS
cord-011302-pfepyvaw	106	40	[	[	-LRB-
cord-011302-pfepyvaw	106	41	14	14	CD
cord-011302-pfepyvaw	106	42	]	]	-RRB-
cord-011302-pfepyvaw	106	43	.	.	.
cord-011302-pfepyvaw	107	1	A	a	DT
cord-011302-pfepyvaw	107	2	modest	modest	JJ
cord-011302-pfepyvaw	107	3	survival	survival	NN
cord-011302-pfepyvaw	107	4	benefit	benefit	NN
cord-011302-pfepyvaw	107	5	was	be	VBD
cord-011302-pfepyvaw	107	6	identified	identify	VBN
cord-011302-pfepyvaw	107	7	.	.	.
cord-011302-pfepyvaw	108	1	This	this	DT
cord-011302-pfepyvaw	108	2	trial	trial	NN
cord-011302-pfepyvaw	108	3	only	only	RB
cord-011302-pfepyvaw	108	4	included	include	VBD
cord-011302-pfepyvaw	108	5	patients	patient	NNS
cord-011302-pfepyvaw	108	6	aged	aged	JJ
cord-011302-pfepyvaw	108	7	52	52	CD
cord-011302-pfepyvaw	108	8	-	-	SYM
cord-011302-pfepyvaw	108	9	71	71	CD
cord-011302-pfepyvaw	108	10	years	year	NNS
cord-011302-pfepyvaw	108	11	old	old	JJ
cord-011302-pfepyvaw	108	12	,	,	,
cord-011302-pfepyvaw	108	13	so	so	CC
cord-011302-pfepyvaw	108	14	caution	caution	NN
cord-011302-pfepyvaw	108	15	must	must	MD
cord-011302-pfepyvaw	108	16	be	be	VB
cord-011302-pfepyvaw	108	17	exercised	exercise	VBN
cord-011302-pfepyvaw	108	18	in	in	IN
cord-011302-pfepyvaw	108	19	applying	apply	VBG
cord-011302-pfepyvaw	108	20	the	the	DT
cord-011302-pfepyvaw	108	21	conclusions	conclusion	NNS
cord-011302-pfepyvaw	108	22	to	to	IN
cord-011302-pfepyvaw	108	23	older	old	JJR
cord-011302-pfepyvaw	108	24	patients	patient	NNS
cord-011302-pfepyvaw	108	25	.	.	.
cord-011302-pfepyvaw	109	1	The	the	DT
cord-011302-pfepyvaw	109	2	comprehensive	comprehensive	JJ
cord-011302-pfepyvaw	109	3	geriatric	geriatric	JJ
cord-011302-pfepyvaw	109	4	assessment	assessment	NN
cord-011302-pfepyvaw	109	5	(	(	-LRB-
cord-011302-pfepyvaw	109	6	CGA	CGA	NNP
cord-011302-pfepyvaw	109	7	)	)	-RRB-
cord-011302-pfepyvaw	109	8	is	be	VBZ
cord-011302-pfepyvaw	109	9	an	an	DT
cord-011302-pfepyvaw	109	10	established	establish	VBN
cord-011302-pfepyvaw	109	11	tool	tool	NN
cord-011302-pfepyvaw	109	12	used	use	VBN
cord-011302-pfepyvaw	109	13	to	to	TO
cord-011302-pfepyvaw	109	14	assess	assess	VB
cord-011302-pfepyvaw	109	15	the	the	DT
cord-011302-pfepyvaw	109	16	needs	need	NNS
cord-011302-pfepyvaw	109	17	of	of	IN
cord-011302-pfepyvaw	109	18	older	old	JJR
cord-011302-pfepyvaw	109	19	people	people	NNS
cord-011302-pfepyvaw	109	20	and	and	CC
cord-011302-pfepyvaw	109	21	implement	implement	VB
cord-011302-pfepyvaw	109	22	investigations	investigation	NNS
cord-011302-pfepyvaw	109	23	and	and	CC
cord-011302-pfepyvaw	109	24	treatments	treatment	NNS
cord-011302-pfepyvaw	109	25	to	to	TO
cord-011302-pfepyvaw	109	26	improve	improve	VB
cord-011302-pfepyvaw	109	27	long	long	JJ
cord-011302-pfepyvaw	109	28	-	-	HYPH
cord-011302-pfepyvaw	109	29	term	term	NN
cord-011302-pfepyvaw	109	30	outcomes	outcome	NNS
cord-011302-pfepyvaw	109	31	.	.	.
cord-011302-pfepyvaw	110	1	The	the	DT
cord-011302-pfepyvaw	110	2	use	use	NN
cord-011302-pfepyvaw	110	3	of	of	IN
cord-011302-pfepyvaw	110	4	this	this	DT
cord-011302-pfepyvaw	110	5	tool	tool	NN
cord-011302-pfepyvaw	110	6	has	have	VBZ
cord-011302-pfepyvaw	110	7	been	be	VBN
cord-011302-pfepyvaw	110	8	shown	show	VBN
cord-011302-pfepyvaw	110	9	to	to	TO
cord-011302-pfepyvaw	110	10	improve	improve	VB
cord-011302-pfepyvaw	110	11	post	post	JJ
cord-011302-pfepyvaw	110	12	-	-	JJ
cord-011302-pfepyvaw	110	13	operative	operative	JJ
cord-011302-pfepyvaw	110	14	outcomes	outcome	NNS
cord-011302-pfepyvaw	110	15	in	in	IN
cord-011302-pfepyvaw	110	16	older	old	JJR
cord-011302-pfepyvaw	110	17	patients	patient	NNS
cord-011302-pfepyvaw	110	18	undergoing	undergo	VBG
cord-011302-pfepyvaw	110	19	elective	elective	JJ
cord-011302-pfepyvaw	110	20	surgery	surgery	NN
cord-011302-pfepyvaw	110	21	across	across	IN
cord-011302-pfepyvaw	110	22	specialties	specialty	NNS
cord-011302-pfepyvaw	110	23	[	[	-LRB-
cord-011302-pfepyvaw	110	24	28	28	CD
cord-011302-pfepyvaw	110	25	]	]	-RRB-
cord-011302-pfepyvaw	110	26	.	.	.
cord-011302-pfepyvaw	111	1	It	-PRON-	PRP
cord-011302-pfepyvaw	111	2	is	be	VBZ
cord-011302-pfepyvaw	111	3	,	,	,
cord-011302-pfepyvaw	111	4	therefore	therefore	RB
cord-011302-pfepyvaw	111	5	,	,	,
cord-011302-pfepyvaw	111	6	clear	clear	JJ
cord-011302-pfepyvaw	111	7	that	that	IN
cord-011302-pfepyvaw	111	8	older	old	JJR
cord-011302-pfepyvaw	111	9	people	people	NNS
cord-011302-pfepyvaw	111	10	have	have	VBP
cord-011302-pfepyvaw	111	11	different	different	JJ
cord-011302-pfepyvaw	111	12	needs	need	NNS
cord-011302-pfepyvaw	111	13	,	,	,
cord-011302-pfepyvaw	111	14	which	which	WDT
cord-011302-pfepyvaw	111	15	when	when	WRB
cord-011302-pfepyvaw	111	16	identified	identify	VBN
cord-011302-pfepyvaw	111	17	and	and	CC
cord-011302-pfepyvaw	111	18	addressed	address	VBN
cord-011302-pfepyvaw	111	19	can	can	MD
cord-011302-pfepyvaw	111	20	improve	improve	VB
cord-011302-pfepyvaw	111	21	outcomes	outcome	NNS
cord-011302-pfepyvaw	111	22	.	.	.
cord-011302-pfepyvaw	112	1	The	the	DT
cord-011302-pfepyvaw	112	2	CGA	CGA	NNP
cord-011302-pfepyvaw	112	3	is	be	VBZ
cord-011302-pfepyvaw	112	4	a	a	DT
cord-011302-pfepyvaw	112	5	robust	robust	JJ
cord-011302-pfepyvaw	112	6	but	but	CC
cord-011302-pfepyvaw	112	7	cumbersome	cumbersome	JJ
cord-011302-pfepyvaw	112	8	assessment	assessment	NN
cord-011302-pfepyvaw	112	9	including	include	VBG
cord-011302-pfepyvaw	112	10	6	6	CD
cord-011302-pfepyvaw	112	11	different	different	JJ
cord-011302-pfepyvaw	112	12	domains	domain	NNS
cord-011302-pfepyvaw	112	13	(	(	-LRB-
cord-011302-pfepyvaw	112	14	medical	medical	JJ
cord-011302-pfepyvaw	112	15	,	,	,
cord-011302-pfepyvaw	112	16	mental	mental	JJ
cord-011302-pfepyvaw	112	17	health	health	NN
cord-011302-pfepyvaw	112	18	,	,	,
cord-011302-pfepyvaw	112	19	functional	functional	JJ
cord-011302-pfepyvaw	112	20	capacity	capacity	NN
cord-011302-pfepyvaw	112	21	,	,	,
cord-011302-pfepyvaw	112	22	social	social	JJ
cord-011302-pfepyvaw	112	23	circumstances	circumstance	NNS
cord-011302-pfepyvaw	112	24	,	,	,
cord-011302-pfepyvaw	112	25	environment	environment	NN
cord-011302-pfepyvaw	112	26	,	,	,
cord-011302-pfepyvaw	112	27	and	and	CC
cord-011302-pfepyvaw	112	28	risk	risk	NN
cord-011302-pfepyvaw	112	29	score	score	NN
cord-011302-pfepyvaw	112	30	)	)	-RRB-
cord-011302-pfepyvaw	112	31	.	.	.
cord-011302-pfepyvaw	113	1	Identification	identification	NN
cord-011302-pfepyvaw	113	2	of	of	IN
cord-011302-pfepyvaw	113	3	simpler	simple	JJR
cord-011302-pfepyvaw	113	4	tools	tool	NNS
cord-011302-pfepyvaw	113	5	,	,	,
cord-011302-pfepyvaw	113	6	possibly	possibly	RB
cord-011302-pfepyvaw	113	7	even	even	RB
cord-011302-pfepyvaw	113	8	specific	specific	JJ
cord-011302-pfepyvaw	113	9	to	to	IN
cord-011302-pfepyvaw	113	10	neurosurgery	neurosurgery	NNP
cord-011302-pfepyvaw	113	11	,	,	,
cord-011302-pfepyvaw	113	12	are	be	VBP
cord-011302-pfepyvaw	113	13	necessary	necessary	JJ
cord-011302-pfepyvaw	113	14	.	.	.
cord-011302-pfepyvaw	114	1	Understanding	understand	VBG
cord-011302-pfepyvaw	114	2	what	what	WP
cord-011302-pfepyvaw	114	3	is	be	VBZ
cord-011302-pfepyvaw	114	4	meant	mean	VBN
cord-011302-pfepyvaw	114	5	by	by	IN
cord-011302-pfepyvaw	114	6	frailty	frailty	NN
cord-011302-pfepyvaw	114	7	is	be	VBZ
cord-011302-pfepyvaw	114	8	also	also	RB
cord-011302-pfepyvaw	114	9	important	important	JJ
cord-011302-pfepyvaw	114	10	,	,	,
cord-011302-pfepyvaw	114	11	as	as	IN
cord-011302-pfepyvaw	114	12	,	,	,
cord-011302-pfepyvaw	115	1	although	although	IN
cord-011302-pfepyvaw	115	2	there	there	EX
cord-011302-pfepyvaw	115	3	is	be	VBZ
cord-011302-pfepyvaw	115	4	some	some	DT
cord-011302-pfepyvaw	115	5	cross	cross	NN
cord-011302-pfepyvaw	115	6	-	-	HYPH
cord-011302-pfepyvaw	115	7	over	over	RP
cord-011302-pfepyvaw	115	8	with	with	IN
cord-011302-pfepyvaw	115	9	disability	disability	NN
cord-011302-pfepyvaw	115	10	and	and	CC
cord-011302-pfepyvaw	115	11	co	co	NN
cord-011302-pfepyvaw	115	12	-	-	NN
cord-011302-pfepyvaw	115	13	morbidity	morbidity	NN
cord-011302-pfepyvaw	115	14	,	,	,
cord-011302-pfepyvaw	115	15	it	-PRON-	PRP
cord-011302-pfepyvaw	115	16	actually	actually	RB
cord-011302-pfepyvaw	115	17	refers	refer	VBZ
cord-011302-pfepyvaw	115	18	to	to	IN
cord-011302-pfepyvaw	115	19	a	a	DT
cord-011302-pfepyvaw	115	20	physiological	physiological	JJ
cord-011302-pfepyvaw	115	21	state	state	NN
cord-011302-pfepyvaw	115	22	of	of	IN
cord-011302-pfepyvaw	115	23	increased	increase	VBN
cord-011302-pfepyvaw	115	24	vulnerability	vulnerability	NN
cord-011302-pfepyvaw	115	25	to	to	IN
cord-011302-pfepyvaw	115	26	stressors	stressor	NNS
cord-011302-pfepyvaw	115	27	due	due	JJ
cord-011302-pfepyvaw	115	28	to	to	IN
cord-011302-pfepyvaw	115	29	decreased	decrease	VBD
cord-011302-pfepyvaw	115	30	physiological	physiological	JJ
cord-011302-pfepyvaw	115	31	reserve	reserve	NN
cord-011302-pfepyvaw	115	32	[	[	-LRB-
cord-011302-pfepyvaw	115	33	12	12	CD
cord-011302-pfepyvaw	115	34	]	]	-RRB-
cord-011302-pfepyvaw	115	35	.	.	.
cord-011302-pfepyvaw	116	1	A	a	DT
cord-011302-pfepyvaw	116	2	frailty	frailty	NN
cord-011302-pfepyvaw	116	3	score	score	NN
cord-011302-pfepyvaw	116	4	based	base	VBN
cord-011302-pfepyvaw	116	5	on	on	IN
cord-011302-pfepyvaw	116	6	the	the	DT
cord-011302-pfepyvaw	116	7	assessment	assessment	NN
cord-011302-pfepyvaw	116	8	of	of	IN
cord-011302-pfepyvaw	116	9	data	datum	NNS
cord-011302-pfepyvaw	116	10	from	from	IN
cord-011302-pfepyvaw	116	11	27,098	27,098	CD
cord-011302-pfepyvaw	116	12	cranial	cranial	JJ
cord-011302-pfepyvaw	116	13	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	116	14	cases	case	NNS
cord-011302-pfepyvaw	116	15	has	have	VBZ
cord-011302-pfepyvaw	116	16	been	be	VBN
cord-011302-pfepyvaw	116	17	reported	report	VBN
cord-011302-pfepyvaw	116	18	,	,	,
cord-011302-pfepyvaw	116	19	where	where	WRB
cord-011302-pfepyvaw	116	20	higher	high	JJR
cord-011302-pfepyvaw	116	21	scores	score	NNS
cord-011302-pfepyvaw	116	22	had	have	VBD
cord-011302-pfepyvaw	116	23	good	good	JJ
cord-011302-pfepyvaw	116	24	sensitivity	sensitivity	NN
cord-011302-pfepyvaw	116	25	and	and	CC
cord-011302-pfepyvaw	116	26	specificity	specificity	NN
cord-011302-pfepyvaw	116	27	for	for	IN
cord-011302-pfepyvaw	116	28	predicting	predict	VBG
cord-011302-pfepyvaw	116	29	increased	increase	VBN
cord-011302-pfepyvaw	116	30	30-day	30-day	CD
cord-011302-pfepyvaw	116	31	mortality	mortality	NN
cord-011302-pfepyvaw	116	32	[	[	-LRB-
cord-011302-pfepyvaw	116	33	39	39	CD
cord-011302-pfepyvaw	116	34	]	]	-RRB-
cord-011302-pfepyvaw	116	35	.	.	.
cord-011302-pfepyvaw	117	1	The	the	DT
cord-011302-pfepyvaw	117	2	score	score	NN
cord-011302-pfepyvaw	117	3	considered	consider	VBN
cord-011302-pfepyvaw	117	4	19	19	CD
cord-011302-pfepyvaw	117	5	predictors	predictor	NNS
cord-011302-pfepyvaw	117	6	of	of	IN
cord-011302-pfepyvaw	117	7	mortality	mortality	NN
cord-011302-pfepyvaw	117	8	,	,	,
cord-011302-pfepyvaw	117	9	with	with	IN
cord-011302-pfepyvaw	117	10	the	the	DT
cord-011302-pfepyvaw	117	11	most	most	RBS
cord-011302-pfepyvaw	117	12	significant	significant	JJ
cord-011302-pfepyvaw	117	13	including	include	VBG
cord-011302-pfepyvaw	117	14	ascites	ascites	NN
cord-011302-pfepyvaw	117	15	,	,	,
cord-011302-pfepyvaw	117	16	ventilator	ventilator	NN
cord-011302-pfepyvaw	117	17	dependency	dependency	NN
cord-011302-pfepyvaw	117	18	and	and	CC
cord-011302-pfepyvaw	117	19	renal	renal	JJ
cord-011302-pfepyvaw	117	20	failure	failure	NN
cord-011302-pfepyvaw	117	21	,	,	,
cord-011302-pfepyvaw	117	22	alongside	alongside	IN
cord-011302-pfepyvaw	117	23	more	more	JJR
cord-011302-pfepyvaw	117	24	common	common	JJ
cord-011302-pfepyvaw	117	25	problems	problem	NNS
cord-011302-pfepyvaw	117	26	such	such	JJ
cord-011302-pfepyvaw	117	27	as	as	IN
cord-011302-pfepyvaw	117	28	anti	anti	JJ
cord-011302-pfepyvaw	117	29	-	-	JJ
cord-011302-pfepyvaw	117	30	hypertensive	hypertensive	JJ
cord-011302-pfepyvaw	117	31	medication	medication	NN
cord-011302-pfepyvaw	117	32	use	use	NN
cord-011302-pfepyvaw	117	33	,	,	,
cord-011302-pfepyvaw	117	34	high	high	JJ
cord-011302-pfepyvaw	117	35	white	white	JJ
cord-011302-pfepyvaw	117	36	cell	cell	NN
cord-011302-pfepyvaw	117	37	count	count	NN
cord-011302-pfepyvaw	117	38	and	and	CC
cord-011302-pfepyvaw	117	39	low	low	JJ
cord-011302-pfepyvaw	117	40	body	body	NN
cord-011302-pfepyvaw	117	41	mass	mass	NN
cord-011302-pfepyvaw	117	42	index	index	NN
cord-011302-pfepyvaw	117	43	.	.	.
cord-011302-pfepyvaw	118	1	The	the	DT
cord-011302-pfepyvaw	118	2	disadvantages	disadvantage	NNS
cord-011302-pfepyvaw	118	3	are	be	VBP
cord-011302-pfepyvaw	118	4	that	that	IN
cord-011302-pfepyvaw	118	5	this	this	DT
cord-011302-pfepyvaw	118	6	score	score	NN
cord-011302-pfepyvaw	118	7	still	still	RB
cord-011302-pfepyvaw	118	8	contains	contain	VBZ
cord-011302-pfepyvaw	118	9	a	a	DT
cord-011302-pfepyvaw	118	10	large	large	JJ
cord-011302-pfepyvaw	118	11	number	number	NN
cord-011302-pfepyvaw	118	12	of	of	IN
cord-011302-pfepyvaw	118	13	variables	variable	NNS
cord-011302-pfepyvaw	118	14	and	and	CC
cord-011302-pfepyvaw	118	15	requires	require	VBZ
cord-011302-pfepyvaw	118	16	prospective	prospective	JJ
cord-011302-pfepyvaw	118	17	evaluation	evaluation	NN
cord-011302-pfepyvaw	118	18	.	.	.
cord-011302-pfepyvaw	119	1	Tools	tool	NNS
cord-011302-pfepyvaw	119	2	such	such	JJ
cord-011302-pfepyvaw	119	3	as	as	IN
cord-011302-pfepyvaw	119	4	the	the	DT
cord-011302-pfepyvaw	119	5	modified	modify	VBN
cord-011302-pfepyvaw	119	6	Frailty	Frailty	NNP
cord-011302-pfepyvaw	119	7	Index	Index	NNP
cord-011302-pfepyvaw	119	8	(	(	-LRB-
cord-011302-pfepyvaw	119	9	mFI	mFI	NNP
cord-011302-pfepyvaw	119	10	)	)	-RRB-
cord-011302-pfepyvaw	119	11	,	,	,
cord-011302-pfepyvaw	119	12	that	that	WDT
cord-011302-pfepyvaw	119	13	have	have	VBP
cord-011302-pfepyvaw	119	14	already	already	RB
cord-011302-pfepyvaw	119	15	been	be	VBN
cord-011302-pfepyvaw	119	16	well	well	RB
cord-011302-pfepyvaw	119	17	validated	validate	VBN
cord-011302-pfepyvaw	119	18	in	in	IN
cord-011302-pfepyvaw	119	19	surgical	surgical	JJ
cord-011302-pfepyvaw	119	20	populations	population	NNS
cord-011302-pfepyvaw	119	21	,	,	,
cord-011302-pfepyvaw	119	22	may	may	MD
cord-011302-pfepyvaw	119	23	be	be	VB
cord-011302-pfepyvaw	119	24	more	more	RBR
cord-011302-pfepyvaw	119	25	useful	useful	JJ
cord-011302-pfepyvaw	119	26	[	[	-LRB-
cord-011302-pfepyvaw	119	27	11	11	CD
cord-011302-pfepyvaw	119	28	,	,	,
cord-011302-pfepyvaw	119	29	40	40	CD
cord-011302-pfepyvaw	119	30	]	]	-RRB-
cord-011302-pfepyvaw	119	31	.	.	.
cord-011302-pfepyvaw	120	1	Youngerman	Youngerman	NNP
cord-011302-pfepyvaw	120	2	reviewed	review	VBD
cord-011302-pfepyvaw	120	3	9149	9149	CD
cord-011302-pfepyvaw	120	4	patients	patient	NNS
cord-011302-pfepyvaw	120	5	with	with	IN
cord-011302-pfepyvaw	120	6	brain	brain	NN
cord-011302-pfepyvaw	120	7	tumours	tumour	NNS
cord-011302-pfepyvaw	120	8	and	and	CC
cord-011302-pfepyvaw	120	9	found	find	VBD
cord-011302-pfepyvaw	120	10	increased	increase	VBN
cord-011302-pfepyvaw	120	11	higher	high	JJR
cord-011302-pfepyvaw	120	12	mFI	mFI	NNS
cord-011302-pfepyvaw	120	13	scores	score	NNS
cord-011302-pfepyvaw	120	14	were	be	VBD
cord-011302-pfepyvaw	120	15	associated	associate	VBN
cord-011302-pfepyvaw	120	16	with	with	IN
cord-011302-pfepyvaw	120	17	increased	increase	VBN
cord-011302-pfepyvaw	120	18	mortality	mortality	NN
cord-011302-pfepyvaw	120	19	,	,	,
cord-011302-pfepyvaw	120	20	severe	severe	JJ
cord-011302-pfepyvaw	120	21	neurological	neurological	JJ
cord-011302-pfepyvaw	120	22	complications	complication	NNS
cord-011302-pfepyvaw	120	23	and	and	CC
cord-011302-pfepyvaw	120	24	prolonged	prolong	VBN
cord-011302-pfepyvaw	120	25	length	length	NN
cord-011302-pfepyvaw	120	26	of	of	IN
cord-011302-pfepyvaw	120	27	stay	stay	NN
cord-011302-pfepyvaw	120	28	[	[	-LRB-
cord-011302-pfepyvaw	120	29	46	46	CD
cord-011302-pfepyvaw	120	30	]	]	-RRB-
cord-011302-pfepyvaw	120	31	.	.	.
cord-011302-pfepyvaw	121	1	Combined	combined	JJ
cord-011302-pfepyvaw	121	2	assessment	assessment	NN
cord-011302-pfepyvaw	121	3	of	of	IN
cord-011302-pfepyvaw	121	4	mFI	mfi	NN
cord-011302-pfepyvaw	121	5	,	,	,
cord-011302-pfepyvaw	121	6	age	age	NN
cord-011302-pfepyvaw	121	7	and	and	CC
cord-011302-pfepyvaw	121	8	ASA	ASA	NNP
cord-011302-pfepyvaw	121	9	(	(	-LRB-
cord-011302-pfepyvaw	121	10	American	American	NNP
cord-011302-pfepyvaw	121	11	Society	Society	NNP
cord-011302-pfepyvaw	121	12	of	of	IN
cord-011302-pfepyvaw	121	13	Anaesthesiologists	Anaesthesiologists	NNP
cord-011302-pfepyvaw	121	14	)	)	-RRB-
cord-011302-pfepyvaw	121	15	classification	classification	NN
cord-011302-pfepyvaw	121	16	gave	give	VBD
cord-011302-pfepyvaw	121	17	the	the	DT
cord-011302-pfepyvaw	121	18	best	good	JJS
cord-011302-pfepyvaw	121	19	predictive	predictive	JJ
cord-011302-pfepyvaw	121	20	ability	ability	NN
cord-011302-pfepyvaw	121	21	on	on	IN
cord-011302-pfepyvaw	121	22	overall	overall	JJ
cord-011302-pfepyvaw	121	23	outcome	outcome	NN
cord-011302-pfepyvaw	121	24	.	.	.
cord-011302-pfepyvaw	122	1	A	a	DT
cord-011302-pfepyvaw	122	2	simpler	simple	JJR
cord-011302-pfepyvaw	122	3	scale	scale	NN
cord-011302-pfepyvaw	122	4	,	,	,
cord-011302-pfepyvaw	122	5	the	the	DT
cord-011302-pfepyvaw	122	6	clinical	clinical	JJ
cord-011302-pfepyvaw	122	7	frailty	frailty	NN
cord-011302-pfepyvaw	122	8	scale	scale	NN
cord-011302-pfepyvaw	122	9	,	,	,
cord-011302-pfepyvaw	122	10	has	have	VBZ
cord-011302-pfepyvaw	122	11	also	also	RB
cord-011302-pfepyvaw	122	12	been	be	VBN
cord-011302-pfepyvaw	122	13	applied	apply	VBN
cord-011302-pfepyvaw	122	14	in	in	IN
cord-011302-pfepyvaw	122	15	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	122	16	patients	patient	NNS
cord-011302-pfepyvaw	122	17	,	,	,
cord-011302-pfepyvaw	122	18	predicting	predict	VBG
cord-011302-pfepyvaw	122	19	prognosis	prognosis	NN
cord-011302-pfepyvaw	122	20	in	in	IN
cord-011302-pfepyvaw	122	21	operated	operate	VBN
cord-011302-pfepyvaw	122	22	CSDH	CSDH	NNP
cord-011302-pfepyvaw	122	23	[	[	-LRB-
cord-011302-pfepyvaw	122	24	29	29	CD
cord-011302-pfepyvaw	122	25	,	,	,
cord-011302-pfepyvaw	122	26	34	34	CD
cord-011302-pfepyvaw	122	27	]	]	-RRB-
cord-011302-pfepyvaw	122	28	.	.	.
cord-011302-pfepyvaw	123	1	Frailty	frailty	NN
cord-011302-pfepyvaw	123	2	has	have	VBZ
cord-011302-pfepyvaw	123	3	also	also	RB
cord-011302-pfepyvaw	123	4	been	be	VBN
cord-011302-pfepyvaw	123	5	correlated	correlate	VBN
cord-011302-pfepyvaw	123	6	with	with	IN
cord-011302-pfepyvaw	123	7	poor	poor	JJ
cord-011302-pfepyvaw	123	8	outcome	outcome	NN
cord-011302-pfepyvaw	123	9	in	in	IN
cord-011302-pfepyvaw	123	10	older	old	JJR
cord-011302-pfepyvaw	123	11	patients	patient	NNS
cord-011302-pfepyvaw	123	12	with	with	IN
cord-011302-pfepyvaw	123	13	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	123	14	SAH	SAH	NNP
cord-011302-pfepyvaw	123	15	,	,	,
cord-011302-pfepyvaw	123	16	however	however	RB
cord-011302-pfepyvaw	123	17	this	this	DT
cord-011302-pfepyvaw	123	18	was	be	VBD
cord-011302-pfepyvaw	123	19	a	a	DT
cord-011302-pfepyvaw	123	20	very	very	RB
cord-011302-pfepyvaw	123	21	simplistic	simplistic	JJ
cord-011302-pfepyvaw	123	22	assessment	assessment	NN
cord-011302-pfepyvaw	123	23	of	of	IN
cord-011302-pfepyvaw	123	24	frailty	frailty	NN
cord-011302-pfepyvaw	123	25	based	base	VBN
cord-011302-pfepyvaw	123	26	on	on	IN
cord-011302-pfepyvaw	123	27	haemoglobin	haemoglobin	NN
cord-011302-pfepyvaw	123	28	,	,	,
cord-011302-pfepyvaw	123	29	albumin	albumin	NN
cord-011302-pfepyvaw	123	30	and	and	CC
cord-011302-pfepyvaw	123	31	BMI	BMI	NNP
cord-011302-pfepyvaw	123	32	[	[	-LRB-
cord-011302-pfepyvaw	123	33	47	47	CD
cord-011302-pfepyvaw	123	34	]	]	-RRB-
cord-011302-pfepyvaw	123	35	.	.	.
cord-011302-pfepyvaw	124	1	Standardised	standardised	JJ
cord-011302-pfepyvaw	124	2	assessments	assessment	NNS
cord-011302-pfepyvaw	124	3	of	of	IN
cord-011302-pfepyvaw	124	4	frailty	frailty	NN
cord-011302-pfepyvaw	124	5	are	be	VBP
cord-011302-pfepyvaw	124	6	needed	need	VBN
cord-011302-pfepyvaw	124	7	,	,	,
cord-011302-pfepyvaw	124	8	with	with	IN
cord-011302-pfepyvaw	124	9	validation	validation	NN
cord-011302-pfepyvaw	124	10	in	in	IN
cord-011302-pfepyvaw	124	11	large	large	JJ
cord-011302-pfepyvaw	124	12	cohorts	cohort	NNS
cord-011302-pfepyvaw	124	13	of	of	IN
cord-011302-pfepyvaw	124	14	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	124	15	patients	patient	NNS
cord-011302-pfepyvaw	124	16	across	across	IN
cord-011302-pfepyvaw	124	17	a	a	DT
cord-011302-pfepyvaw	124	18	range	range	NN
cord-011302-pfepyvaw	124	19	of	of	IN
cord-011302-pfepyvaw	124	20	pathologies	pathology	NNS
cord-011302-pfepyvaw	124	21	.	.	.
cord-011302-pfepyvaw	125	1	This	this	DT
cord-011302-pfepyvaw	125	2	may	may	MD
cord-011302-pfepyvaw	125	3	then	then	RB
cord-011302-pfepyvaw	125	4	support	support	VB
cord-011302-pfepyvaw	125	5	the	the	DT
cord-011302-pfepyvaw	125	6	development	development	NN
cord-011302-pfepyvaw	125	7	of	of	IN
cord-011302-pfepyvaw	125	8	prognostication	prognostication	NN
cord-011302-pfepyvaw	125	9	tools	tool	NNS
cord-011302-pfepyvaw	125	10	and	and	CC
cord-011302-pfepyvaw	125	11	aid	aid	VB
cord-011302-pfepyvaw	125	12	clinical	clinical	JJ
cord-011302-pfepyvaw	125	13	decisionmaking	decisionmaking	NN
cord-011302-pfepyvaw	125	14	and	and	CC
cord-011302-pfepyvaw	125	15	family	family	NN
cord-011302-pfepyvaw	125	16	discussions	discussion	NNS
cord-011302-pfepyvaw	125	17	.	.	.
cord-011302-pfepyvaw	126	1	At	at	IN
cord-011302-pfepyvaw	126	2	what	what	WDT
cord-011302-pfepyvaw	126	3	point	point	NN
cord-011302-pfepyvaw	126	4	we	-PRON-	PRP
cord-011302-pfepyvaw	126	5	consider	consider	VBP
cord-011302-pfepyvaw	126	6	a	a	DT
cord-011302-pfepyvaw	126	7	person	person	NN
cord-011302-pfepyvaw	126	8	to	to	TO
cord-011302-pfepyvaw	126	9	be	be	VB
cord-011302-pfepyvaw	126	10	"	"	``
cord-011302-pfepyvaw	126	11	elderly	elderly	JJ
cord-011302-pfepyvaw	126	12	"	"	''
cord-011302-pfepyvaw	126	13	is	be	VBZ
cord-011302-pfepyvaw	126	14	shifting	shift	VBG
cord-011302-pfepyvaw	126	15	,	,	,
cord-011302-pfepyvaw	126	16	as	as	IN
cord-011302-pfepyvaw	126	17	patients	patient	NNS
cord-011302-pfepyvaw	126	18	are	be	VBP
cord-011302-pfepyvaw	126	19	fitter	fit	JJR
cord-011302-pfepyvaw	126	20	and	and	CC
cord-011302-pfepyvaw	126	21	more	more	RBR
cord-011302-pfepyvaw	126	22	independent	independent	JJ
cord-011302-pfepyvaw	126	23	until	until	IN
cord-011302-pfepyvaw	126	24	later	later	RB
cord-011302-pfepyvaw	126	25	in	in	IN
cord-011302-pfepyvaw	126	26	life	life	NN
cord-011302-pfepyvaw	126	27	.	.	.
cord-011302-pfepyvaw	127	1	There	there	EX
cord-011302-pfepyvaw	127	2	are	be	VBP
cord-011302-pfepyvaw	127	3	also	also	RB
cord-011302-pfepyvaw	127	4	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	127	5	advances	advance	NNS
cord-011302-pfepyvaw	127	6	which	which	WDT
cord-011302-pfepyvaw	127	7	may	may	MD
cord-011302-pfepyvaw	127	8	preferentially	preferentially	RB
cord-011302-pfepyvaw	127	9	benefit	benefit	VB
cord-011302-pfepyvaw	127	10	older	old	JJR
cord-011302-pfepyvaw	127	11	patients	patient	NNS
cord-011302-pfepyvaw	127	12	with	with	IN
cord-011302-pfepyvaw	127	13	multiple	multiple	JJ
cord-011302-pfepyvaw	127	14	co	co	NNS
cord-011302-pfepyvaw	127	15	-	-	NNS
cord-011302-pfepyvaw	127	16	morbidities	morbidity	NNS
cord-011302-pfepyvaw	127	17	such	such	JJ
cord-011302-pfepyvaw	127	18	as	as	IN
cord-011302-pfepyvaw	127	19	endovascular	endovascular	JJ
cord-011302-pfepyvaw	127	20	coiling	coiling	NN
cord-011302-pfepyvaw	127	21	and	and	CC
cord-011302-pfepyvaw	127	22	MIS	mis	NN
cord-011302-pfepyvaw	127	23	surgery	surgery	NN
cord-011302-pfepyvaw	127	24	for	for	IN
cord-011302-pfepyvaw	127	25	ICH	ICH	NNP
cord-011302-pfepyvaw	127	26	.	.	.
cord-011302-pfepyvaw	128	1	Patients	patient	NNS
cord-011302-pfepyvaw	128	2	aged	age	VBN
cord-011302-pfepyvaw	128	3	over	over	IN
cord-011302-pfepyvaw	128	4	65	65	CD
cord-011302-pfepyvaw	128	5	years	year	NNS
cord-011302-pfepyvaw	128	6	of	of	IN
cord-011302-pfepyvaw	128	7	age	age	NN
cord-011302-pfepyvaw	128	8	certainly	certainly	RB
cord-011302-pfepyvaw	128	9	do	do	VBP
cord-011302-pfepyvaw	128	10	benefit	benefit	NN
cord-011302-pfepyvaw	128	11	from	from	IN
cord-011302-pfepyvaw	128	12	acute	acute	JJ
cord-011302-pfepyvaw	128	13	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	128	14	interventions	intervention	NNS
cord-011302-pfepyvaw	128	15	,	,	,
cord-011302-pfepyvaw	128	16	but	but	CC
cord-011302-pfepyvaw	128	17	there	there	EX
cord-011302-pfepyvaw	128	18	is	be	VBZ
cord-011302-pfepyvaw	128	19	more	more	JJR
cord-011302-pfepyvaw	128	20	uncertainty	uncertainty	NN
cord-011302-pfepyvaw	128	21	and	and	CC
cord-011302-pfepyvaw	128	22	risk	risk	NN
cord-011302-pfepyvaw	128	23	for	for	IN
cord-011302-pfepyvaw	128	24	those	those	DT
cord-011302-pfepyvaw	128	25	aged	age	VBN
cord-011302-pfepyvaw	128	26	over	over	IN
cord-011302-pfepyvaw	128	27	80	80	CD
cord-011302-pfepyvaw	128	28	.	.	.
cord-011302-pfepyvaw	129	1	An	an	DT
cord-011302-pfepyvaw	129	2	age	age	NN
cord-011302-pfepyvaw	129	3	cut	cut	VBN
cord-011302-pfepyvaw	129	4	-	-	HYPH
cord-011302-pfepyvaw	129	5	off	off	RP
cord-011302-pfepyvaw	129	6	itself	-PRON-	PRP
cord-011302-pfepyvaw	129	7	may	may	MD
cord-011302-pfepyvaw	129	8	not	not	RB
cord-011302-pfepyvaw	129	9	be	be	VB
cord-011302-pfepyvaw	129	10	helpful	helpful	JJ
cord-011302-pfepyvaw	129	11	,	,	,
cord-011302-pfepyvaw	129	12	but	but	CC
cord-011302-pfepyvaw	129	13	rather	rather	RB
cord-011302-pfepyvaw	129	14	frailty	frailty	NN
cord-011302-pfepyvaw	129	15	should	should	MD
cord-011302-pfepyvaw	129	16	be	be	VB
cord-011302-pfepyvaw	129	17	considered	consider	VBN
cord-011302-pfepyvaw	129	18	instead	instead	RB
cord-011302-pfepyvaw	129	19	,	,	,
cord-011302-pfepyvaw	129	20	and	and	CC
cord-011302-pfepyvaw	129	21	we	-PRON-	PRP
cord-011302-pfepyvaw	129	22	advocate	advocate	VBP
cord-011302-pfepyvaw	129	23	improved	improve	VBD
cord-011302-pfepyvaw	129	24	reporting	reporting	NN
cord-011302-pfepyvaw	129	25	of	of	IN
cord-011302-pfepyvaw	129	26	this	this	DT
cord-011302-pfepyvaw	129	27	metric	metric	NN
cord-011302-pfepyvaw	129	28	in	in	IN
cord-011302-pfepyvaw	129	29	future	future	JJ
cord-011302-pfepyvaw	129	30	trials	trial	NNS
cord-011302-pfepyvaw	129	31	and	and	CC
cord-011302-pfepyvaw	129	32	studies	study	NNS
cord-011302-pfepyvaw	129	33	.	.	.
cord-011302-pfepyvaw	130	1	Most	most	RBS
cord-011302-pfepyvaw	130	2	importantly	importantly	RB
cord-011302-pfepyvaw	130	3	,	,	,
cord-011302-pfepyvaw	130	4	given	give	VBN
cord-011302-pfepyvaw	130	5	the	the	DT
cord-011302-pfepyvaw	130	6	lack	lack	NN
cord-011302-pfepyvaw	130	7	of	of	IN
cord-011302-pfepyvaw	130	8	robust	robust	JJ
cord-011302-pfepyvaw	130	9	evidence	evidence	NN
cord-011302-pfepyvaw	130	10	,	,	,
cord-011302-pfepyvaw	130	11	determining	determine	VBG
cord-011302-pfepyvaw	130	12	patient	patient	JJ
cord-011302-pfepyvaw	130	13	eligibility	eligibility	NN
cord-011302-pfepyvaw	130	14	for	for	IN
cord-011302-pfepyvaw	130	15	intervention	intervention	NN
cord-011302-pfepyvaw	130	16	is	be	VBZ
cord-011302-pfepyvaw	130	17	often	often	RB
cord-011302-pfepyvaw	130	18	left	leave	VBN
cord-011302-pfepyvaw	130	19	to	to	IN
cord-011302-pfepyvaw	130	20	the	the	DT
cord-011302-pfepyvaw	130	21	treating	treat	VBG
cord-011302-pfepyvaw	130	22	clinician	clinician	NN
cord-011302-pfepyvaw	130	23	.	.	.
cord-011302-pfepyvaw	131	1	Whilst	whilst	IN
cord-011302-pfepyvaw	131	2	it	-PRON-	PRP
cord-011302-pfepyvaw	131	3	is	be	VBZ
cord-011302-pfepyvaw	131	4	always	always	RB
cord-011302-pfepyvaw	131	5	possible	possible	JJ
cord-011302-pfepyvaw	131	6	to	to	TO
cord-011302-pfepyvaw	131	7	intervene	intervene	VB
cord-011302-pfepyvaw	131	8	,	,	,
cord-011302-pfepyvaw	131	9	it	-PRON-	PRP
cord-011302-pfepyvaw	131	10	is	be	VBZ
cord-011302-pfepyvaw	131	11	not	not	RB
cord-011302-pfepyvaw	131	12	always	always	RB
cord-011302-pfepyvaw	131	13	appropriate	appropriate	JJ
cord-011302-pfepyvaw	131	14	and	and	CC
cord-011302-pfepyvaw	131	15	a	a	DT
cord-011302-pfepyvaw	131	16	significantly	significantly	RB
cord-011302-pfepyvaw	131	17	lower	low	JJR
cord-011302-pfepyvaw	131	18	likelihood	likelihood	NN
cord-011302-pfepyvaw	131	19	of	of	IN
cord-011302-pfepyvaw	131	20	maintaining	maintain	VBG
cord-011302-pfepyvaw	131	21	the	the	DT
cord-011302-pfepyvaw	131	22	quality	quality	NN
cord-011302-pfepyvaw	131	23	of	of	IN
cord-011302-pfepyvaw	131	24	life	life	NN
cord-011302-pfepyvaw	131	25	in	in	IN
cord-011302-pfepyvaw	131	26	older	old	JJR
cord-011302-pfepyvaw	131	27	patients	patient	NNS
cord-011302-pfepyvaw	131	28	for	for	IN
cord-011302-pfepyvaw	131	29	the	the	DT
cord-011302-pfepyvaw	131	30	conditions	condition	NNS
cord-011302-pfepyvaw	131	31	discussed	discuss	VBN
cord-011302-pfepyvaw	131	32	must	must	MD
cord-011302-pfepyvaw	131	33	be	be	VB
cord-011302-pfepyvaw	131	34	recognised	recognise	VBN
cord-011302-pfepyvaw	131	35	.	.	.
cord-011302-pfepyvaw	132	1	On	on	IN
cord-011302-pfepyvaw	132	2	the	the	DT
cord-011302-pfepyvaw	132	3	other	other	JJ
cord-011302-pfepyvaw	132	4	hand	hand	NN
cord-011302-pfepyvaw	132	5	,	,	,
cord-011302-pfepyvaw	132	6	a	a	DT
cord-011302-pfepyvaw	132	7	therapeutic	therapeutic	JJ
cord-011302-pfepyvaw	132	8	nihilism	nihilism	NN
cord-011302-pfepyvaw	132	9	may	may	MD
cord-011302-pfepyvaw	132	10	be	be	VB
cord-011302-pfepyvaw	132	11	deterministic	deterministic	JJ
cord-011302-pfepyvaw	132	12	and	and	CC
cord-011302-pfepyvaw	132	13	thwart	thwart	VB
cord-011302-pfepyvaw	132	14	development	development	NN
cord-011302-pfepyvaw	132	15	of	of	IN
cord-011302-pfepyvaw	132	16	improved	improved	JJ
cord-011302-pfepyvaw	132	17	clinical	clinical	JJ
cord-011302-pfepyvaw	132	18	practice	practice	NN
cord-011302-pfepyvaw	132	19	in	in	IN
cord-011302-pfepyvaw	132	20	this	this	DT
cord-011302-pfepyvaw	132	21	group	group	NN
cord-011302-pfepyvaw	132	22	of	of	IN
cord-011302-pfepyvaw	132	23	patients	patient	NNS
cord-011302-pfepyvaw	132	24	.	.	.
cord-011302-pfepyvaw	133	1	Conflicts	conflict	NNS
cord-011302-pfepyvaw	133	2	of	of	IN
cord-011302-pfepyvaw	133	3	interest	interest	NN
cord-011302-pfepyvaw	134	1	On	on	IN
cord-011302-pfepyvaw	134	2	behalf	behalf	NN
cord-011302-pfepyvaw	134	3	of	of	IN
cord-011302-pfepyvaw	134	4	all	all	DT
cord-011302-pfepyvaw	134	5	authors	author	NNS
cord-011302-pfepyvaw	134	6	,	,	,
cord-011302-pfepyvaw	134	7	the	the	DT
cord-011302-pfepyvaw	134	8	corresponding	correspond	VBG
cord-011302-pfepyvaw	134	9	author	author	NN
cord-011302-pfepyvaw	134	10	states	state	VBZ
cord-011302-pfepyvaw	134	11	that	that	IN
cord-011302-pfepyvaw	134	12	there	there	EX
cord-011302-pfepyvaw	134	13	is	be	VBZ
cord-011302-pfepyvaw	134	14	no	no	DT
cord-011302-pfepyvaw	134	15	conflict	conflict	NN
cord-011302-pfepyvaw	134	16	of	of	IN
cord-011302-pfepyvaw	134	17	interest	interest	NN
cord-011302-pfepyvaw	134	18	.	.	.
cord-011302-pfepyvaw	135	1	Development	development	NN
cord-011302-pfepyvaw	135	2	of	of	IN
cord-011302-pfepyvaw	135	3	the	the	DT
cord-011302-pfepyvaw	135	4	Subdural	Subdural	NNP
cord-011302-pfepyvaw	135	5	Hematoma	hematoma	NN
cord-011302-pfepyvaw	135	6	in	in	IN
cord-011302-pfepyvaw	135	7	the	the	DT
cord-011302-pfepyvaw	135	8	Elderly	Elderly	NNP
cord-011302-pfepyvaw	135	9	(	(	-LRB-
cord-011302-pfepyvaw	135	10	SHE	she	NN
cord-011302-pfepyvaw	135	11	)	)	-RRB-
cord-011302-pfepyvaw	135	12	score	score	NN
cord-011302-pfepyvaw	135	13	to	to	TO
cord-011302-pfepyvaw	135	14	predict	predict	VB
cord-011302-pfepyvaw	135	15	mortality	mortality	NN
cord-011302-pfepyvaw	135	16	Hypothermia	hypothermia	NN
cord-011302-pfepyvaw	135	17	for	for	IN
cord-011302-pfepyvaw	135	18	Intracranial	intracranial	JJ
cord-011302-pfepyvaw	135	19	Hypertension	hypertension	NN
cord-011302-pfepyvaw	135	20	after	after	IN
cord-011302-pfepyvaw	135	21	Traumatic	Traumatic	NNP
cord-011302-pfepyvaw	135	22	Brain	Brain	NNP
cord-011302-pfepyvaw	135	23	Injury	Injury	NNP
cord-011302-pfepyvaw	135	24	Spontaneous	spontaneous	JJ
cord-011302-pfepyvaw	135	25	intracerebral	intracerebral	JJ
cord-011302-pfepyvaw	135	26	hemorrhage	hemorrhage	NN
cord-011302-pfepyvaw	135	27	in	in	IN
cord-011302-pfepyvaw	135	28	the	the	DT
cord-011302-pfepyvaw	135	29	elderly	elderly	JJ
cord-011302-pfepyvaw	135	30	population	population	NN
cord-011302-pfepyvaw	135	31	(	(	-LRB-
cord-011302-pfepyvaw	135	32	S10.006	S10.006	NNP
cord-011302-pfepyvaw	135	33	)	)	-RRB-
cord-011302-pfepyvaw	136	1	The	the	DT
cord-011302-pfepyvaw	136	2	management	management	NN
cord-011302-pfepyvaw	136	3	and	and	CC
cord-011302-pfepyvaw	136	4	outcome	outcome	NN
cord-011302-pfepyvaw	136	5	for	for	IN
cord-011302-pfepyvaw	136	6	patients	patient	NNS
cord-011302-pfepyvaw	136	7	with	with	IN
cord-011302-pfepyvaw	136	8	chronic	chronic	JJ
cord-011302-pfepyvaw	136	9	subdural	subdural	JJ
cord-011302-pfepyvaw	136	10	hematoma	hematoma	NN
cord-011302-pfepyvaw	136	11	:	:	:
cord-011302-pfepyvaw	136	12	a	a	DT
cord-011302-pfepyvaw	136	13	prospective	prospective	JJ
cord-011302-pfepyvaw	136	14	,	,	,
cord-011302-pfepyvaw	136	15	multicenter	multicenter	JJ
cord-011302-pfepyvaw	136	16	,	,	,
cord-011302-pfepyvaw	136	17	observational	observational	JJ
cord-011302-pfepyvaw	136	18	cohort	cohort	NN
cord-011302-pfepyvaw	136	19	study	study	NN
cord-011302-pfepyvaw	136	20	in	in	IN
cord-011302-pfepyvaw	136	21	the	the	DT
cord-011302-pfepyvaw	136	22	United	United	NNP
cord-011302-pfepyvaw	136	23	Kingdom	Kingdom	NNP
cord-011302-pfepyvaw	136	24	Global	Global	NNP
cord-011302-pfepyvaw	136	25	Neurotrauma	Neurotrauma	NNP
cord-011302-pfepyvaw	136	26	Research	Research	NNP
cord-011302-pfepyvaw	136	27	G	G	NNP
cord-011302-pfepyvaw	136	28	(	(	-LRB-
cord-011302-pfepyvaw	136	29	2012	2012	CD
cord-011302-pfepyvaw	136	30	)	)	-RRB-
cord-011302-pfepyvaw	137	1	A	a	DT
cord-011302-pfepyvaw	137	2	trial	trial	NN
cord-011302-pfepyvaw	137	3	of	of	IN
cord-011302-pfepyvaw	137	4	intracranial	intracranial	JJ
cord-011302-pfepyvaw	137	5	-	-	HYPH
cord-011302-pfepyvaw	137	6	pressure	pressure	NN
cord-011302-pfepyvaw	137	7	monitoring	monitoring	NN
cord-011302-pfepyvaw	137	8	in	in	IN
cord-011302-pfepyvaw	137	9	traumatic	traumatic	JJ
cord-011302-pfepyvaw	137	10	brain	brain	NN
cord-011302-pfepyvaw	137	11	injury	injury	NN
cord-011302-pfepyvaw	137	12	Neurosurgery	Neurosurgery	NNP
cord-011302-pfepyvaw	137	13	and	and	CC
cord-011302-pfepyvaw	137	14	elderly	elderly	JJ
cord-011302-pfepyvaw	137	15	:	:	:
cord-011302-pfepyvaw	137	16	analysis	analysis	NN
cord-011302-pfepyvaw	137	17	through	through	IN
cord-011302-pfepyvaw	137	18	the	the	DT
cord-011302-pfepyvaw	137	19	years	year	NNS
cord-011302-pfepyvaw	137	20	Decompressive	Decompressive	NNP
cord-011302-pfepyvaw	137	21	craniectomy	craniectomy	VBP
cord-011302-pfepyvaw	137	22	in	in	IN
cord-011302-pfepyvaw	137	23	diffuse	diffuse	JJ
cord-011302-pfepyvaw	137	24	traumatic	traumatic	JJ
cord-011302-pfepyvaw	137	25	brain	brain	NN
cord-011302-pfepyvaw	137	26	injury	injury	NN
cord-011302-pfepyvaw	137	27	Pathophysiology	pathophysiology	NN
cord-011302-pfepyvaw	137	28	of	of	IN
cord-011302-pfepyvaw	137	29	chronic	chronic	JJ
cord-011302-pfepyvaw	137	30	subdural	subdural	JJ
cord-011302-pfepyvaw	137	31	haematoma	haematoma	NN
cord-011302-pfepyvaw	137	32	:	:	:
cord-011302-pfepyvaw	137	33	inflammation	inflammation	NN
cord-011302-pfepyvaw	137	34	,	,	,
cord-011302-pfepyvaw	137	35	angiogenesis	angiogenesis	NN
cord-011302-pfepyvaw	137	36	and	and	CC
cord-011302-pfepyvaw	137	37	implications	implication	NNS
cord-011302-pfepyvaw	137	38	for	for	IN
cord-011302-pfepyvaw	137	39	pharmacotherapy	pharmacotherapy	NN
cord-011302-pfepyvaw	138	1	The	the	DT
cord-011302-pfepyvaw	138	2	efficacy	efficacy	NN
cord-011302-pfepyvaw	138	3	of	of	IN
cord-011302-pfepyvaw	138	4	dexamethasone	dexamethasone	NN
cord-011302-pfepyvaw	138	5	on	on	IN
cord-011302-pfepyvaw	138	6	reduction	reduction	NN
cord-011302-pfepyvaw	138	7	in	in	IN
cord-011302-pfepyvaw	138	8	the	the	DT
cord-011302-pfepyvaw	138	9	reoperation	reoperation	NN
cord-011302-pfepyvaw	138	10	rate	rate	NN
cord-011302-pfepyvaw	138	11	of	of	IN
cord-011302-pfepyvaw	138	12	chronic	chronic	JJ
cord-011302-pfepyvaw	138	13	subdural	subdural	JJ
cord-011302-pfepyvaw	138	14	hematomathe	hematomathe	NNP
cord-011302-pfepyvaw	138	15	DRESH	DRESH	NNP
cord-011302-pfepyvaw	138	16	study	study	NN
cord-011302-pfepyvaw	138	17	:	:	:
cord-011302-pfepyvaw	138	18	straightforward	straightforward	JJ
cord-011302-pfepyvaw	138	19	study	study	NN
cord-011302-pfepyvaw	138	20	protocol	protocol	NN
cord-011302-pfepyvaw	138	21	for	for	IN
cord-011302-pfepyvaw	138	22	a	a	DT
cord-011302-pfepyvaw	138	23	randomized	randomized	JJ
cord-011302-pfepyvaw	138	24	controlled	control	VBN
cord-011302-pfepyvaw	138	25	trial	trial	NN
cord-011302-pfepyvaw	138	26	Prognosis	prognosis	NN
cord-011302-pfepyvaw	138	27	of	of	IN
cord-011302-pfepyvaw	138	28	acute	acute	JJ
cord-011302-pfepyvaw	138	29	subdural	subdural	JJ
cord-011302-pfepyvaw	138	30	hematoma	hematoma	NN
cord-011302-pfepyvaw	138	31	in	in	IN
cord-011302-pfepyvaw	138	32	the	the	DT
cord-011302-pfepyvaw	138	33	elderly	elderly	JJ
cord-011302-pfepyvaw	138	34	:	:	:
cord-011302-pfepyvaw	138	35	a	a	DT
cord-011302-pfepyvaw	138	36	systematic	systematic	JJ
cord-011302-pfepyvaw	138	37	review	review	NN
cord-011302-pfepyvaw	138	38	Are	be	VBP
cord-011302-pfepyvaw	138	39	the	the	DT
cord-011302-pfepyvaw	138	40	frail	frail	JJ
cord-011302-pfepyvaw	138	41	destined	destine	VBN
cord-011302-pfepyvaw	138	42	to	to	TO
cord-011302-pfepyvaw	138	43	fail	fail	VB
cord-011302-pfepyvaw	138	44	?	?	.
cord-011302-pfepyvaw	139	1	Frailty	frailty	NN
cord-011302-pfepyvaw	139	2	index	index	NN
cord-011302-pfepyvaw	139	3	as	as	IN
cord-011302-pfepyvaw	139	4	predictor	predictor	NN
cord-011302-pfepyvaw	139	5	of	of	IN
cord-011302-pfepyvaw	139	6	surgical	surgical	JJ
cord-011302-pfepyvaw	139	7	morbidity	morbidity	NN
cord-011302-pfepyvaw	139	8	and	and	CC
cord-011302-pfepyvaw	139	9	mortality	mortality	NN
cord-011302-pfepyvaw	139	10	in	in	IN
cord-011302-pfepyvaw	139	11	the	the	DT
cord-011302-pfepyvaw	139	12	elderly	elderly	JJ
cord-011302-pfepyvaw	139	13	Untangling	untangle	VBG
cord-011302-pfepyvaw	139	14	the	the	DT
cord-011302-pfepyvaw	139	15	concepts	concept	NNS
cord-011302-pfepyvaw	139	16	of	of	IN
cord-011302-pfepyvaw	139	17	disability	disability	NN
cord-011302-pfepyvaw	139	18	,	,	,
cord-011302-pfepyvaw	139	19	frailty	frailty	NN
cord-011302-pfepyvaw	139	20	,	,	,
cord-011302-pfepyvaw	139	21	and	and	CC
cord-011302-pfepyvaw	139	22	comorbidity	comorbidity	NN
cord-011302-pfepyvaw	139	23	:	:	:
cord-011302-pfepyvaw	139	24	implications	implication	NNS
cord-011302-pfepyvaw	139	25	for	for	IN
cord-011302-pfepyvaw	139	26	improved	improve	VBN
cord-011302-pfepyvaw	139	27	targeting	targeting	NN
cord-011302-pfepyvaw	139	28	and	and	CC
cord-011302-pfepyvaw	139	29	care	care	VB
cord-011302-pfepyvaw	139	30	Geriatric	geriatric	JJ
cord-011302-pfepyvaw	139	31	traumatic	traumatic	JJ
cord-011302-pfepyvaw	139	32	brain	brain	NN
cord-011302-pfepyvaw	139	33	injury	injury	NN
cord-011302-pfepyvaw	139	34	:	:	:
cord-011302-pfepyvaw	139	35	epidemiology	epidemiology	NN
cord-011302-pfepyvaw	139	36	,	,	,
cord-011302-pfepyvaw	139	37	outcomes	outcome	NNS
cord-011302-pfepyvaw	139	38	,	,	,
cord-011302-pfepyvaw	139	39	knowledge	knowledge	NN
cord-011302-pfepyvaw	139	40	gaps	gap	NNS
cord-011302-pfepyvaw	139	41	,	,	,
cord-011302-pfepyvaw	139	42	and	and	CC
cord-011302-pfepyvaw	139	43	future	future	JJ
cord-011302-pfepyvaw	139	44	directions	direction	NNS
cord-011302-pfepyvaw	139	45	Steroids	steroid	NNS
cord-011302-pfepyvaw	139	46	in	in	IN
cord-011302-pfepyvaw	139	47	chronic	chronic	JJ
cord-011302-pfepyvaw	139	48	subdural	subdural	JJ
cord-011302-pfepyvaw	139	49	hematomas	hematoma	NNS
cord-011302-pfepyvaw	139	50	(	(	-LRB-
cord-011302-pfepyvaw	139	51	SUCRE	SUCRE	NNP
cord-011302-pfepyvaw	139	52	trial	trial	NN
cord-011302-pfepyvaw	139	53	)	)	-RRB-
cord-011302-pfepyvaw	139	54	:	:	:
cord-011302-pfepyvaw	139	55	study	study	NN
cord-011302-pfepyvaw	139	56	protocol	protocol	NN
cord-011302-pfepyvaw	139	57	for	for	IN
cord-011302-pfepyvaw	139	58	a	a	DT
cord-011302-pfepyvaw	139	59	randomized	randomized	JJ
cord-011302-pfepyvaw	139	60	controlled	control	VBN
cord-011302-pfepyvaw	139	61	trial	trial	NN
cord-011302-pfepyvaw	139	62	Trial	Trial	NNP
cord-011302-pfepyvaw	139	63	of	of	IN
cord-011302-pfepyvaw	139	64	decompressive	decompressive	JJ
cord-011302-pfepyvaw	139	65	craniectomy	craniectomy	NN
cord-011302-pfepyvaw	139	66	for	for	IN
cord-011302-pfepyvaw	139	67	traumatic	traumatic	JJ
cord-011302-pfepyvaw	139	68	intracranial	intracranial	JJ
cord-011302-pfepyvaw	139	69	hypertension	hypertension	NN
cord-011302-pfepyvaw	139	70	International	International	NNP
cord-011302-pfepyvaw	139	71	Mission	Mission	NNP
cord-011302-pfepyvaw	139	72	for	for	IN
cord-011302-pfepyvaw	139	73	Prognosis	Prognosis	NNP
cord-011302-pfepyvaw	139	74	and	and	CC
cord-011302-pfepyvaw	139	75	Analysis	Analysis	NNP
cord-011302-pfepyvaw	139	76	of	of	IN
cord-011302-pfepyvaw	139	77	Clinical	Clinical	NNP
cord-011302-pfepyvaw	139	78	Trials	Trials	NNPS
cord-011302-pfepyvaw	139	79	in	in	IN
cord-011302-pfepyvaw	139	80	TBI	TBI	NNP
cord-011302-pfepyvaw	139	81	(	(	-LRB-
cord-011302-pfepyvaw	139	82	2020	2020	CD
cord-011302-pfepyvaw	139	83	)	)	-RRB-
cord-011302-pfepyvaw	140	1	IMPACT	IMPACT	NNP
cord-011302-pfepyvaw	141	1	Prognostic	prognostic	JJ
cord-011302-pfepyvaw	141	2	calculator	calculator	NN
cord-011302-pfepyvaw	141	3	Aneurysm	Aneurysm	NNP
cord-011302-pfepyvaw	141	4	occlusion	occlusion	NN
cord-011302-pfepyvaw	141	5	in	in	IN
cord-011302-pfepyvaw	141	6	elderly	elderly	JJ
cord-011302-pfepyvaw	141	7	patients	patient	NNS
cord-011302-pfepyvaw	141	8	with	with	IN
cord-011302-pfepyvaw	141	9	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	141	10	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	141	11	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	141	12	:	:	:
cord-011302-pfepyvaw	141	13	a	a	DT
cord-011302-pfepyvaw	141	14	cost	cost	NN
cord-011302-pfepyvaw	141	15	-	-	HYPH
cord-011302-pfepyvaw	141	16	utility	utility	NN
cord-011302-pfepyvaw	141	17	analysis	analysis	NN
cord-011302-pfepyvaw	141	18	Dexamethasone	Dexamethasone	NNP
cord-011302-pfepyvaw	141	19	for	for	IN
cord-011302-pfepyvaw	141	20	adult	adult	NN
cord-011302-pfepyvaw	141	21	patients	patient	NNS
cord-011302-pfepyvaw	141	22	with	with	IN
cord-011302-pfepyvaw	141	23	a	a	DT
cord-011302-pfepyvaw	141	24	symptomatic	symptomatic	JJ
cord-011302-pfepyvaw	141	25	chronic	chronic	JJ
cord-011302-pfepyvaw	141	26	subdural	subdural	JJ
cord-011302-pfepyvaw	141	27	haematoma	haematoma	NN
cord-011302-pfepyvaw	141	28	(	(	-LRB-
cord-011302-pfepyvaw	141	29	Dex	Dex	NNP
cord-011302-pfepyvaw	141	30	-	-	HYPH
cord-011302-pfepyvaw	141	31	CSDH	CSDH	NNP
cord-011302-pfepyvaw	141	32	)	)	-RRB-
cord-011302-pfepyvaw	141	33	trial	trial	NN
cord-011302-pfepyvaw	141	34	:	:	:
cord-011302-pfepyvaw	141	35	study	study	NN
cord-011302-pfepyvaw	141	36	protocol	protocol	NN
cord-011302-pfepyvaw	141	37	for	for	IN
cord-011302-pfepyvaw	141	38	a	a	DT
cord-011302-pfepyvaw	141	39	randomised	randomised	JJ
cord-011302-pfepyvaw	141	40	controlled	control	VBN
cord-011302-pfepyvaw	141	41	trial	trial	NN
cord-011302-pfepyvaw	142	1	Do	do	VB
cord-011302-pfepyvaw	142	2	age	age	NN
cord-011302-pfepyvaw	142	3	and	and	CC
cord-011302-pfepyvaw	142	4	anticoagulants	anticoagulant	NNS
cord-011302-pfepyvaw	142	5	affect	affect	VBP
cord-011302-pfepyvaw	142	6	the	the	DT
cord-011302-pfepyvaw	142	7	natural	natural	JJ
cord-011302-pfepyvaw	142	8	history	history	NN
cord-011302-pfepyvaw	142	9	of	of	IN
cord-011302-pfepyvaw	142	10	acute	acute	JJ
cord-011302-pfepyvaw	142	11	subdural	subdural	JJ
cord-011302-pfepyvaw	142	12	hematomas	hematoma	NNS
cord-011302-pfepyvaw	142	13	?	?	.
cord-011302-pfepyvaw	143	1	The	the	DT
cord-011302-pfepyvaw	143	2	barrow	barrow	NN
cord-011302-pfepyvaw	143	3	ruptured	rupture	VBD
cord-011302-pfepyvaw	143	4	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	143	5	Early	early	JJ
cord-011302-pfepyvaw	143	6	surgery	surgery	NN
cord-011302-pfepyvaw	143	7	versus	versus	IN
cord-011302-pfepyvaw	143	8	initial	initial	JJ
cord-011302-pfepyvaw	143	9	conservative	conservative	JJ
cord-011302-pfepyvaw	143	10	treatment	treatment	NN
cord-011302-pfepyvaw	143	11	in	in	IN
cord-011302-pfepyvaw	143	12	patients	patient	NNS
cord-011302-pfepyvaw	143	13	with	with	IN
cord-011302-pfepyvaw	143	14	spontaneous	spontaneous	JJ
cord-011302-pfepyvaw	143	15	supratentorial	supratentorial	NNP
cord-011302-pfepyvaw	143	16	intracerebral	intracerebral	NNP
cord-011302-pfepyvaw	143	17	haematomas	haematomas	NNP
cord-011302-pfepyvaw	143	18	in	in	IN
cord-011302-pfepyvaw	143	19	the	the	DT
cord-011302-pfepyvaw	143	20	International	International	NNP
cord-011302-pfepyvaw	143	21	Surgical	Surgical	NNP
cord-011302-pfepyvaw	143	22	Trial	Trial	NNP
cord-011302-pfepyvaw	143	23	in	in	IN
cord-011302-pfepyvaw	143	24	Intracerebral	Intracerebral	NNP
cord-011302-pfepyvaw	143	25	Haemorrhage	Haemorrhage	NNP
cord-011302-pfepyvaw	143	26	(	(	-LRB-
cord-011302-pfepyvaw	143	27	STICH	STICH	NNP
cord-011302-pfepyvaw	143	28	)	)	-RRB-
cord-011302-pfepyvaw	143	29	:	:	:
cord-011302-pfepyvaw	144	1	a	a	DT
cord-011302-pfepyvaw	144	2	randomised	randomised	JJ
cord-011302-pfepyvaw	144	3	trial	trial	NN
cord-011302-pfepyvaw	144	4	Early	early	JJ
cord-011302-pfepyvaw	144	5	surgery	surgery	NN
cord-011302-pfepyvaw	144	6	versus	versus	IN
cord-011302-pfepyvaw	144	7	initial	initial	JJ
cord-011302-pfepyvaw	144	8	conservative	conservative	JJ
cord-011302-pfepyvaw	144	9	treatment	treatment	NN
cord-011302-pfepyvaw	144	10	in	in	IN
cord-011302-pfepyvaw	144	11	patients	patient	NNS
cord-011302-pfepyvaw	144	12	with	with	IN
cord-011302-pfepyvaw	144	13	spontaneous	spontaneous	JJ
cord-011302-pfepyvaw	144	14	supratentorial	supratentorial	NNP
cord-011302-pfepyvaw	144	15	lobar	lobar	NNP
cord-011302-pfepyvaw	144	16	intracerebral	intracerebral	NNP
cord-011302-pfepyvaw	144	17	haematomas	haematomas	NNP
cord-011302-pfepyvaw	144	18	(	(	-LRB-
cord-011302-pfepyvaw	144	19	STICH	STICH	NNP
cord-011302-pfepyvaw	144	20	II	II	NNP
cord-011302-pfepyvaw	144	21	)	)	-RRB-
cord-011302-pfepyvaw	144	22	:	:	:
cord-011302-pfepyvaw	144	23	a	a	DT
cord-011302-pfepyvaw	144	24	randomised	randomised	JJ
cord-011302-pfepyvaw	144	25	trial	trial	NN
cord-011302-pfepyvaw	144	26	Dexamethasone	Dexamethasone	NNP
cord-011302-pfepyvaw	144	27	therapy	therapy	NN
cord-011302-pfepyvaw	144	28	versus	versus	IN
cord-011302-pfepyvaw	144	29	surgery	surgery	NN
cord-011302-pfepyvaw	144	30	for	for	IN
cord-011302-pfepyvaw	144	31	chronic	chronic	JJ
cord-011302-pfepyvaw	144	32	subdural	subdural	JJ
cord-011302-pfepyvaw	144	33	haematoma	haematoma	NN
cord-011302-pfepyvaw	144	34	(	(	-LRB-
cord-011302-pfepyvaw	144	35	DECSA	DECSA	NNP
cord-011302-pfepyvaw	144	36	trial	trial	NN
cord-011302-pfepyvaw	144	37	)	)	-RRB-
cord-011302-pfepyvaw	144	38	:	:	:
cord-011302-pfepyvaw	144	39	study	study	NN
cord-011302-pfepyvaw	144	40	protocol	protocol	NN
cord-011302-pfepyvaw	144	41	for	for	IN
cord-011302-pfepyvaw	144	42	a	a	DT
cord-011302-pfepyvaw	144	43	randomised	randomised	JJ
cord-011302-pfepyvaw	144	44	controlled	control	VBN
cord-011302-pfepyvaw	144	45	trial	trial	NN
cord-011302-pfepyvaw	144	46	International	International	NNP
cord-011302-pfepyvaw	144	47	Subarachnoid	Subarachnoid	NNP
cord-011302-pfepyvaw	144	48	Aneurysm	Aneurysm	NNP
cord-011302-pfepyvaw	144	49	Trial	Trial	NNP
cord-011302-pfepyvaw	144	50	(	(	-LRB-
cord-011302-pfepyvaw	144	51	ISAT	ISAT	NNP
cord-011302-pfepyvaw	144	52	)	)	-RRB-
cord-011302-pfepyvaw	144	53	of	of	IN
cord-011302-pfepyvaw	144	54	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	144	55	clipping	clipping	NN
cord-011302-pfepyvaw	144	56	versus	versus	IN
cord-011302-pfepyvaw	144	57	endovascular	endovascular	JJ
cord-011302-pfepyvaw	144	58	coiling	coiling	NN
cord-011302-pfepyvaw	144	59	in	in	IN
cord-011302-pfepyvaw	144	60	2143	2143	CD
cord-011302-pfepyvaw	144	61	patients	patient	NNS
cord-011302-pfepyvaw	144	62	with	with	IN
cord-011302-pfepyvaw	144	63	ruptured	ruptured	JJ
cord-011302-pfepyvaw	144	64	intracranial	intracranial	JJ
cord-011302-pfepyvaw	144	65	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	144	66	:	:	:
cord-011302-pfepyvaw	144	67	a	a	DT
cord-011302-pfepyvaw	144	68	randomised	randomised	JJ
cord-011302-pfepyvaw	144	69	trial	trial	NN
cord-011302-pfepyvaw	144	70	National	National	NNP
cord-011302-pfepyvaw	144	71	Institute	Institute	NNP
cord-011302-pfepyvaw	144	72	for	for	IN
cord-011302-pfepyvaw	144	73	Health	Health	NNP
cord-011302-pfepyvaw	144	74	and	and	CC
cord-011302-pfepyvaw	144	75	Clinical	Clinical	NNP
cord-011302-pfepyvaw	144	76	Excellence	Excellence	NNP
cord-011302-pfepyvaw	144	77	(	(	-LRB-
cord-011302-pfepyvaw	144	78	NICE	NICE	NNP
cord-011302-pfepyvaw	144	79	)	)	-RRB-
cord-011302-pfepyvaw	144	80	(	(	-LRB-
cord-011302-pfepyvaw	144	81	2014	2014	CD
cord-011302-pfepyvaw	144	82	)	)	-RRB-
cord-011302-pfepyvaw	145	1	Head	Head	NNP
cord-011302-pfepyvaw	145	2	injury	injury	NN
cord-011302-pfepyvaw	145	3	:	:	:
cord-011302-pfepyvaw	145	4	assessment	assessment	NN
cord-011302-pfepyvaw	145	5	and	and	CC
cord-011302-pfepyvaw	145	6	early	early	JJ
cord-011302-pfepyvaw	145	7	management	management	NN
cord-011302-pfepyvaw	145	8	clinical	clinical	JJ
cord-011302-pfepyvaw	145	9	guidelines	guideline	NNS
cord-011302-pfepyvaw	146	1	[	[	-LRB-
cord-011302-pfepyvaw	146	2	CG176	CG176	NNP
cord-011302-pfepyvaw	146	3	Subarachnoid	Subarachnoid	NNP
cord-011302-pfepyvaw	146	4	haemorrhage	haemorrhage	NN
cord-011302-pfepyvaw	146	5	in	in	IN
cord-011302-pfepyvaw	146	6	patients	patient	NNS
cord-011302-pfepyvaw	146	7	%	%	NN
cord-011302-pfepyvaw	146	8	3e	3e	NNP
cord-011302-pfepyvaw	146	9	or	or	CC
cord-011302-pfepyvaw	146	10	=	=	SYM
cord-011302-pfepyvaw	146	11	75	75	CD
cord-011302-pfepyvaw	146	12	years	year	NNS
cord-011302-pfepyvaw	146	13	:	:	:
cord-011302-pfepyvaw	146	14	clinical	clinical	JJ
cord-011302-pfepyvaw	146	15	course	course	NN
cord-011302-pfepyvaw	146	16	,	,	,
cord-011302-pfepyvaw	146	17	treatment	treatment	NN
cord-011302-pfepyvaw	146	18	and	and	CC
cord-011302-pfepyvaw	146	19	outcome	outcome	NN
cord-011302-pfepyvaw	147	1	The	the	DT
cord-011302-pfepyvaw	147	2	impact	impact	NN
cord-011302-pfepyvaw	147	3	of	of	IN
cord-011302-pfepyvaw	147	4	pre	pre	JJ
cord-011302-pfepyvaw	147	5	-	-	JJ
cord-011302-pfepyvaw	147	6	operative	operative	JJ
cord-011302-pfepyvaw	147	7	comprehensive	comprehensive	JJ
cord-011302-pfepyvaw	147	8	geriatric	geriatric	JJ
cord-011302-pfepyvaw	147	9	assessment	assessment	NN
cord-011302-pfepyvaw	147	10	on	on	IN
cord-011302-pfepyvaw	147	11	postoperative	postoperative	JJ
cord-011302-pfepyvaw	147	12	outcomes	outcome	NNS
cord-011302-pfepyvaw	147	13	in	in	IN
cord-011302-pfepyvaw	147	14	older	old	JJR
cord-011302-pfepyvaw	147	15	patients	patient	NNS
cord-011302-pfepyvaw	147	16	undergoing	undergo	VBG
cord-011302-pfepyvaw	147	17	scheduled	schedule	VBN
cord-011302-pfepyvaw	147	18	surgery	surgery	NN
cord-011302-pfepyvaw	147	19	:	:	:
cord-011302-pfepyvaw	147	20	a	a	DT
cord-011302-pfepyvaw	147	21	systematic	systematic	JJ
cord-011302-pfepyvaw	147	22	review	review	NN
cord-011302-pfepyvaw	147	23	A	a	DT
cord-011302-pfepyvaw	147	24	global	global	JJ
cord-011302-pfepyvaw	147	25	clinical	clinical	JJ
cord-011302-pfepyvaw	147	26	measure	measure	NN
cord-011302-pfepyvaw	147	27	of	of	IN
cord-011302-pfepyvaw	147	28	fitness	fitness	NN
cord-011302-pfepyvaw	147	29	and	and	CC
cord-011302-pfepyvaw	147	30	frailty	frailty	NN
cord-011302-pfepyvaw	147	31	in	in	IN
cord-011302-pfepyvaw	147	32	elderly	elderly	JJ
cord-011302-pfepyvaw	147	33	people	people	NNS
cord-011302-pfepyvaw	147	34	International	international	JJ
cord-011302-pfepyvaw	147	35	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	147	36	aneurysm	aneurysm	NN
cord-011302-pfepyvaw	147	37	trial	trial	NN
cord-011302-pfepyvaw	147	38	of	of	IN
cord-011302-pfepyvaw	147	39	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	147	40	clipping	clipping	NN
cord-011302-pfepyvaw	147	41	versus	versus	IN
cord-011302-pfepyvaw	147	42	endovascular	endovascular	JJ
cord-011302-pfepyvaw	147	43	coiling	coil	VBG
cord-011302-pfepyvaw	147	44	Use	use	NN
cord-011302-pfepyvaw	147	45	of	of	IN
cord-011302-pfepyvaw	147	46	drains	drain	NNS
cord-011302-pfepyvaw	147	47	versus	versus	IN
cord-011302-pfepyvaw	147	48	no	no	DT
cord-011302-pfepyvaw	147	49	drains	drain	NNS
cord-011302-pfepyvaw	147	50	after	after	IN
cord-011302-pfepyvaw	147	51	burr	burr	NN
cord-011302-pfepyvaw	147	52	-	-	HYPH
cord-011302-pfepyvaw	147	53	hole	hole	NN
cord-011302-pfepyvaw	147	54	evacuation	evacuation	NN
cord-011302-pfepyvaw	147	55	of	of	IN
cord-011302-pfepyvaw	147	56	chronic	chronic	JJ
cord-011302-pfepyvaw	147	57	subdural	subdural	JJ
cord-011302-pfepyvaw	147	58	haematoma	haematoma	NN
cord-011302-pfepyvaw	147	59	:	:	:
cord-011302-pfepyvaw	147	60	a	a	DT
cord-011302-pfepyvaw	147	61	randomised	randomised	JJ
cord-011302-pfepyvaw	147	62	controlled	control	VBN
cord-011302-pfepyvaw	147	63	trial	trial	NN
cord-011302-pfepyvaw	147	64	Minimally	minimally	RB
cord-011302-pfepyvaw	147	65	invasive	invasive	JJ
cord-011302-pfepyvaw	147	66	surgery	surgery	NN
cord-011302-pfepyvaw	147	67	for	for	IN
cord-011302-pfepyvaw	147	68	intracerebral	intracerebral	JJ
cord-011302-pfepyvaw	147	69	hemorrhage	hemorrhage	NN
cord-011302-pfepyvaw	148	1	Aneurysmal	aneurysmal	JJ
cord-011302-pfepyvaw	148	2	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	148	3	hemorrhage	hemorrhage	NN
cord-011302-pfepyvaw	148	4	in	in	IN
cord-011302-pfepyvaw	148	5	elderly	elderly	JJ
cord-011302-pfepyvaw	148	6	patients	patient	NNS
cord-011302-pfepyvaw	148	7	:	:	:
cord-011302-pfepyvaw	148	8	long	long	JJ
cord-011302-pfepyvaw	148	9	-	-	HYPH
cord-011302-pfepyvaw	148	10	term	term	NN
cord-011302-pfepyvaw	148	11	outcome	outcome	NN
cord-011302-pfepyvaw	148	12	and	and	CC
cord-011302-pfepyvaw	148	13	prognostic	prognostic	JJ
cord-011302-pfepyvaw	148	14	factors	factor	NNS
cord-011302-pfepyvaw	148	15	in	in	IN
cord-011302-pfepyvaw	148	16	an	an	DT
cord-011302-pfepyvaw	148	17	interdisciplinary	interdisciplinary	JJ
cord-011302-pfepyvaw	148	18	treatment	treatment	NN
cord-011302-pfepyvaw	148	19	approach	approach	NN
cord-011302-pfepyvaw	148	20	Importance	importance	NN
cord-011302-pfepyvaw	148	21	of	of	IN
cord-011302-pfepyvaw	148	22	frailty	frailty	NN
cord-011302-pfepyvaw	148	23	evaluation	evaluation	NN
cord-011302-pfepyvaw	148	24	in	in	IN
cord-011302-pfepyvaw	148	25	the	the	DT
cord-011302-pfepyvaw	148	26	prediction	prediction	NN
cord-011302-pfepyvaw	148	27	of	of	IN
cord-011302-pfepyvaw	148	28	the	the	DT
cord-011302-pfepyvaw	148	29	prognosis	prognosis	NN
cord-011302-pfepyvaw	148	30	of	of	IN
cord-011302-pfepyvaw	148	31	patients	patient	NNS
cord-011302-pfepyvaw	148	32	with	with	IN
cord-011302-pfepyvaw	148	33	chronic	chronic	JJ
cord-011302-pfepyvaw	148	34	subdural	subdural	JJ
cord-011302-pfepyvaw	148	35	hematoma	hematoma	NN
cord-011302-pfepyvaw	148	36	Oertel	Oertel	NNP
cord-011302-pfepyvaw	148	37	Matthias	Matthias	NNP
cord-011302-pfepyvaw	148	38	F	F	NNP
cord-011302-pfepyvaw	148	39	(	(	-LRB-
cord-011302-pfepyvaw	148	40	2012	2012	CD
cord-011302-pfepyvaw	148	41	)	)	-RRB-
cord-011302-pfepyvaw	149	1	Intracerebral	Intracerebral	NNP
cord-011302-pfepyvaw	149	2	hemorrhage	hemorrhage	NN
cord-011302-pfepyvaw	149	3	in	in	IN
cord-011302-pfepyvaw	149	4	the	the	DT
cord-011302-pfepyvaw	149	5	Very	Very	NNP
cord-011302-pfepyvaw	149	6	Old	Old	NNP
cord-011302-pfepyvaw	149	7	Endovascular	Endovascular	NNP
cord-011302-pfepyvaw	149	8	treatment	treatment	NN
cord-011302-pfepyvaw	149	9	of	of	IN
cord-011302-pfepyvaw	149	10	intracranial	intracranial	JJ
cord-011302-pfepyvaw	149	11	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	149	12	in	in	IN
cord-011302-pfepyvaw	149	13	elderly	elderly	JJ
cord-011302-pfepyvaw	149	14	patients	patient	NNS
cord-011302-pfepyvaw	149	15	Efficacy	Efficacy	NNP
cord-011302-pfepyvaw	149	16	and	and	CC
cord-011302-pfepyvaw	149	17	safety	safety	NN
cord-011302-pfepyvaw	149	18	of	of	IN
cord-011302-pfepyvaw	149	19	minimal	minimal	JJ
cord-011302-pfepyvaw	149	20	invasive	invasive	JJ
cord-011302-pfepyvaw	149	21	surgery	surgery	NN
cord-011302-pfepyvaw	149	22	treatment	treatment	NN
cord-011302-pfepyvaw	149	23	in	in	IN
cord-011302-pfepyvaw	149	24	hypertensive	hypertensive	JJ
cord-011302-pfepyvaw	149	25	intracerebral	intracerebral	JJ
cord-011302-pfepyvaw	149	26	hemorrhage	hemorrhage	NN
cord-011302-pfepyvaw	149	27	:	:	:
cord-011302-pfepyvaw	149	28	a	a	DT
cord-011302-pfepyvaw	149	29	systematic	systematic	JJ
cord-011302-pfepyvaw	149	30	review	review	NN
cord-011302-pfepyvaw	149	31	and	and	CC
cord-011302-pfepyvaw	149	32	meta	meta	NNP
cord-011302-pfepyvaw	149	33	-	-	HYPH
cord-011302-pfepyvaw	149	34	analysis	analysis	NN
cord-011302-pfepyvaw	150	1	The	the	DT
cord-011302-pfepyvaw	150	2	MRC	MRC	NNP
cord-011302-pfepyvaw	150	3	CRASH	crash	NN
cord-011302-pfepyvaw	150	4	trial	trial	NN
cord-011302-pfepyvaw	150	5	collaborators	collaborator	NNS
cord-011302-pfepyvaw	150	6	(	(	-LRB-
cord-011302-pfepyvaw	150	7	2020	2020	CD
cord-011302-pfepyvaw	150	8	)	)	-RRB-
cord-011302-pfepyvaw	151	1	Head	Head	NNP
cord-011302-pfepyvaw	151	2	Injury	Injury	NNP
cord-011302-pfepyvaw	151	3	Prognosis	prognosis	NN
cord-011302-pfepyvaw	151	4	,	,	,
cord-011302-pfepyvaw	151	5	CRASH	CRASH	NNP
cord-011302-pfepyvaw	151	6	Preoperative	Preoperative	NNP
cord-011302-pfepyvaw	151	7	frailty	frailty	NN
cord-011302-pfepyvaw	151	8	score	score	NN
cord-011302-pfepyvaw	151	9	for	for	IN
cord-011302-pfepyvaw	151	10	30-day	30-day	CD
cord-011302-pfepyvaw	151	11	morbidity	morbidity	NN
cord-011302-pfepyvaw	151	12	and	and	CC
cord-011302-pfepyvaw	151	13	mortality	mortality	NN
cord-011302-pfepyvaw	151	14	after	after	IN
cord-011302-pfepyvaw	151	15	cranial	cranial	NNP
cord-011302-pfepyvaw	151	16	neurosurgery	neurosurgery	NNP
cord-011302-pfepyvaw	151	17	Association	Association	NNP
cord-011302-pfepyvaw	151	18	of	of	IN
cord-011302-pfepyvaw	151	19	the	the	DT
cord-011302-pfepyvaw	151	20	modified	modify	VBN
cord-011302-pfepyvaw	151	21	frailty	frailty	NN
cord-011302-pfepyvaw	151	22	index	index	NN
cord-011302-pfepyvaw	151	23	with	with	IN
cord-011302-pfepyvaw	151	24	30-day	30-day	CD
cord-011302-pfepyvaw	151	25	surgical	surgical	JJ
cord-011302-pfepyvaw	151	26	readmission	readmission	NN
cord-011302-pfepyvaw	151	27	Head	Head	NNP
cord-011302-pfepyvaw	151	28	injury	injury	NN
cord-011302-pfepyvaw	151	29	in	in	IN
cord-011302-pfepyvaw	151	30	the	the	DT
cord-011302-pfepyvaw	151	31	elderly	elderly	JJ
cord-011302-pfepyvaw	152	1	:	:	:
cord-011302-pfepyvaw	152	2	what	what	WP
cord-011302-pfepyvaw	152	3	are	be	VBP
cord-011302-pfepyvaw	152	4	the	the	DT
cord-011302-pfepyvaw	152	5	outcomes	outcome	NNS
cord-011302-pfepyvaw	152	6	of	of	IN
cord-011302-pfepyvaw	152	7	neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	152	8	care	care	NN
cord-011302-pfepyvaw	152	9	?	?	.
cord-011302-pfepyvaw	153	1	Neurosurgical	neurosurgical	JJ
cord-011302-pfepyvaw	153	2	care	care	NN
cord-011302-pfepyvaw	153	3	in	in	IN
cord-011302-pfepyvaw	153	4	the	the	DT
cord-011302-pfepyvaw	153	5	elderly	elderly	JJ
cord-011302-pfepyvaw	153	6	:	:	:
cord-011302-pfepyvaw	154	1	increasing	increase	VBG
cord-011302-pfepyvaw	154	2	demands	demand	NNS
cord-011302-pfepyvaw	154	3	necessitate	necessitate	VBP
cord-011302-pfepyvaw	154	4	future	future	JJ
cord-011302-pfepyvaw	154	5	healthcare	healthcare	NN
cord-011302-pfepyvaw	154	6	planning	plan	VBG
cord-011302-pfepyvaw	154	7	Unruptured	unruptured	JJ
cord-011302-pfepyvaw	154	8	intracranial	intracranial	JJ
cord-011302-pfepyvaw	154	9	aneurysms	aneurysm	NNS
cord-011302-pfepyvaw	154	10	:	:	:
cord-011302-pfepyvaw	154	11	natural	natural	JJ
cord-011302-pfepyvaw	154	12	history	history	NN
cord-011302-pfepyvaw	154	13	,	,	,
cord-011302-pfepyvaw	154	14	clinical	clinical	JJ
cord-011302-pfepyvaw	154	15	outcome	outcome	NN
cord-011302-pfepyvaw	154	16	,	,	,
cord-011302-pfepyvaw	154	17	and	and	CC
cord-011302-pfepyvaw	154	18	risks	risk	NNS
cord-011302-pfepyvaw	154	19	of	of	IN
cord-011302-pfepyvaw	154	20	surgical	surgical	JJ
cord-011302-pfepyvaw	154	21	and	and	CC
cord-011302-pfepyvaw	154	22	endovascular	endovascular	JJ
cord-011302-pfepyvaw	154	23	treatment	treatment	NN
cord-011302-pfepyvaw	154	24	Significant	significant	JJ
cord-011302-pfepyvaw	154	25	increase	increase	NN
cord-011302-pfepyvaw	154	26	in	in	IN
cord-011302-pfepyvaw	154	27	acute	acute	JJ
cord-011302-pfepyvaw	154	28	subdural	subdural	JJ
cord-011302-pfepyvaw	154	29	hematoma	hematoma	NN
cord-011302-pfepyvaw	154	30	in	in	IN
cord-011302-pfepyvaw	154	31	octo	octo	NNP
cord-011302-pfepyvaw	154	32	-	-	:
cord-011302-pfepyvaw	154	33	and	and	CC
cord-011302-pfepyvaw	154	34	nonagenarians	nonagenarian	NNS
cord-011302-pfepyvaw	154	35	:	:	:
cord-011302-pfepyvaw	154	36	surgical	surgical	JJ
cord-011302-pfepyvaw	154	37	treatment	treatment	NN
cord-011302-pfepyvaw	154	38	,	,	,
cord-011302-pfepyvaw	154	39	functional	functional	JJ
cord-011302-pfepyvaw	154	40	outcome	outcome	NN
cord-011302-pfepyvaw	154	41	,	,	,
cord-011302-pfepyvaw	154	42	and	and	CC
cord-011302-pfepyvaw	154	43	predictors	predictor	NNS
cord-011302-pfepyvaw	154	44	in	in	IN
cord-011302-pfepyvaw	154	45	this	this	DT
cord-011302-pfepyvaw	154	46	patient	patient	JJ
cord-011302-pfepyvaw	154	47	cohort	cohort	NN
cord-011302-pfepyvaw	154	48	Acute	acute	JJ
cord-011302-pfepyvaw	154	49	subdural	subdural	JJ
cord-011302-pfepyvaw	154	50	hematoma	hematoma	NN
cord-011302-pfepyvaw	154	51	in	in	IN
cord-011302-pfepyvaw	154	52	patients	patient	NNS
cord-011302-pfepyvaw	154	53	on	on	IN
cord-011302-pfepyvaw	154	54	oral	oral	JJ
cord-011302-pfepyvaw	154	55	anticoagulant	anticoagulant	NN
cord-011302-pfepyvaw	154	56	therapy	therapy	NN
cord-011302-pfepyvaw	154	57	:	:	:
cord-011302-pfepyvaw	154	58	management	management	NN
cord-011302-pfepyvaw	154	59	and	and	CC
cord-011302-pfepyvaw	154	60	outcome	outcome	NN
cord-011302-pfepyvaw	155	1	The	the	DT
cord-011302-pfepyvaw	155	2	modified	modify	VBN
cord-011302-pfepyvaw	155	3	frailty	frailty	NN
cord-011302-pfepyvaw	155	4	index	index	NN
cord-011302-pfepyvaw	155	5	and	and	CC
cord-011302-pfepyvaw	155	6	30-day	30-day	CD
cord-011302-pfepyvaw	155	7	adverse	adverse	JJ
cord-011302-pfepyvaw	155	8	events	event	NNS
cord-011302-pfepyvaw	155	9	in	in	IN
cord-011302-pfepyvaw	155	10	oncologic	oncologic	NNP
cord-011302-pfepyvaw	155	11	neurosurgery	neurosurgery	NNP
cord-011302-pfepyvaw	156	1	A	a	DT
cord-011302-pfepyvaw	156	2	prognostic	prognostic	JJ
cord-011302-pfepyvaw	156	3	model	model	NN
cord-011302-pfepyvaw	156	4	for	for	IN
cord-011302-pfepyvaw	156	5	early	early	JJ
cord-011302-pfepyvaw	156	6	post	post	JJ
cord-011302-pfepyvaw	156	7	-	-	JJ
cord-011302-pfepyvaw	156	8	treatment	treatment	JJ
cord-011302-pfepyvaw	156	9	outcome	outcome	NN
cord-011302-pfepyvaw	156	10	of	of	IN
cord-011302-pfepyvaw	156	11	elderly	elderly	JJ
cord-011302-pfepyvaw	156	12	patients	patient	NNS
cord-011302-pfepyvaw	156	13	with	with	IN
cord-011302-pfepyvaw	156	14	aneurysmal	aneurysmal	NNP
cord-011302-pfepyvaw	156	15	subarachnoid	subarachnoid	NN
cord-011302-pfepyvaw	156	16	hemorrhage	hemorrhage	NN